var title_f33_6_33888="Hypocalcemia tutorial";
var content_f33_6_33888=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F59063&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F59063&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hypocalcemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 420px; height: 87px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    QT interval prolongation is the hallmark of hypocalcemia. In this example, the corrected QT interval is &gt;0.6 seconds (normal &le;0.44 seconds).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33888=[""].join("\n");
var outline_f33_6_33888=null;
var title_f33_6_33889="Heterotopic pregnancy";
var content_f33_6_33889=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F65256&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F65256&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Heterotopic pregnancy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 393px; height: 315px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Heterotopic pregnancy at 6 weeks gestational age in a patient undergoing in vitro fertilization. Note the two intrauterine gestational sacs (arrowheads) and an echogenic ring-like mass (arrow) outside of the uterus with adjacent blood clot.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Deborah Levine, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33889=[""].join("\n");
var outline_f33_6_33889=null;
var title_f33_6_33890="Colovesical fistula BE";
var content_f33_6_33890=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F69515&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F69515&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Barium enema of colovesical fistula",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A barium enema in a 54-year-old woman with pneumaturia and left lower quadrant pain reveals a fistulous tract arising in the mid-sigmoid colon (red arrow), passing into an abscess cavity (black arrow), and then into the bladder where contrast is also seen (blue arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33890=[""].join("\n");
var outline_f33_6_33890=null;
var title_f33_6_33891="Doppler effect echocardiography";
var content_f33_6_33891=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F70672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F70672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Doppler effect with moving structures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 417px; height: 493px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pairs of transmitting (T) and receiving (R) transducers illustrate the Doppler effect as it occurs in relationship to targets that are stationary, moving toward, or moving away from the transducer. With a stationary target (panel A), the carrier frequency [f(t)] from the transmitting transducer strikes the target and is reflected back to the receiving transducer at the reflected frequency [f(r)], which is unaltered. An increase in f(r) is seen with a target moving toward the transducer (panel B), while f(r) is reduced with a target moving away from the transducer (panel C). In all cases, the extent to which f(t) is increased or reduced is proportional to the velocity of the target.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33891=[""].join("\n");
var outline_f33_6_33891=null;
var title_f33_6_33892="Butalbital compound: Patient drug information";
var content_f33_6_33892=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Butalbital compound: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/15/36087?source=see_link\">",
"     see \"Butalbital compound: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F143699\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Fiorinal&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F143700\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Fiorinal&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10011581\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10011583\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat tension headaches.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10011582\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701672",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to butalbital, aspirin, caffeine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703810",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have porphyria.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10011587\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697693",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may be habit-forming with long-term use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697302",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor. You may be more sensitive to this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696708",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Birth control pills and other hormone-based birth control may not work to stop pregnancy. Use 2 kinds of birth control while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10011588\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10011590\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699001",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Ringing in ears.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10011585\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698544",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a diary of your headaches.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10011586\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10011591\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10011592\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11563 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-AE2128909E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33892=[""].join("\n");
var outline_f33_6_33892=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143699\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F143700\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011581\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011583\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011582\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011587\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011588\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011590\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011585\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011586\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011591\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10011592\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?35/15/36087?source=related_link\">",
"      Butalbital compound: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_6_33893="CMV esophagitis Light";
var content_f33_6_33893=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F52984&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F52984&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CMV esophagitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 317px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Light micrograph from a patient with esophagitis due to cytomegalovirus (CMV) shows mucosal inflammation and large cells containing eosinophilic intranuclear and basophilic intracytoplasmic inclusions (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Odze, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33893=[""].join("\n");
var outline_f33_6_33893=null;
var title_f33_6_33894="Liothyronine: Pediatric drug information";
var content_f33_6_33894=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Liothyronine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?1/51/1846?source=see_link\">",
"    see \"Liothyronine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?43/27/44468?source=see_link\">",
"    see \"Liothyronine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5709013\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F189046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Cytomel&reg;;",
"     </li>",
"     <li>",
"      Triostat&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F189047\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Cytomel&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1059834\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Thyroid Product",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11443850\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Congenital hypothyroidism:",
"     </b>",
"     Oral: 5 mcg/day; increase by 5 mcg every 3 days to a maximum dosage of 20 mcg/day;",
"     <b>",
"      Note:",
"     </b>",
"     AAP recommends levothyroxine over liothyronine for treatment of hypothyroidism in neonates (AAP, 2006)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Postcardiac surgery replacement:",
"     </b>",
"     Limited data available; optimal dosage not established; further studies needed:  Continuous I.V. infusion: 0.05-0.15 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     adjusted to maintain a serum T",
"     <sub>",
"      3",
"     </sub>",
"     concentration 80-200 ng/dL; dosing based on experience in five neonates who, on postoperative days 0-2, required mechanical ventilation and exhibited total serum T",
"     <sub>",
"      3",
"     </sub>",
"     &lt;60 ng/dL (Chowdhury, 2001; Dimmick, 2008)",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1059826\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?1/51/1846?source=see_link\">",
"      see \"Liothyronine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Congenital hypothyroidism:",
"     </b>",
"     Infants and Children &lt;3 years: Oral: 5 mcg/day; increase by 5 mcg every 3 days to a maximum dosage of 20 mcg/day for infants, 50 mcg/day for children 1-3 years of age",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypothyroidism:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: Oral: 5 mcg/day increase in 5 mcg/day increments every 3-4 days;",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Usual maintenance dose:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants: 20 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Children 1-3 years: 50 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Children &gt;3 years: Full adult dosage may be necessary",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: Oral: 25 mcg/day increase in 12.5-25 mcg/day increments every 1-2 weeks to a maximum of 100 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Goiter, nontoxic:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children: Oral: 5 mcg/day increase in 5 mcg/day increments every 1-2 weeks; usual maintenance dose 15-20 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: Oral: 5 mcg/day; increase in 5-10 mcg/day increments every 1-2 weeks; when 25 mcg is reached, increase dosage in 12.5-25 mcg increments every 1-2 weeks; usual maintenance dosage: 75 mcg/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      T",
"      <sub>",
"       3",
"      </sub>",
"      suppression test:",
"     </b>",
"     Adults: Oral: 75-100 mcg/day for 7 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Myxedema coma:",
"     </b>",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: 25-50 mcg; reduce dosage in patients with known or suspected cardiovascular disease to 10-20 mcg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Normally, at least 4 hours should be allowed between I.V. doses to adequately assess therapeutic response and no more than 12 hours should elapse between doses to avoid fluctuations in hormone levels.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Oral (",
"     <b>",
"      Note:",
"     </b>",
"     Due to potential poor oral absorption in the acute phase of myxedema, oral therapy should be avoided until the clinical situation has been stabilized): 5 mcg/day; increase in 5-10 mcg/day increments every 1-2 weeks; when 25 mcg/day is reached; increase by 5-25 mcg/day increments every 1-2 weeks; usual maintenance dose: 50-100 mcg/day",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F189023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 10 mcg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Triostat&reg;: 10 mcg/mL (1 mL) [contains ethanol 6.8%]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 5 mcg, 25 mcg, 50 mcg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cytomel&reg;: 5 mcg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cytomel&reg;: 25 mcg, 50 mcg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F189008\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1059838\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Administer on an empty stomach",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: I.V.: For I.V. use only; do not administer SubQ or I.M.; should not be admixed with other solutions",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1059830\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store tablets at controlled room temperature; refrigerate parenteral solution at temperatures between 2&deg;C and 8&deg;C (36&deg;F to 46&deg;F)",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1059837\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Replacement or supplemental therapy in congenital or acquired hypothyroidism, treatment or prevention of euthyroid goiters including thyroid nodules and chronic lymphocytic thyroiditis; as a diagnostic aid in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F189090\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Liothyronine may be confused with levothyroxine",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       T3 is an error-prone abbreviation (mistaken as acetaminophen and codeine [ie, Tylenol&reg; #3])",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F189089\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arrhythmia, cardiopulmonary arrest, hypotension, MI, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Allergic skin reactions, angina, CHF, fever, hypertension, phlebitis, twitching",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1059842\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to liothyronine sodium or any component; recent MI or thyrotoxicosis; uncorrected adrenal insufficiency",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1059825\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with extreme caution in patients with cardiovascular disease, adrenal insufficiency, or coronary artery disease; use with extreme caution in patients receiving digoxin or vasopressors; use with caution in patients with diabetes mellitus and diabetes insipidus as symptoms of their disease may be exaggerated or aggravated; myxedematous patients are very sensitive to thyroid supplements; initiate therapy at very low doses and increase gradually",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1059824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not for use in the treatment of obesity or for weight loss",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; in euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction; larger doses may produce serious or even life-threatening toxic effects particularly when used with some anorectic drugs (sympathomimetic amines). Short duration of action permits more rapid assessment of dosage changes and rapid diminution of adverse effects upon discontinuation; transient partial loss of hair in pediatrics may be seen in the first few months of therapy.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299607\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F189017\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bile Acid Sequestrants: May decrease the serum concentration of Thyroid Products. Management: Administer oral thyroid products at least 4 h prior to colesevelam, and at least 1 h before or 4-6 h after cholestyramine.  Specific recommendations for colestipol are not available. Monitor for decreased concentrations/effects of the thyroid product.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Polystyrene Sulfonate: May decrease the serum concentration of Thyroid Products. Management: To minimize risk of interaction, separate dosing of oral calcium polystyrene sulfonate and thyroid products (eg, levothyroxine) or administer calcium polystyrene sulfonate rectally. Monitor for signs/symptoms of hypothyroidism with concomitant use (oral).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Salts: May diminish the therapeutic effect of Thyroid Products. Management: Separate the doses of the thyroid product and the oral calcium supplement by at least 4 hours.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May decrease the serum concentration of Thyroid Products.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Estrogen Derivatives: May diminish the therapeutic effect of Thyroid Products.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May decrease the serum concentration of Thyroid Products. Phenytoin may also displace thyroid hormones from protein binding sites.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lanthanum: May decrease the serum concentration of Thyroid Products. Management: Administer oral thyroid products at least two hours before or after lanthanum.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May decrease the serum concentration of Thyroid Products. Phenytoin may also displace thyroid hormones from protein binding sites.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rifampin: May decrease the serum concentration of Thyroid Products.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Iodide I131: Thyroid Products may diminish the therapeutic effect of Sodium Iodide I131.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Polystyrene Sulfonate: May decrease the serum concentration of Thyroid Products. Management: To minimize risk of interaction, separate dosing of oral sodium polystyrene sulfonate and thyroid products (e.g., levothyroxine) or administer sodium polystyrene sulfonate rectally. Monitor for signs/symptoms of hypothyroidism with concomitant use (oral).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: Thyroid Products may increase the metabolism of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dyphylline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Thyroid Products may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1059844\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Limit intake of goitrogenic foods (asparagus, cabbage, peas, turnip greens, broccoli, spinach, brussel sprouts, lettuce, soybeans)",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F189019\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F189034\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Endogenous thyroid hormones minimally cross the placenta; the fetal thyroid becomes active around the end of the first trimester. Liothyronine has not been found to increase the risk of teratogenic or adverse effects following maternal use during pregnancy.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Uncontrolled maternal hypothyroidism may result in adverse neonatal and maternal outcomes. To prevent adverse events, normal maternal thyroid function should be maintained prior to conception and throughout pregnancy. Levothyroxine is considered the treatment of choice for the control of hypothyroidism during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1059833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     T",
"     <sub>",
"      3",
"     </sub>",
"     , TSH, heart rate, blood pressure, clinical signs of hypo- and hyperthyroidism; TSH is the most reliable guide for evaluating adequacy of thyroid replacement dosage. TSH may be elevated during the first few months of thyroid replacement despite patients being clinically euthyroid.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Suggested frequency for monitoring thyroid function tests in children: Every 1-2 months during the first year of life, every 2-3 months between ages 1-3 years, and every 3-12 months thereafter until growth is completed; repeat tests two weeks after any change in dosage.",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1059836\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <table border=\"1\" frame=\"void\" rules=\"all\">",
"     <caption style=\"text-align:center;\">",
"      Thyroid Function Tests",
"     </caption>",
"     <col align=\"left\" width=\"80\">",
"     </col>",
"     <col align=\"center\" width=\"100\">",
"     </col>",
"     <col align=\"left\" width=\"200\">",
"     </col>",
"     <tbody valign=\"top\">",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         T",
"         <sub>",
"          4",
"         </sub>",
"         (thyroxine)",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1-7 d",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         10.1-20.9 mcg/dL",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         8-14 d",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         9.8-16.6 mcg/dL",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1 mo to 1 y",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         5.5-16.0 mcg/dL",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         &gt;1 y",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         4.0-12.0 mcg/dL",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"       </td>",
"       <td align=\"left\">",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         FTI",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1-3 d",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         9.3-26.6",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1-4 wk",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         7.6-20.8",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1-4 mo",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         7.4-17.9",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         4-12 mo",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         5.1-14.5",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1-6 y",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         5.7-13.3",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         &gt;6 y",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         4.8-14.0",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"       </td>",
"       <td align=\"left\">",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         T",
"         <sub>",
"          3",
"         </sub>",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Newborns",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         100-470 ng/dL",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1-5 y",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         100-260 ng/dL",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         5-10 y",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         90-240 ng/dL",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         10 y to Adult",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         70-210 ng/dL",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"       </td>",
"       <td align=\"left\">",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         T",
"         <sub>",
"          3",
"         </sub>",
"         uptake",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         35%-45%",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"       </td>",
"       <td align=\"left\">",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         TSH",
"        </p>",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         Cord",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         3-22 micro international units/mL",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         1-3 d",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         &lt;40 micro international units/mL",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         3-7 d",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         &lt;25 micro international units/mL",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td align=\"left\">",
"       </td>",
"       <td align=\"center\">",
"        <p style=\"text-indent:0em;\">",
"         &gt;7 d",
"        </p>",
"       </td>",
"       <td align=\"left\">",
"        <p style=\"text-indent:0em;\">",
"         0-10 micro international units/mL",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1059823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Primary active compound is T",
"     <sub>",
"      3",
"     </sub>",
"     (triiodothyronine), which may be converted from T",
"     <sub>",
"      4",
"     </sub>",
"     (thyroxine) by deiodination in liver and peripheral tissues; exact mechanism of action is unknown; however, it is believed the thyroid hormone exerts its many metabolic effects through control of DNA transcription and protein synthesis; involved in normal metabolism, growth, and development; promotes gluconeogenesis, increases utilization and mobilization of glycogen stores, and stimulates protein synthesis, increases basal metabolic rate",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1059840\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V., Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Within a few hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect: Within 48 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Up to 72 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1059841\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: Well absorbed (&sim;85% to 90%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: In the liver to inactive compounds",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 25 hours (range: 16-49 hours); hypothyroid 1.4 days; hyperthyroid 0.6 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: 76% to 83% In urine",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1059832\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?43/27/44468?source=see_link\">",
"      see \"Liothyronine: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Do not change brands without physician's knowledge; report immediately to physician any chest pain, increased pulse, palpitations, heat intolerance, excessive sweating; do not discontinue without notifying physician",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1059843\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Equivalent doses: The following statement on relative potency of thyroid products is included in a joint statement by American Thyroid Association (ATA), American Association of Clinical Endocrinologists (AACE) and The Endocrine Society (TES): For purposes of conversion, levothyroxine sodium (T",
"     <sub>",
"      4",
"     </sub>",
"     ) 100 mcg is usually considered equivalent to desiccated thyroid 60 mg, thyroglobulin 60 mg, or liothyronine sodium (T",
"     <sub>",
"      3",
"     </sub>",
"     ) 25 mcg. However, these are rough guidelines only and do not obviate the careful re-evaluation of a patient when switching thyroid hormone preparations, including a change from one brand of levothyroxine to another. Joint position statement is available at file://www.thyroid.org/professionals/advocacy/04_12_08_thyroxine.html.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     A synthetic form of",
"     <i>",
"      L",
"     </i>",
"     -Triiodothyronine (T",
"     <sub>",
"      3",
"     </sub>",
"     ) can be used in patients allergic to products derived from pork or beef.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Several medications have effects on thyroid production or conversion. The impact in thyroid replacement has not been specifically evaluated, but patient response should be monitored:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Methimazole: Decreases thyroid hormone secretion, while propylthiouracil decrease thyroid hormone secretion and decreases conversion of T",
"     <sub>",
"      4",
"     </sub>",
"     to T",
"     <sub>",
"      3",
"     </sub>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Beta-adrenergic antagonists: Decrease conversion of T",
"     <sub>",
"      4",
"     </sub>",
"     to T",
"     <sub>",
"      3",
"     </sub>",
"     (dose related, propranolol &ge;160 mg/day); patients may be clinically euthyroid.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Iodide, iodine-containing radiographic contrast agents may decrease thyroid hormone secretion; may also increase thyroid hormone secretion, especially in patients with Graves' disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Other agents reported to impact on thyroid production/conversion include aminoglutethimide, amiodarone, chloral hydrate, diazepam, ethionamide, interferon-alpha, interleukin-2, lithium, lovastatin (case report), glucocorticoids (dose-related), mercaptopurine, sulfonamides, thiazide diuretics, and tolbutamide.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     In addition, a number of medications have been noted to cause transient depression in TSH secretion, which may complicate interpretation of monitoring tests for thyroid hormones, including corticosteroids, octreotide, and dopamine. Metoclopramide may increase TSH secretion.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics, Rose SR, Section on Endocrinology and Committee on Genetics, American Thyroid Association, et al, \"Update of Newborn Screening and Therapy for Congenital Hypothyroidism,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2006, 117(6):2290-303.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/6/33894/abstract-text/16740880/pubmed\" id=\"16740880\" target=\"_blank\">",
"        16740880",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chowdhury D, Ojamaa K, Parnell VA, et al, \"A Prospective Randomized Clinical Study of Thyroid Hormone Treatment After Operations for Complex Congenital Heart Disease,\"",
"      <i>",
"       J Thorac Cardiovasc Surg",
"      </i>",
"      , 2001, 122(5):1023-5",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/6/33894/abstract-text/11689811/pubmed\" id=\"11689811\" target=\"_blank\">",
"        11689811",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dimmick S, Badawi N, and Randell T, \"Thyroid Hormone Supplementation for the Prevention of Morbidity and Mortality in Infants Undergoing Cardiac Surgery,\"",
"      <i>",
"       Cochrane Database Syst Rev",
"      </i>",
"      , 2004, (3):CD004220.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?33/6/33894/abstract-text/15266523/pubmed\" id=\"15266523\" target=\"_blank\">",
"        15266523",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12557 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-199.231.185.123-B6CE745EC8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33894=[""].join("\n");
var outline_f33_6_33894=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5709013\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189046\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189047\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059834\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11443850\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059826\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189023\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189008\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059838\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059830\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059837\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189090\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189089\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059842\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059825\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059824\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299607\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189017\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059844\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189019\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189034\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059833\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059836\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059823\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059840\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059841\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059832\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1059843\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12557\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12557|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?1/51/1846?source=related_link\">",
"      Liothyronine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?43/27/44468?source=related_link\">",
"      Liothyronine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_6_33895="Cervical cytology: Evaluation of atypical squamous cells (ASC-US and ASC-H)";
var content_f33_6_33895=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cervical cytology: Evaluation of atypical squamous cells (ASC-US and ASC-H)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/6/33895/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33895/contributors\">",
"     Anne Kathryn Goodman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33895/contributors\">",
"     Christine H Holschneider, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/6/33895/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33895/contributors\">",
"     Barbara Goff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/6/33895/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33895/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?33/6/33895/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;On cytologic examination of the cervix, atypical squamous cells (ASC) display cellular abnormalities more marked than simple reactive changes, but not meeting criteria for squamous intraepithelial neoplasia (SIL). Current ASC terminology consists of ASC-US, which is qualified as \"of undetermined significance,\" and ASC-H, in which a high grade squamous intraepithelial lesion (HSIL) cannot be excluded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    ASC is the most common abnormal finding during cervical cancer screening: it is reported in about 5 percent of cervical screening tests [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/2\">",
"     2",
"    </a>",
"    ]. Unfortunately, ASC is a less reproducible diagnosis than other cytologic abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/3\">",
"     3",
"    </a>",
"    ] and is frequently associated with spontaneously resolving, self-limited disease.",
"   </p>",
"   <p>",
"    The American Society for Colposcopy and Cervical Pathology's (ASCCP) 2006 consensus guideline for the evaluation of women with minimally abnormal cervical cytology (ASC-US and ASC-H) is provided below [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/4\">",
"     4",
"    </a>",
"    ]. These are discussed below and can be found in algorithmic form online at",
"    <a class=\"external\" href=\"file://www.asccp.org/\">",
"     www.ASCCP.org",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    A guideline for routine screening for cervical cancer and interpretation of the cytology report are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/16/38154?source=see_link\">",
"     \"Screening for cervical cancer: Rationale and recommendations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/15/40185?source=see_link\">",
"     \"Cervical cytology: Interpretation of results\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26537698\">",
"    <span class=\"h1\">",
"     RISK OF CERVICAL INTRAEPITHELIAL NEOPLASIA OR CERVICAL CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of invasive cervical cancer in women with ASC results is low, but many will require treatment or surveillance for high-grade cervical intraepithelial neoplasia (CIN). A study of approximately one million cervical cytology specimens reported the following results of cervical biopsy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      ASC-US &ndash; CIN2 or more severe (15 percent); cervical cancer (0.2 percent); data were reported only for specimens that were positive for high risk subtypes of human papillomavirus infection (HPV)",
"     </li>",
"     <li>",
"      ASC-H &ndash; CIN2+ (38 percent); cervical cancer (2.7 percent); HPV high risk-positive specimens were associated with a higher incidence of CIN2+ than HPV-negative specimens (50 versus 11 percent) or cervical cancer (2.2 verus 1.0 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EVALUATION OF ASC-US",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three reasonable approaches to management of patients with atypical squamous cells of undetermined significance (ASC-US) are described below. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Evaluation strategies'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The preferred approach for women age 21 years or older with a cervical cytology finding of ASC-US is to have reflex human papillomavirus (HPV) testing (ie, collecting a specimen for HPV testing when the cytology sample is collected), but performing the HPV test only if the cytologic results are ASC-US. If testing for high risk strains of HPV testing is positive, women should undergo colposcopy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/4,6-9\">",
"     4,6-9",
"    </a>",
"    ]. Reflex testing in adult women saves the patient from the inconvenience of a second visit for HPV testing, is cost effective because this information allows 40 to 60 percent of patients to avoid colposcopy, and potentially decreases the number of patients lost to follow-up [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/10-12\">",
"     10-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data from the Atypical Squamous Cell of Undetermined",
"    <span class=\"nowrap\">",
"     Significance/Low-Grade",
"    </span>",
"    Squamous Intraepithelial Lesions Triage Study (ALTS) Group showed that HPV-reflex testing has the best test performance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/7\">",
"     7",
"    </a>",
"    ]. In this randomized trial, the sensitivity of the HPV-based approach for detecting CIN 3 or above was significantly higher than with immediate colposcopy (72 versus 54 percent), with a significant reduction in the need for colposcopy referral (56 versus 100 percent). The sensitivity of cytologic evaluation was 55 percent when patients were referred for HSIL or worse. For HPV-reflex testing and cytologic evaluation to have similar sensitivities, two cytology smears would have to be performed six months apart with colposcopy referral for ASC-US or above; this would result in a 67 percent rate of colposcopy referral.",
"   </p>",
"   <p>",
"    Meta-analyses including subsequent trials have affirmed these findings [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/8,13\">",
"     8,13",
"    </a>",
"    ]. Among women with initial ASC-US cytology, the HPV reflex testing (using the Hybrid Capture 2 assay) provided significantly higher sensitivity for detection of CIN 2,3 compared with repeat cervical cytology (95 versus 82 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/8\">",
"     8",
"    </a>",
"    ]). Specificity was moderate-to-poor for both approaches (67 and 58 percent, respectively), but was significantly higher in trials in which the mean age of subjects was older. Sensitivity was not affected by age.",
"   </p>",
"   <p>",
"    In addition, mathematical models have consistently shown that cervical cancer screening using reflex HPV-testing is the most cost-effective screening strategy for women in the United States diagnosed with ASC-US [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/10,11,14\">",
"     10,11,14",
"    </a>",
"    ]. Comparison groups included ignoring ASC as a potentially pathologic finding, immediate colposcopy, repeat cytology, and two visit HPV testing. However, the results of these cost analyses are influenced by the age of the population screened. Although HPV testing performs similarly for the detection of high-grade lesions in all age groups (&lt;25, 25-34, 35-44, 45-54, 55-64, &gt;64 years) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/15\">",
"     15",
"    </a>",
"    ], the rate of colposcopy referral is significantly lower in women &ge;29 years of age than in younger women because of the decreasing prevalence of HPV with age (",
"    <a class=\"graphic graphic_table graphicRef76523 \" href=\"mobipreview.htm?39/23/40315\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study by the ALTS Group provides large-scale evidence that the risk of prevalent or incipient cervical neoplasia is linked to the HPV type [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/17\">",
"     17",
"    </a>",
"    ]. Of 5060 patients with ASC-US or LSIL who participated in ALTS, almost 70 percent tested positive for at least one HPV type. Of those who tested positive, 44 percent were positive for a single type, the remainder tested positive for 2 to 12 HPV types. Women infected with HPV 16 alone had a two-year cumulative risk of &ge;CIN 2 and &ge;CIN 3 of 50.6 and 39.1 percent, respectively. Other high risk HPV types were associated with a much lower cumulative risk of CIN 2,3 (18.8 and 7.9 percent, respectively). The risk of CIN 3 in women infected with multiple high risk HPV types other than HPV-16 was higher than that in those infected with a single high risk type (10.9 versus 7.9 percent, respectively); but if the infection comprised both high and low risk types, then the risk was similar to that associated with the patient's highest risk type.",
"   </p>",
"   <p>",
"    If cervical cytology is performed in adolescents (defined as ages 13 to 20 according to the ASCCP guidelines), reflex HPV testing may be of little use as a means of triage, since as many as 80 percent may test positive for HPV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/18\">",
"     18",
"    </a>",
"    ]. Repeat cytology is preferred in this population. American College of Obstetricians and Gynecologists (ACOG) guidelines stress that HPV testing should not be used in patients younger than 21 years, and if inadvertently performed, a positive result should not influence management. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Adolescents'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Special circumstances, such as active cervicovaginal infection or atrophy, may defer immediate triage (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Special circumstances and populations'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Evaluation strategies",
"    </span>",
"    &nbsp;&mdash;&nbsp;For nonadolescent women, there are three acceptable management schemes for evaluation of ASC-US. Options for adolescents are described below (see",
"    <a class=\"local\" href=\"#H9\">",
"     'Adolescents'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Reflex HPV testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reflex HPV testing (also referred to as secondary HPV testing) is the collection a specimen for HPV testing when the cytology sample is collected, but performing the HPV test",
"    <strong>",
"     only",
"    </strong>",
"    if the cytologic results are ASC-US, as noted above. Positive or negative HPV testing results are defined as positive or negative for high-risk subtypes (",
"    <a class=\"graphic graphic_table graphicRef76394 \" href=\"mobipreview.htm?0/27/443\">",
"     table 2",
"    </a>",
"    ). HPV testing usually tests for these subtypes, and not for low-risk HPV subtypes or for a single subtype. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/32/35337?source=see_link&amp;anchor=H7#H7\">",
"     \"Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing\", section on 'HPV testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Based upon guidelines from the American Society for Colposcopy and Cervical Pathology and the American Cancer Society (",
"    <a class=\"graphic graphic_table graphicRef82951 \" href=\"mobipreview.htm?24/21/24925\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/19\">",
"     19",
"    </a>",
"    ]: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Positive HPV test &mdash; Women age 21 years or older with a positive HPV test are evaluated with colposcopy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/14/24808?source=see_link\">",
"       \"Colposcopy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Negative HPV test",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Ages 21 to 29 years &ndash; Repeat cervical cytology in three years",
"     </li>",
"     <li>",
"      Ages 30 to 65 years &ndash; Screen with cervical cytology and HPV testing in five years &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    HPV-negative ASC-US is usually due to disturbances in maturation or cellular changes related to inflammation or atrophy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    HPV testing instead of cytology at 12 months has been proposed since the specificity of HPV testing is high in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/21\">",
"     21",
"    </a>",
"    ]; however, the sensitivities of the two tests have not been compared in controlled trials. If HPV testing remains negative at 12 months, these authors have also proposed that the patient return to routine screening intervals, based upon her age and prior screening history.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5749506\">",
"    <span class=\"h4\">",
"     Persistent HPV-negative ASC-US",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some women have persistent HPV-negative ASC-US. This is most likely due to inflammation or atrophy. Such women can be followed with annual cervical cytology if there are no symptoms of postcoital or abnormal uterine bleeding and if a pelvic examination is normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Repeat cytology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cytologic evaluation can be repeated in 6 and 12 months and, if normal, routine screening may be resumed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/4,18\">",
"     4,18",
"    </a>",
"    ]. A second abnormal smear (ASC-US or greater) is evaluated with colposcopy. About 65 percent of women will be referred for colposcopy using this strategy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rationale for repeated cytologic evaluations is the potential that a significant abnormality will be missed on a single repeat smear (15 to 33 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/22\">",
"     22",
"    </a>",
"    ], as well as inter- and intraobserver variability in diagnosis of ASC. The disadvantages of this approach are the need for multiple follow-up visits, potential delay in histological diagnosis, and a lack of data regarding optimum frequency and duration of testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Immediate referral to colposcopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colposcopy with directed biopsies, as indicated, yields timely information about the presence or absence of significant disease. However, colposcopy is expensive, can be uncomfortable, and potentially leads to overdiagnosis and overtreatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/14/24808?source=see_link\">",
"     \"Colposcopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Special circumstances and populations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Special circumstances that should be considered include:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Adolescents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cervical cancer screening of adolescents (defined as ages 13 to 20 according to the ASCCP guidelines) is",
"    <strong>",
"     NOT",
"    </strong>",
"    recommended by the ACOG; the only exceptions to this are adolescents infected with human immunodeficiency virus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/18,23\">",
"     18,23",
"    </a>",
"    ]. This recommendation is consistent with guidelines for other professional societies. In the general adolescent patient population, the prevalence of transient HPV infection (and transient cytologic abnormality) is very high while the prevalence of invasive cancer is near zero [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/16/38154?source=see_link&amp;anchor=H22#H22\">",
"     \"Screening for cervical cancer: Rationale and recommendations\", section on 'Initial screening'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If cervical cytology is performed in adolescents, further evaluation of ASC-US should be performed with repeat cytology in one year rather with reflex HPV testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/23\">",
"     23",
"    </a>",
"    ]. This is consistent with ACOG and ASCCP guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/4,18,23,27\">",
"     4,18,23,27",
"    </a>",
"    ]. At that time, colposcopy is reasonable if cytology shows HSIL or greater, otherwise (ie, ASCUS, LSIL, or no intraepithelial neoplasia) repeating cytologic evaluation in another 12 months is appropriate. Persistence of ASC-US for 24 months or progression to a more severe abnormality warrants referral for colposcopy, given that transient HPV infections and the mild cytologic abnormalities associated with them typically will have resolved by this time [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Pregnant women",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women with ASC-US are managed in the same way as nonpregnant women, except endocervical curettage is not performed. However, it should be noted that pregnancy-related physiologic and anatomic changes result in the production of more metaplastic cells and reactive changes and inflammation make diagnosis of ASC more challenging in this population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Infection or reactive changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of infection or reactive changes does not preclude further evaluation of ASC-US. When an infectious organism is identified or suggested, the patient should be contacted to determine if she is symptomatic. Antibiotic therapy is generally indicated for symptomatic infections, as well as some asymptomatic infections [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/30\">",
"     30",
"    </a>",
"    ]. After treatment of the infection, evaluation of ASC-US is performed, as described above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Postmenopausal women",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postmenopausal women are managed the same way as premenopausal women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/4\">",
"     4",
"    </a>",
"    ]. Cellular changes (eg, nuclear enlargement) associated with postmenopausal vaginal atrophy may be mistaken for ASC. In the past, estrogen administration followed by repeat cytology was suggested to help distinguish atypical atrophic epithelium, which matured into normal squamous epithelium with estrogen therapy, from true intraepithelial neoplasia, which is not affected by estrogen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/31\">",
"     31",
"    </a>",
"    ]. However, this is no longer recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Human immunodeficiency virus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ASCCP 2006 consensus guidelines advise that immunosuppressed women, including women who are HIV positive, with ASC-US may be managed the same as women in the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/4,27\">",
"     4,27",
"    </a>",
"    ]. Women in this population do not appear to be at increased risk of CIN 2,3 or HPV positivity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/4/36934?source=see_link&amp;anchor=H4#H4\">",
"     \"Screening for cervical cancer in HIV infected women\", section on 'Evaluation of abnormal results'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Colposcopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The colposcopy and biopsy procedures are described in detail separately. Endocervical curettage (ECC) is not performed in pregnant women. In nonpregnant women, ECC is recommended if no lesion is identified or the examination is unsatisfactory, but may be performed even in the setting of a satisfactory colposcopy with identification of a lesion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/13,22\">",
"     13,22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/14/24808?source=see_link\">",
"     \"Colposcopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Management after colposcopy/biopsy",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       Colposcopy/biopsy",
"      </span>",
"      shows CIN 2 or 3 &mdash; CIN 2,3 is treated as appropriate. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/2/30762?source=see_link\">",
"       \"Cervical intraepithelial neoplasia: Management\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Colposcopy/biopsy",
"      </span>",
"      shows CIN 1 or less with",
"      <span class=\"nowrap\">",
"       negative/unknown",
"      </span>",
"      HPV &mdash; If",
"      <span class=\"nowrap\">",
"       colposcopy/biopsy",
"      </span>",
"      is normal (CIN 1 or less) and HPV testing was negative or not performed, then follow-up cytologic testing in 12 months is recommended, given that in this setting the risk of missing a significant abnormality is very low [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/4,27\">",
"       4,27",
"      </a>",
"      ]. There is no role for additional diagnostic excisional procedures in these women.",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Colposcopy/biopsy",
"      </span>",
"      shows CIN 1 or less with positive HPV &mdash; Eighty to 85 percent of women referred for colposcopy because of HPV DNA positive ASC-US or LSIL have CIN 1 or less detected on biopsy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/34,35\">",
"       34,35",
"      </a>",
"      ]. Of these women, 10 to 12 percent have histologically confirmed CIN 2,3 within two years of follow-up. Therefore, an effective method for monitoring these patients is important. It is acceptable to either repeat cytologic examination at 6 and 12 months or perform an HPV test at 12 months, with colposcopy for ASC or higher or a positive HPV test [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/4,27\">",
"       4,27",
"      </a>",
"      ]. Women with two consecutive negative cytology results or a negative HPV test can resume routine screening.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The only randomized trial evaluating approaches to post-colposcopy monitoring concluded that HPV testing at 12 months post-procedure with repeat colposcopic referral if the HPV result was positive for high risk types was more efficient than semiannual cytology or combined cytology and HPV DNA testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/34\">",
"     34",
"    </a>",
"    ]. Sensitivity for a single HPV DNA test at 12 months was 92 percent, with a 55 percent rate of colposcopy referral. To achieve comparable sensitivity with the other follow-up methods, more visits would be required and there would be a higher rate of colposcopy referral, 64 to 70 percent.",
"   </p>",
"   <p>",
"    Hormonal contraception is not contraindicated in HPV positive women with mild cervical abnormalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     EVALUATION OF ASC-H",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women (including adolescents) with ASC-H on cytologic examination should be referred for colposcopy and endocervical curettage (ECC is not performed in pregnancy), without HPV testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/4,27\">",
"     4,27",
"    </a>",
"    ]. Ten to 68 percent of these women will have CIN 2 or higher [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/37\">",
"     37",
"    </a>",
"    ]. Biopsy proven CIN 2,3 is treated, as appropriate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/2/30762?source=see_link\">",
"     \"Cervical intraepithelial neoplasia: Management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If no lesion or a CIN 1 lesion is identified, follow-up cytology in 6 and 12 months or HPV DNA testing in 12 months is acceptable. Colposcopy should be repeated if repeat cytology shows ASC-US or greater or for a positive HPV test result. Diagnostic excisional biopsy is not warranted because the likelihood that a CIN 2,3 lesion was missed is much lower than for women with HSIL and negative colposcopy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/60/6086?source=see_link\">",
"     \"Cervical cytology: Evaluation of low grade squamous intraepithelial lesions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The woman may return to routine surveillance after two cytologic tests negative for intraepithelial neoplasia or a negative HPV test.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;During pregnancy, a substantial increase in immature squamous metaplasia can mimic ASC-H and colposcopic findings may not be as reliable. One study showed that ASC-H in pregnant women had a lower positive predictive value for an underlying HSIL than in the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33895/abstract/38\">",
"     38",
"    </a>",
"    ]. Conservative management with colposcopy, but no excisional procedures, is always indicated for ASC-H during pregnancy, unless colposcopy or colposcopic biopsy suggest invasive disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atypical squamous cells (ASC) are classified as either ASC-US, which is qualified as \"of undetermined significance,\" or ASC-H, in which a high grade squamous intraepithelial lesion (HSIL) cannot be excluded. ASC requires further evaluation to exclude the presence of a precancerous or cancerous condition. (See",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Women with ASC-US",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The preferred approach for evaluation of women age 21 or older with ASC-US is reflex HPV testing with triage of women positive for high risk HPV types to colposcopy. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Evaluation of ASC-US'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women with biopsy proven CIN 2,3 are treated, as appropriate. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Management after colposcopy/biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women with CIN 1 or less and a positive HPV test can be followed with either repeat cytologic examination at 6 and 12 months or an HPV test at 12 months, with colposcopy for ASC or higher or for a positive HPV test. Women with two consecutive negative cytology results or a negative HPV test can resume routine cervical cancer screening. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Management after colposcopy/biopsy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Women with ASC-H",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Women with ASC-H should be referred for colposcopy and endocervical sampling. Biopsy proven CIN 2,3 is treated, as appropriate. If no lesion or a CIN 1 lesion is identified, follow-up with either cytology in 6 and 12 months or HPV DNA testing in 12 months is acceptable. Colposcopy is repeated if repeat cytology shows ASC-US or greater or for a positive HPV test result. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Evaluation of ASC-H'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/1\">",
"      Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287:2114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/2\">",
"      Cox JT. Management of women with cervical cytology interpreted as ASC-US or as ASC-H. Clin Obstet Gynecol 2005; 48:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/3\">",
"      Stoler MH, Schiffman M, Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001; 285:1500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/4\">",
"      Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007; 197:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/5\">",
"      Castle PE, Fetterman B, Thomas Cox J, et al. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer. Obstet Gynecol 2010; 116:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/6\">",
"      Wright TC Jr, Lorincz A, Ferris DG, et al. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 1998; 178:962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/7\">",
"      ASCUS-LSIL Traige Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003; 188:1383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/8\">",
"      Arbyn M, Buntinx F, Van Ranst M, et al. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004; 96:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/9\">",
"      Cox T, Cuzick J. HPV DNA testing in cervical cancer screening: from evidence to policies. Gynecol Oncol 2006; 103:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/10\">",
"      Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002; 287:2382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/11\">",
"      Kulasingam SL, Kim JJ, Lawrence WF, et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS). J Natl Cancer Inst 2006; 98:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/12\">",
"      Stout NK, Goldhaber-Fiebert JD, Ortendahl JD, Goldie SJ. Trade-offs in cervical cancer prevention: balancing benefits and risks. Arch Intern Med 2008; 168:1881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/13\">",
"      Arbyn M, Paraskevaidis E, Martin-Hirsch P, et al. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol 2005; 99:S7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/14\">",
"      Legood R, Gray A, Wolstenholme J, Moss S. Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies. BMJ 2006; 332:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/15\">",
"      Eltoum IA, Chhieng DC, Roberson J, et al. Reflex human papilloma virus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women. Cancer 2005; 105:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/16\">",
"      Sherman ME, Schiffman M, Cox JT, Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study Group. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst 2002; 94:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/17\">",
"      Wheeler CM, Hunt WC, Schiffman M, et al. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis 2006; 194:1291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/18\">",
"      Committee on Practice Bulletins--Gynecology. ACOG Practice Bulletin Number 131: Screening for cervical cancer. Obstet Gynecol 2012; 120:1222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/19\">",
"      Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/20\">",
"      Nucci MR, Crum CP. Redefining early cervical neoplasia: recent progress. Adv Anat Pathol 2007; 14:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/21\">",
"      Safaeian M, Solomon D, Wacholder S, et al. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance. Obstet Gynecol 2007; 109:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/22\">",
"      Slawson DC, Bennett JH, Herman JM. Follow-up Papanicolaou smear for cervical atypia: are we missing significant disease? A HARNET Study. J Fam Pract 1993; 36:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/23\">",
"      American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 463: Cervical cancer in adolescents: screening, evaluation, and management. Obstet Gynecol 2010; 116:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/24\">",
"      Boardman LA, Stanko C, Weitzen S, Sung CJ. Atypical squamous cells of undetermined significance: human papillomavirus testing in adolescents. Obstet Gynecol 2005; 105:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/25\">",
"      Sherman ME, Solomon D, Schiffman M, ASCUS LSIL Triage Study Group. Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol 2001; 116:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/26\">",
"      Wright JD, Pinto AB, Powell MA, et al. Atypical squamous cells of undetermined significance in girls and women. Obstet Gynecol 2004; 103:632.",
"     </a>",
"    </li>",
"    <li>",
"     www.ASCCP.org (Accessed on December 22, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/28\">",
"      Michael CW, Esfahani FM. Pregnancy-related changes: a retrospective review of 278 cervical smears. Diagn Cytopathol 1997; 17:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/29\">",
"      Pisharodi LR, Jovanoska S. Spectrum of cytologic changes in pregnancy. A review of 100 abnormal cervicovaginal smears, with emphasis on diagnostic pitfalls. Acta Cytol 1995; 39:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/30\">",
"      Connor JP, Elam G, Goldberg JM. Empiric vaginal metronidazole in the management of the ASCUS Papanicolaou smear: a randomized controlled trial. Obstet Gynecol 2002; 99:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/31\">",
"      Abati A, Jaffurs W, Wilder AM. Squamous atypia in the atrophic cervical vaginal smear: a new look at an old problem. Cancer 1998; 84:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/32\">",
"      Massad LS, Schneider MF, Watts DH, et al. HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance. J Womens Health (Larchmt) 2004; 13:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/33\">",
"      Kirby TO, Allen ME, Alvarez RD, et al. High-risk human papillomavirus and cervical intraepithelial neoplasia at time of atypical squamous cells of undetermined significance cytologic results in a population with human immunodeficiency virus. J Low Genit Tract Dis 2004; 8:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/34\">",
"      Guido R, Schiffman M, Solomon D, et al. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 2003; 188:1401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/35\">",
"      Cox JT, Schiffman M, Solomon D, ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003; 188:1406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/36\">",
"      Castle PE, Walker JL, Schiffman M, Wheeler CM. Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly abnormal cytology. Int J Cancer 2005; 117:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/37\">",
"      Bonvicino A, Huitron S, Fadare O. Papanicolaou test interpretations of \"atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion\" : an investigation of requisite duration and number of colposcopic procedures to a definitive diagnosis of high-grade dysplasia in routine practice. Cancer 2007; 111:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33895/abstract/38\">",
"      Onuma K, Saad RS, Kanbour-Shakir A, et al. Clinical implications of the diagnosis \"atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion\" in pregnant women. Cancer 2006; 108:282.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3214 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-FC043B0C43-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33895=[""].join("\n");
var outline_f33_6_33895=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26537698\">",
"      RISK OF CERVICAL INTRAEPITHELIAL NEOPLASIA OR CERVICAL CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EVALUATION OF ASC-US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Evaluation strategies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Reflex HPV testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H5749506\">",
"      Persistent HPV-negative ASC-US",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Repeat cytology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Immediate referral to colposcopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Special circumstances and populations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Adolescents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Pregnant women",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Infection or reactive changes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Human immunodeficiency virus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Colposcopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Management after colposcopy/biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      EVALUATION OF ASC-H",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Women with ASC-US",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Women with ASC-H",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/3214\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/3214|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/23/40315\" title=\"table 1\">",
"      ASCUS triage based on age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/27/443\" title=\"table 2\">",
"      Risk of cervical CA with HPV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/21/24925\" title=\"table 3\">",
"      US recs cerv cancer screen",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/32/35337?source=related_link\">",
"      Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/60/6086?source=related_link\">",
"      Cervical cytology: Evaluation of low grade squamous intraepithelial lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/15/40185?source=related_link\">",
"      Cervical cytology: Interpretation of results",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/2/30762?source=related_link\">",
"      Cervical intraepithelial neoplasia: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/14/24808?source=related_link\">",
"      Colposcopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/4/36934?source=related_link\">",
"      Screening for cervical cancer in HIV infected women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/16/38154?source=related_link\">",
"      Screening for cervical cancer: Rationale and recommendations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_6_33896="Continuous noninvasive ventilatory support for patients with neuromuscular or chest wall disease";
var content_f33_6_33896=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Continuous noninvasive ventilatory support for patients with neuromuscular or chest wall disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/6/33896/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33896/contributors\">",
"     John R Bach, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/6/33896/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33896/contributors\">",
"     Talmadge E King, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33896/contributors\">",
"     R Sean Morrison, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/6/33896/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33896/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?33/6/33896/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with neuromuscular or chest wall disease develop respiratory muscle dysfunction that can result in difficulty clearing airway secretions with ventilation-perfusion mismatching, and alveolar hypoventilation. Noninvasive ventilatory assistance is usually first needed at night, but eventually, daytime assistance may also be needed. Indeed, virtually all patients with neuromuscular disease except those with severe bulbar amyotrophic lateral sclerosis (ALS) can avoid tracheostomy indefinitely by using noninvasive inspiratory and expiratory aids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of daytime noninvasive ventilatory assistance when full ventilator setting nocturnal support is insufficient will be reviewed here. Nocturnal ventilatory support, the types of ventilators, and the role of tracheostomy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/36/41543?source=see_link\">",
"     \"Practical aspects of nocturnal noninvasive ventilation in neuromuscular and chest wall disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptomatic alveolar hypoventilation is the primary factor determining the need for ongoing nocturnal ventilatory assistance. Typical symptoms include fatigue, exertional dyspnea, reduced appetite, inattention, and impaired concentration and memory. Initially, hypoventilation occurs during rapid eye movement (REM) sleep and is manifest by oxyhemoglobin desaturation and hypercapnia. Hypoventilation subsequently extends throughout sleep and eventually into daytime hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/6/5222?source=see_link\">",
"     \"The effect of sleep in patients with neuromuscular and chest wall disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptoms and blood gas derangements related to chronic hypoventilation can be relieved by nocturnal noninvasive positive pressure ventilation (NPPV). When the need for ventilatory support extends into the daytime hours, the properly informed patient can use noninvasive respiratory muscle aids during the day to avoid respiratory failure and the need for tracheostomy ventilation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     TYPES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The respiratory muscles can be aided by manually or mechanically applying forces to the body or delivering intermittent pressure to the airway. Some devices assist inspiratory muscles, whereas others facilitate coughing, predominantly by assisting expiratory muscles. Specific types of useful devices include the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Devices that apply intermittent pressure changes directly to the airway (eg, mouthpiece and nasal noninvasive positive pressure ventilation [NPPV])",
"     </li>",
"     <li>",
"      Body ventilators (eg, intermittent abdominal pressure ventilator [IAPV])",
"     </li>",
"     <li>",
"      Manual and mechanical exsufflation devices that apply force directly to the body to mechanically displace respiratory muscles to increase cough flows (see",
"      <a class=\"local\" href=\"#H7\">",
"       'Cough assistance'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most useful of the daytime inspiratory aids are mouthpiece NPPV and the IAPV [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27095?source=see_link\">",
"     \"Types of noninvasive nocturnal ventilatory support in neuromuscular and chest wall disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Mouthpiece NPPV",
"    </span>",
"    &nbsp;&mdash;&nbsp;A convenient method of daytime ventilatory support involves the delivery of positive pressure via a mouthpiece kept adjacent to the mouth for easy access to assisted breaths as needed. Intermittent mouthpiece ventilation has been used in conjunction with nocturnal NPPV for up to 28 years of continuous noninvasive ventilation for patients with Duchenne muscular dystrophy (",
"    <a class=\"graphic graphic_picture graphicRef57248 \" href=\"mobipreview.htm?31/17/32020\">",
"     picture 1",
"    </a>",
"    ), 55 years for post-polio patients, 16 years for patients with Werdnig-Hoffmann disease (spinal muscular atrophy type 1), and years for high level spinal cord tetraplegia, as well as for others [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/8-11\">",
"     8-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one center, 98 patients with Duchenne muscular dystrophy required continuous NPPV including daytime mouthpiece NPPV and nocturnal nasal NPPV for a mean of 9 years and up to 28 years. Mouthpiece NPPV maintained normal alveolar ventilation for patients with as little as 0 mL of vital capacity (VC) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mouthpiece NPPV can also be used nocturnally with a lipseal retention mouthpiece (Malincrodt, Pickering, Ontario). As an alternative, interface designs that deliver air via both lipseal phalanges and nasal prongs provide closed systems of noninvasive ventilatory support with minimal",
"    <span class=\"nowrap\">",
"     strap/skin",
"    </span>",
"    pressure and have become more popular (",
"    <a class=\"graphic graphic_picture graphicRef70694 \" href=\"mobipreview.htm?39/62/40933\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Nasal NPPV",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal NPPV is used during daytime hours if neck rotation or lip strength is not adequate for the patient to grab a mouthpiece (",
"    <a class=\"graphic graphic_picture graphicRef80371 \" href=\"mobipreview.htm?8/45/8920\">",
"     picture 3",
"    </a>",
"    ). During periods of nasal congestion,",
"    <span class=\"nowrap\">",
"     mouthpiece/lipseal",
"    </span>",
"    NPPV can be substituted. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/36/41543?source=see_link\">",
"     \"Practical aspects of nocturnal noninvasive ventilation in neuromuscular and chest wall disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Intermittent abdominal pressure ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intermittent abdominal pressure ventilation (IAPV) is provided by a device that consists of a wide belt or girdle with an inflatable sac inside it (eg, Pneumobelt). The sac is cyclically inflated by air delivered from a portable positive pressure ventilator. Sac inflation compresses the abdomen, and the resulting movement of the abdominal contents elevates the diaphragm, forcing expiration to a volume less than functional residual capacity. With sac deflation, the diaphragm returns to its resting position and air enters the patient's upper airway. IAPV is only effective when the patient is in the sitting position. The patient can add to IAPV-provided volumes with spontaneous tidal volumes or by glossopharyngeal breathing. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27095?source=see_link&amp;anchor=H6#H6\">",
"     \"Types of noninvasive nocturnal ventilatory support in neuromuscular and chest wall disease\", section on 'Abdominal respirators'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     COUGH ASSISTANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ability to generate sufficient expiratory flow for effective coughing is the most important factor permitting use of noninvasive ventilation as an alternative to tracheostomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/8\">",
"     8",
"    </a>",
"    ]. An effective cough involves a deep inspiration or assisted insufflation, followed by the creation of sufficient thoracoabdominal pressure to generate an explosive decompression and high expiratory flows. Although noninvasive inspiratory aids can provide deep insufflations by air stacking, expiratory muscle aids are required to optimize cough peak flow rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For patients with a vital capacity of less than 1.5 liters, cough should be preceded by air stacking or a deep insufflation. A manual resuscitator (eg, Ambu bag) or portable ventilator can be used to deliver volumes of air consecutively for air stacking. Volumes are delivered to maximum lung inflation, that is, until the glottis can hold no additional air. Volume-cycled ventilators permit stacking of breaths to larger lung volumes to increase peak cough flows and are, therefore, preferred for assisted ventilation over pressure-cycling ventilators which do not permit breath stacking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Alternatively, the Cough-Assist&trade; (Respironics International Inc., Murrysville, Pa) can pressure-cycle single, deep insufflations which are then followed by deep exsufflations with concomitantly applied abdominal thrusts for mechanically assisted coughing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Manually assisted cough",
"    </span>",
"    &nbsp;&mdash;&nbsp;When patients with neuromuscular weakness are unable to generate adequate cough flow rates, their cough flow can be augmented by air stacking to deep lung volumes followed by applying forceful manual thrusts to the abdomen directed posterior and cephalad. Manually assisted coughing (also known as quad coughing) may be ineffective in the presence of severe scoliosis or severe impairment of bulbar-innervated muscles.",
"   </p>",
"   <p>",
"    Manually assisted coughing should be used cautiously following meals due to the risk of aspiration. Abdominal thrusts should also not be used following abdominal trauma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Mechanical insufflation-exsufflation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most effective method for generating adequate cough peak flow rates and clearing airway secretions is the use of mechanical insufflation-exsufflation (MI-E) in combination with manually assisted coughing. The CoughAssist&trade; can insufflate the lungs with positive pressures of 40 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O or more. Following insufflation, exsufflation is achieved by the pressure dropping to 40 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O or more below atmospheric pressure (ie, -40 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O) in 0.02 seconds to generate about 10 L per second of expiratory flow. An abdominal thrust is applied during the exsufflation for a \"mechanically assisted cough\" (MAC). The goal is to fully inflate then fully empty the lungs in 4 to 6 seconds.",
"   </p>",
"   <p>",
"    MI-E is used whenever the patient needs to cough or has airway mucus. When mucus plugs cause oxyhemoglobin desaturation, clearance of the secretions by MI-E improves vital capacity and oxyhemoglobin saturation (SpO",
"    <sub>",
"     2",
"    </sub>",
"    ). In one study, a 55 percent increase in VC was noted following MI-E in congested patients with neuromuscular conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/14\">",
"     14",
"    </a>",
"    ]. In another study, MI-E improved VC by 15 to 50 percent and normalized pulse oxyhemoglobin saturation (Sp0",
"    <sub>",
"     2",
"    </sub>",
"    ) in patients with neuromuscular disease who were in acute respiratory failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/15\">",
"     15",
"    </a>",
"    ]. MI-E applied through a tracheostomy tube also eliminates the need for tracheal suctioning and is greatly preferred by patients over deep suctioning. No pulmonary complications have been reported to result from the use of MI-E [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Glossopharyngeal breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both inspiratory and, indirectly, expiratory muscle activity can be assisted by glossopharyngeal breathing (GPB) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/16\">",
"     16",
"    </a>",
"    ]. GPB is described in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27095?source=see_link&amp;anchor=H10#H10\">",
"     \"Types of noninvasive nocturnal ventilatory support in neuromuscular and chest wall disease\", section on 'Glossopharyngeal breathing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    GPB can generate volumes for coughing that approach the deep lung volumes achieved by air stacking (2 to 3 L over vital capacity), depending on the number of \"gulps\" taken and their efficiency. Many patients have no ventilator free breathing ability other than by GPB. It can also provide security in the event of sudden ventilator failure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PATIENT SELECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with the diagnoses listed in the table (",
"    <a class=\"graphic graphic_table graphicRef66520 \" href=\"mobipreview.htm?5/41/5788\">",
"     table 1",
"    </a>",
"    ) are often candidates for the use of noninvasive aids. Ventilatory support either in the acute setting or on a long-term basis can usually be managed by noninvasive positive pressure ventilation (NPPV) as an alternative to endotracheal intubation or tracheostomy if the following criteria are met:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient is mentally competent, cooperative, and not using heavy sedation or opiates.",
"     </li>",
"     <li>",
"      Supplemental domiciliary oxygen therapy is avoided. Supplemental oxygen depresses ventilatory drive increasing hypercapnia and rendering the pulse oximeter useless for monitoring decreases in alveolar ventilation and increases in secretions, both of which cause the SpO",
"      <sub>",
"       2",
"      </sub>",
"      to decrease below 95 percent. Supplemental O",
"      <sub>",
"       2",
"      </sub>",
"      is both unnecessary in the absence of severe intrinsic lung disease and potentially harmful [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Oxygen saturation is maintained above 94 percent by aggressive, mechanically assisted coughing (MAC), the combination of mechanical insufflation-exsufflation with an exsufflation-timed abdominal thrust, as necessary. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Cough assistance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bulbar muscle function is adequate to avoid continuous aspiration that would cause the oxyhemoglobin saturation baseline to decrease below 95 percent.",
"     </li>",
"     <li>",
"      There is no significant risk of substance abuse or uncontrollable seizures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     PRACTICAL ASPECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with neuromuscular and chest wall disease usually tolerate alveolar hypoventilation until acute respiratory distress is provoked by an otherwise benign upper respiratory tract infection, or possibly by an elective surgical procedure requiring general anesthesia. Ventilator-free breathing may or may not be possible during and following the acute episode.",
"   </p>",
"   <p>",
"    To avoid the need for intubation, patients should be trained in noninvasive ventilation and assisted coughing before any such episode occurs, and should use them sufficiently aggressively to maintain oxyhemoglobin saturation (SpO",
"    <sub>",
"     2",
"    </sub>",
"    ) over 94 percent during the episode. Thus, home monitoring of patients requiring daytime noninvasive ventilation and manually assisted cough should include measurement of pulse oxyhemoglobin saturation during intercurrent respiratory tract infections.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulse oxyhemoglobin saturation &ndash; SpO",
"      <sub>",
"       2",
"      </sub>",
"      monitoring is useful to gauge the extent of diurnal or nocturnal hypoventilation and the extent of airway congestion. An oximeter that can average data hourly during nocturnal monitoring is useful for quantitation purposes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patient monitoring also should include regular clinic evaluations of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vital capacity (VC) &ndash; Vital capacity is measured in sitting and supine positions and with thoracolumbar bracing on and off (if applicable).",
"     </li>",
"     <li>",
"      The maximum insufflation capacity &ndash; The maximum insufflation capacity (MIC) represents the maximum quantity of air that the patient can hold with a closed glottis. The air is obtained by some combination of air stacking (receiving and holding insufflations with a closed glottis until maximum insufflation is achieved) and glossopharyngeal breathing. The greater the MIC, the greater the cough peak flow rates and the potential to increase voice volume and maintain pulmonary compliance (by decreasing microatelectasis and providing a greater range of motion to the lungs and chest wall articulations).",
"     </li>",
"     <li>",
"      Capnography &ndash; Capnography is useful for demonstrating diurnal and nocturnal hypercapnia. Daytime maximum end-tidal PCO",
"      <sub>",
"       2",
"      </sub>",
"      above 45 mmHg indicates more severe hypercapnia and oxyhemoglobin desaturation below 95 percent during sleep.",
"     </li>",
"     <li>",
"      Cough peak flow rates &ndash; Cough peak flow rates, both unassisted and assisted by air stacking to deep lung insufflation followed by abdominal thrust, are measured using a peak flow meter (eg, Assess peak flow meter) or any digital spirometer that measures expiratory flow. Effective rates range from 300 to 1200",
"      <span class=\"nowrap\">",
"       L/min",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/18\">",
"       18",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Manually assisted cough'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Preventing pneumonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of developing pneumonia during an upper respiratory tract infection is inversely related to cough peak flow rates and the ability to use manually assisted coughing.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients are at high risk for developing pneumonia during an upper respiratory tract infection when cough peak flow rates are below 300",
"      <span class=\"nowrap\">",
"       L/min",
"      </span>",
"      and pneumonia appears to be inevitable at rates below 160",
"      <span class=\"nowrap\">",
"       L/min",
"      </span>",
"      unless using mechanical insufflation-exsufflation effectively. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Mechanical insufflation-exsufflation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the vital capacity (VC) is relatively preserved, typically 2 L or more, a low cough peak flow rate is indicative of severe bulbar muscle dysfunction or airway obstruction from another etiology. Although manually assisted coughing and mechanical insufflation-exsufflation may be helpful, significant benefit is often precluded by the patient's inability to maintain upper airway patency in order to permit the flows necessary to eliminate airway secretions. This happens almost exclusively in bulbar amyotrophic lateral sclerosis (ALS).",
"     </li>",
"     <li>",
"      If the VC is below 40 percent of predicted and assisted cough peak flow rates are below 300",
"      <span class=\"nowrap\">",
"       L/min,",
"      </span>",
"      the patient is at risk for pneumonia and respiratory failure when VC and cough flows decrease further during upper respiratory tract infections. This can usually be prevented by an effective protocol of respiratory muscle assistance [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/8,19\">",
"       8,19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Protocol",
"    </span>",
"    &nbsp;&mdash;&nbsp;At our institution, patients obtain an oximeter and have rapid access to a portable volume ventilator and a CoughAssist&trade; when their vital capacities are below 40 percent of predicted or cough peak flows are below 270",
"    <span class=\"nowrap\">",
"     L/min.",
"    </span>",
"    A volume-cycled ventilator is used for ventilatory assistance because of the need for these patients to air stack ventilator-delivered volumes to maximum insufflation levels to optimize peak cough flow rates, voice volume, and lung elasticity. The low pressure alarm can also be useful to assure safe and effective nocturnal utilization of noninvasive positive pressure ventilation (NPPV) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The patient is instructed to maintain SpO",
"    <sub>",
"     2",
"    </sub>",
"    always greater than 94 percent without the aid of supplemental oxygen in the home. The patient is also told that a SpO",
"    <sub>",
"     2",
"    </sub>",
"    below 95 percent can result from three possible causes: hypoventilation, bronchial mucus plugging, or intrinsic lung disease. The last of these causes usually involves atelectasis or pneumonia, which results from ineffective airway mucus clearance and inadequate alveolar ventilation.",
"   </p>",
"   <p>",
"    During upper respiratory infections, even when not otherwise necessary, continuous NPPV is often required to maintain alveolar ventilation and to permit stacking of ventilator delivered volumes to optimize cough flows. When NPPV is used, oxyhemoglobin desaturation is usually due to mucus plugging, not hypoventilation. The SpO",
"    <sub>",
"     2",
"    </sub>",
"    returns to baseline as the airway mucus is eliminated by some combination of assisted coughing and mechanical insufflation-exsufflation. Properly equipped and instructed patients with assisted cough peak flow rates greater than 160",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    very infrequently develop pneumonia or require hospitalization for respiratory management.",
"   </p>",
"   <p>",
"    If the SpO",
"    <sub>",
"     2",
"    </sub>",
"    remains",
"    <strong>",
"     below 95 percent",
"    </strong>",
"    despite use of NPPV and aggressive assisted coughing, pneumonia is likely to be present, and hospitalization is often necessary. As the infection resolves, the patient usually weans to the pre-morbid noninvasive ventilation regimen. In contrast, patients who undergo tracheostomy typically remain continuously ventilator-dependent indefinitely.",
"   </p>",
"   <p>",
"    Gradually, as patients become symptomatic from alveolar hypoventilation despite nocturnal use of noninvasive ventilation, they become full-time NPPV users. The extent of daytime use can be guided by oximetry feedback. The patient is provided with a 15 mm angled mouthpiece for convenient daytime ventilatory support. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/36/41543?source=see_link\">",
"     \"Practical aspects of nocturnal noninvasive ventilation in neuromuscular and chest wall disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Tracheostomy to noninvasive ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with neuromuscular or chest wall disease who have a tracheostomy for mechanical ventilation are candidates for noninvasive positive pressure ventilation (NPPV) and decannulation of their trachea, if the criteria in the table (",
"    <a class=\"graphic graphic_table graphicRef64672 \" href=\"mobipreview.htm?22/5/22619\">",
"     table 2",
"    </a>",
"    ) are fulfilled. Specifically, patients should have sufficiently intact bulbar musculature to maintain their arterial oxygen saturation (SpO",
"    <sub>",
"     2",
"    </sub>",
"    ) at 95 percent or higher in ambient air with or without ventilator use. This includes patients with spinal cord injury, previous poliomyelitis, type II or III spinal muscular atrophy, and most myopathies including for Duchenne muscular dystrophy. Even individuals with non-bulbar ALS who undergo tracheostomy during an episode of acute respiratory failure have improved quality of life with decannulation and transition to the use of noninvasive respiratory muscle aids.",
"   </p>",
"   <p>",
"    The following are key steps in the transition from tracheostomy to noninvasive aids:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aggressive mechanical insufflation-exsufflation (MI-E) via the tracheostomy tube (with cuff inflated, if present) is performed until SpO",
"      <sub>",
"       2",
"      </sub>",
"      is normal without supplemental oxygen. If the SpO",
"      <sub>",
"       2",
"      </sub>",
"      cannot be maintained above 94 percent in ambient air, the transition to NPPV should be delayed.",
"     </li>",
"     <li>",
"      A fenestrated tracheostomy tube is placed to allow trials of nasal and mouthpiece NPPV with the tracheostomy tube capped. If the patient develops respiratory distress when the fenestrated tube is capped, the problem may be that the airway around and through the fenestrated tube is not adequate. In this case, the tracheostomy tube is replaced with a smaller diameter tube.",
"     </li>",
"     <li>",
"      The nasogastric tube is removed, if present.",
"     </li>",
"     <li>",
"      If nasal NPPV is used, various nasal interfaces should be tried to optimize seal and comfort (",
"      <a class=\"graphic graphic_picture graphicRef63293 \" href=\"mobipreview.htm?28/63/29695\">",
"       picture 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef52499 \" href=\"mobipreview.htm?28/23/29055\">",
"       picture 5",
"      </a>",
"      and",
"      <a class=\"graphic graphic_picture graphicRef75445 \" href=\"mobipreview.htm?25/33/26143\">",
"       picture 6",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/8,19,20\">",
"       8,19,20",
"      </a>",
"      ]. Note that when used with an active ventilator circuit, one with an exhalation value, the exhalation ports of these interfaces must be covered or capped.",
"     </li>",
"     <li>",
"      NPPV may be used continuously, if needed, but without supplemental oxygen.",
"     </li>",
"     <li>",
"      Once adequate ventilation using NPPV has been demonstrated over the course of a few days, the tracheostomy tube is removed. A temporary tracheostomy button can be placed in the tracheostomy opening to permit the patient to practice NPPV without letting the ostomy close and without the partial airway obstruction that would be caused by practicing NPPV with the continued presence of a tracheostomy tube.",
"     </li>",
"     <li>",
"      Regular clearance of airway secretions by manually and mechanically assisted coughing via a mouthpiece or oronasal mask continues after decannulation of the trachea.",
"     </li>",
"     <li>",
"      If a tracheostomy button is used, once an adequate nocturnal SpO",
"      <sub>",
"       2",
"      </sub>",
"      is documented during NPPV in ambient air [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/6\">",
"       6",
"      </a>",
"      ], the button is removed and the tracheostomy site allowed to close. An airtight dressing is applied over the site until it closes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Extubation to NPPV for weaning",
"    </span>",
"    &nbsp;&mdash;&nbsp;When a patient receiving mechanical ventilation via translaryngeal tube is unable to be weaned from ventilatory support, endotracheal tube removal and transition to full-time noninvasive aids, especially when delivered via a simple mouth piece, permit the patient to take fewer and fewer assisted breaths as he or she feels capable. Patients usually wean to nocturnal-only NPPV provided that their vital capacity (VC) exceeds 250 mL. Patients with lower VCs usually require ongoing continuous NPPV. No weaning schedule is imposed on the patient, and the anxiety inherent in the \"standard\" weaning approaches is avoided. Patients know that they can take assisted breaths anytime they feel the need, and can use feedback from pulse oximetry to guide ventilator use [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/8,19,21\">",
"     8,19,21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/5/14423?source=see_link\">",
"     \"Methods of weaning from mechanical ventilation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one study, 155 of 157 intubated patients who refused tracheostomy and who failed spontaneous breathing trials both before and after extubation were extubated to continuous full-setting noninvasive ventilatory support and mechanically assisted cough [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/22\">",
"     22",
"    </a>",
"    ]. Ninety-three had failed extubations and were transferred to a center specifically for extubation to full noninvasive ventilatory support. All &ldquo;unweanable&rdquo; patients with assisted cough peak flows over 160",
"    <span class=\"nowrap\">",
"     L/min",
"    </span>",
"    were successfully extubated to NPPV on the first attempt whereas about 80 percent of extubation attempts were successful in patients with cough peak flows of 0 to 160",
"    <span class=\"nowrap\">",
"     L/min.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Deflation of the cuff",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cuff deflation is used to allow patients to talk while mechanically ventilated through a tracheostomy tube, to practice NPPV, and to prevent complications from cuff pressure on the trachea. When deflating a cuff, the ventilator insufflation volume should be increased, often to 1500 mL or more, to compensate for air leakage through the upper airway. In general, the delivered volumes are increased until they generate the same airway pressures that were generated by the smaller delivered volumes before cuff deflation. The patient is encouraged to learn to control and use the insufflation \"leak\" of air across the vocal cords for effective speech. The leak also carries airway debris up to the mouth.",
"   </p>",
"   <p>",
"    If the leak is inadequate for speech, a cuffless tube can be used or the tracheostomy tube downsized. Cuff removal, however, prevents optimal mechanical insufflation-exsufflation (MI-E) for elimination of airway secretions. In contrast, a wider gauge tube should be placed if there is too much leakage for effective alveolar ventilation, as indicated by decreases in SpO",
"    <sub>",
"     2",
"    </sub>",
"    . In general, patients who can speak with deflated cuffs are strong candidates to have their tracheostomy tubes removed in favor of NPPV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR TRACHEOSTOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;No extent of inspiratory or expiratory muscle failure is by itself an indication for tracheostomy. The only indication for tracheostomy for patients with neuromuscular weakness is aspiration of airway secretions to the extent that the SpO",
"    <sub>",
"     2",
"    </sub>",
"    cannot be maintained above 94 percent by NPPV and manually assisted coughing. Generally speaking, this only occurs for patients with advanced amyotrophic lateral sclerosis (ALS) and bulbar impairment. As these patients approach the need for continuous ventilatory support, it is important to review with the patient what their goals and preferences are for ongoing medical care and ventilatory support. It is helpful to know what aspects of their underlying disease or associated medical interventions might lead them to want to limit therapy. These conversations may take place over several meetings and may include family members and significant others. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/6/29801?source=see_link\">",
"     \"Palliative care: Benefits, services, and models of care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/60/30666?source=see_link\">",
"     \"Assessment and management of dyspnea in palliative care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44024?source=see_link\">",
"     \"Ethical issues near the end of life\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Continuously NPPV dependent patients who require intubation for acute respiratory failure can usually be extubated back to NPPV once their lung disease has cleared [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/22\">",
"     22",
"    </a>",
"    ]. Avoidance of tracheostomy eliminates the risk of glottic and subglottic stenosis and other serious and potentially fatal complications of tracheostomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/23\">",
"     23",
"    </a>",
"    ]. Long-term tracheostomy tube cuff inflation is also associated with the following problems:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased risk of trachiectasis and tracheal perforation",
"     </li>",
"     <li>",
"      Prevention of effective verbalization",
"     </li>",
"     <li>",
"      Impaired elevation of the larynx and esophageal dysfunction during swallowing",
"     </li>",
"     <li>",
"      Increased risk of aspiration [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/9,24,25\">",
"       9,24,25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PITFALLS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In order to avoid endotracheal intubation, patients with severe hypoventilation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    very poor pulmonary compliance may need to use NPPV around-the-clock. Low-span bilevel positive airway pressure, inspiratory minus expiratory positive airway pressure less than 10 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O, is rarely adequate. Full-setting NPPV is needed to better normalize alveolar ventilation, better rest inspiratory muscles, optimize air stacking, and augment cough flows.",
"   </p>",
"   <p>",
"    Frequently, patients who are able to walk (ie, myotonic dystrophy or kyphoscoliosis) do not use NPPV sufficiently during daytime hours, and do not benefit sufficiently from nocturnal NPPV alone. These patients often have repeated respiratory complications until they spend most of their time in wheelchairs, from which they can conveniently use mouthpiece NPPV.",
"   </p>",
"   <p>",
"    The clinician is often tempted to prescribe oxygen therapy. However, if arterial blood gases can be normalized by NPPV and manually assisted coughing, then oxygen therapy is not needed and can be hazardous. When oxygen supplementation is used along with NPPV, it decreases the efficiency of nocturnal NPPV, increases the risk of pulmonary complications, and exacerbates hypercapnia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/17\">",
"     17",
"    </a>",
"    ]. In general, supplemental oxygen should not be used at home for patients except for patients with advanced ALS and bulbar impairment who need but refuse tracheotomy for secretion management and ventilation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     OTHER CONSIDERATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the same general interventions and cautions for patients with primary lung disease are also applicable to patients with neuromuscular disease. Patients are cautioned to avoid extremes of temperature, humidity, fatigue, crowded areas, or exposure to respiratory tract pathogens, sedatives, and opiates. Patients should be advised to receive influenza and pneumococcal vaccines. They should also be instructed about using respiratory muscle aids in the event of an upper respiratory tract infection or the need for surgical intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Nutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heavy meals and obesity should be avoided, if possible. General weight charts are not applicable to these patients. However, a specific weight chart has been developed for patients with Duchenne muscular dystrophy (DMD) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/26\">",
"     26",
"    </a>",
"    ]. A useful equation for estimating caloric need for DMD patients up to 20 years of age is [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/27\">",
"     27",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    &nbsp;Daily energy intake (Kcal) &nbsp;= &nbsp;2000 &nbsp;- &nbsp;[age (years) &nbsp;x &nbsp;50]",
"   </p>",
"   <p>",
"    As bulbar muscles weaken, these patients must often limit oral intake to high calorie, thick liquids. Some patients with neuromuscular disease eventually require indwelling gastrostomy tubes for enteral nutrition. These tubes, when needed, should only be placed under local anesthesia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Physical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although most patients with neuromuscular disease who require pulmonary intervention are wheelchair dependent, some who require up to 24 hour ventilatory support can walk. Musculotendinous releases and physical and occupational therapy are useful to maintain orthopedic status and function. In addition, preventing back deformity can permit the use of the intermittent abdominal pressure ventilator and prevent the untoward effects of back deformity on cardiopulmonary and physical functioning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no evidence that exercise improves pulmonary function or prognosis in patients with neuromuscular disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/30\">",
"     30",
"    </a>",
"    ]. Activities of daily living can be greatly facilitated by use of a wheelchair, adaptive equipment, and energy conservation. There are a multitude of orthoses and other assistance devices for helping the patient with dressing, grooming, personal hygiene, transfers, wheelchair mobility, and possibly ambulation. Environmental control systems can permit the severely disabled individual to have access to the telephone and all electrical appliances. Robotic arms that can be mounted on wheelchairs can permit ventilator users to feed themselves, open doors, perform some personal hygiene, and manipulate objects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33896/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For many patients, an efficient bowel and bladder management program greatly facilitates the activities of daily living. Constipation, associated with increased gastrointestinal transit time, is common. High fluid intake should be encouraged.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most useful single technique for facilitating a bowel movement is using a lift, so that the patient's hips are flexed and the buttocks are in a dependent position over a commode. This can decrease post-suppository evacuation waiting time from hours to minutes.",
"     </li>",
"     <li>",
"      A condom catheter drainage system can permit patients to urinate without the need for personal assistance or interruption of the activities of daily living.",
"     </li>",
"     <li>",
"      Use of mattresses that slowly rotate patients from side to side during sleep can decrease arousals and eliminate the need for assisted turning.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with neuromuscular or chest wall disease, respiratory insufficiency is manifest by symptomatic alveolar hypoventilation, difficulty clearing airway secretions, and ventilation-perfusion mismatching. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When alveolar hypoventilation extends into the daytime hours, daytime use of noninvasive respiratory muscle aids can avoid invasive mechanical ventilation. The criteria listed define which patients are candidates for noninvasive ventilatory assistance. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Patient selection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most useful daytime inspiratory aid is mouthpiece noninvasive positive pressure ventilation (NPPV). Mouthpiece NPPV delivers positive pressure via a 15 mL angled mouthpiece that is kept adjacent to the mouth for easy access to assisted breaths. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Types'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who have neck rotation or lip strength that is inadequate for grabbing a mouthpiece, nasal NPPV or the IAPV can be used during daytime hours. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Types'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The ability to generate sufficient expiratory flow for effective coughing is the most important factor permitting the long-term use of noninvasive ventilation. When neuromuscular disease causes an ineffective cough, insufflation to increase lung recoil combined with exsufflation and abdominal thrusts can make cough flows more effective. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Cough assistance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Home monitoring of oxygen saturation (SpO",
"      <sub>",
"       2",
"      </sub>",
"      ) is needed to assure adequacy of cough and ventilation, especially during upper respiratory infections. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Practical aspects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Many patients with neuromuscular or chest wall disease who have a tracheostomy for mechanical ventilation during a respiratory infection are candidates for NPPV and removal of the tracheostomy tube, if the criteria in the table (",
"      <a class=\"graphic graphic_table graphicRef64672 \" href=\"mobipreview.htm?22/5/22619\">",
"       table 2",
"      </a>",
"      ) are fulfilled. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Tracheostomy to noninvasive ventilation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The only indication for tracheostomy for patients with neuromuscular weakness is aspiration of airway secretions to the extent that the SpO",
"      <sub>",
"       2",
"      </sub>",
"      cannot be maintained above 94 percent by NPPV and manually assisted coughing. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Indications for tracheostomy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/1\">",
"      Bach JR. Tracheostomy for advanced neuromuscular disease. Con. Chron Respir Dis 2007; 4:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/2\">",
"      Redding GJ, Okamoto GA, Guthrie RD, et al. Sleep patterns in nonambulatory boys with Duchenne muscular dystrophy. Arch Phys Med Rehabil 1985; 66:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/3\">",
"      Soudon, P. Ventilation assistee au long cours dans les maladies neuro-musculaire: Experience actuelle. Readaptation Revalidatie 1987; 3:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/4\">",
"      Bach JR. Update and perspectives on noninvasive respiratory muscle aids. Part 1: The inspiratory aids. Chest 1994; 105:1230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/5\">",
"      Bach JR. Update and perspective on noninvasive respiratory muscle aids. Part 2: The expiratory aids. Chest 1994; 105:1538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/6\">",
"      Bach JR, Alba AS, Saporito LR. Intermittent positive pressure ventilation via the mouth as an alternative to tracheostomy for 257 ventilator users. Chest 1993; 103:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/7\">",
"      Bach JR, Alba AS. Intermittent abdominal pressure ventilator in a regimen of noninvasive ventilatory support. Chest 1991; 99:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/8\">",
"      Gomez-Merino E, Bach JR. Duchenne muscular dystrophy: prolongation of life by noninvasive ventilation and mechanically assisted coughing. Am J Phys Med Rehabil 2002; 81:411.",
"     </a>",
"    </li>",
"    <li>",
"     Bach JR. The Management of Patients with Neuromuscular Disease, Hanley &amp; Belfus, Philadelphia 2004. p.331.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/10\">",
"      Bach JR, Baird JS, Plosky D, et al. Spinal muscular atrophy type 1: management and outcomes. Pediatr Pulmonol 2002; 34:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/11\">",
"      Bach JR, Alba AS. Noninvasive options for ventilatory support of the traumatic high level quadriplegic patient. Chest 1990; 98:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/12\">",
"      Bach JR, Martinez D. Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival. Respir Care 2011; 56:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/13\">",
"      Kang SW, Bach JR. Maximum insufflation capacity: vital capacity and cough flows in neuromuscular disease. Am J Phys Med Rehabil 2000; 79:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/14\">",
"      BARACH AL, BECK GJ. Exsufflation with negative pressure; physiologic and clinical studies in poliomyelitis, bronchial asthma, pulmonary emphysema, and bronchiectasis. AMA Arch Intern Med 1954; 93:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/15\">",
"      Bach JR. Mechanical insufflation-exsufflation. Comparison of peak expiratory flows with manually assisted and unassisted coughing techniques. Chest 1993; 104:1553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/16\">",
"      Bach JR, Alba AS, Bodofsky E, et al. Glossopharyngeal breathing and noninvasive aids in the management of post-polio respiratory insufficiency. Birth Defects Orig Artic Ser 1987; 23:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/17\">",
"      Bach JR, Rajaraman R, Ballanger F, et al. Neuromuscular ventilatory insufficiency: effect of home mechanical ventilator use v oxygen therapy on pneumonia and hospitalization rates. Am J Phys Med Rehabil 1998; 77:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/18\">",
"      LEINER GC, ABRAMOWITZ S, SMALL MJ, et al. EXPIRATORY PEAK FLOW RATE. STANDARD VALUES FOR NORMAL SUBJECTS. USE AS A CLINICAL TEST OF VENTILATORY FUNCTION. Am Rev Respir Dis 1963; 88:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/19\">",
"      Bach JR, Bianchi C, Aufiero E. Oximetry and indications for tracheotomy for amyotrophic lateral sclerosis. Chest 2004; 126:1502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/20\">",
"      Bach, JR, Sortor, S, Saporito, LR. Interfaces for non-invasive intermittent positive pressure ventilatory support in North America. Eur Respir Rev 1993; 3:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/21\">",
"      Bach JR. Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory AIDS. Chest 2002; 122:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/22\">",
"      Bach JR, Gon&ccedil;alves MR, Hamdani I, Winck JC. Extubation of patients with neuromuscular weakness: a new management paradigm. Chest 2010; 137:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/23\">",
"      Richard I, Giraud M, Perrouin-Verbe B, et al. Laryngotracheal stenosis after intubation or tracheostomy in patients with neurological disease. Arch Phys Med Rehabil 1996; 77:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/24\">",
"      Bach JR, Tilton MC. Life satisfaction and well-being measures in ventilator assisted individuals with traumatic tetraplegia. Arch Phys Med Rehabil 1994; 75:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/25\">",
"      Bach JR. A comparison of long-term ventilatory support alternatives from the perspective of the patient and care giver. Chest 1993; 104:1702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/26\">",
"      Griffiths RD, Edwards RH. A new chart for weight control in Duchenne muscular dystrophy. Arch Dis Child 1988; 63:1256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/27\">",
"      Griffiths, RD. Controlling weight in muscle disease to reduce the burden. Physiotherapy 1989; 75:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/28\">",
"      Bach JR, Gonzalez M, Sharma A, et al. Open gastrostomy for noninvasive ventilation users with neuromuscular disease. Am J Phys Med Rehabil 2010; 89:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33896/abstract/29\">",
"      Duport G, Gayet E, Pries P, et al. Spinal deformities and wheelchair seating in Duchenne muscular dystrophy: twenty years of research and clinical experience. Semin Neurol 1995; 15:29.",
"     </a>",
"    </li>",
"    <li>",
"     Fowler WM, Goodgold J. Rehabilitation management of neuromuscular diseases. In: Rehabilitation Medicine, Goodgold J (Ed), CV Mosby Co, Washington 1988. p.298.",
"    </li>",
"    <li>",
"     Bach JR, Valenza J, Ogin S. Stage 2: Stage of loss of ambulation. In: The Management of Patients with Neuromuscular Disease, Bach JR (Ed), Hanley &amp; Belfus, Philadelphia 2004. p.125.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5116 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-CACC98E3A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33896=[""].join("\n");
var outline_f33_6_33896=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      TYPES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Mouthpiece NPPV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Nasal NPPV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Intermittent abdominal pressure ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      COUGH ASSISTANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Manually assisted cough",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Mechanical insufflation-exsufflation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Glossopharyngeal breathing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PATIENT SELECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      PRACTICAL ASPECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Preventing pneumonia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Protocol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Tracheostomy to noninvasive ventilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Extubation to NPPV for weaning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Deflation of the cuff",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      INDICATIONS FOR TRACHEOSTOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PITFALLS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      OTHER CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Nutrition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Physical therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/5116\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/5116|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?31/17/32020\" title=\"picture 1\">",
"      Continuous oral NPPV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?39/62/40933\" title=\"picture 2\">",
"      Lipseal-nasal prong NPPV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?8/45/8920\" title=\"picture 3\">",
"      Continuous nasal NPPV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?28/63/29695\" title=\"picture 4\">",
"      Nocturnal nasal NPPV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?28/23/29055\" title=\"picture 5\">",
"      Nasal CPAP masks",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?25/33/26143\" title=\"picture 6\">",
"      Nasal pillows",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/5116|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?5/41/5788\" title=\"table 1\">",
"      Neuromuscular and chest wall conditions managed with NPPV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/5/22619\" title=\"table 2\">",
"      Criteria for extubation or decannulation to continuous NPPV",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/60/30666?source=related_link\">",
"      Assessment and management of dyspnea in palliative care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/63/44024?source=related_link\">",
"      Ethical issues near the end of life",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/5/14423?source=related_link\">",
"      Methods of weaning from mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/6/29801?source=related_link\">",
"      Palliative care: Benefits, services, and models of care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/36/41543?source=related_link\">",
"      Practical aspects of nocturnal noninvasive ventilation in neuromuscular and chest wall disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/6/5222?source=related_link\">",
"      The effect of sleep in patients with neuromuscular and chest wall disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27095?source=related_link\">",
"      Types of noninvasive nocturnal ventilatory support in neuromuscular and chest wall disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_6_33897="Diagnosis of congenital long QT syndrome";
var content_f33_6_33897=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis of congenital long QT syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/6/33897/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33897/contributors\">",
"     Stephen P Seslar, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33897/contributors\">",
"     Peter J Zimetbaum, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33897/contributors\">",
"     Charles I Berul, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33897/contributors\">",
"     Mark E Josephson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/6/33897/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33897/contributors\">",
"     John K Triedman, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33897/contributors\">",
"     Samuel Asirvatham, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?33/6/33897/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?33/6/33897/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?33/6/33897/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long QT syndrome (LQTS) is a disorder of ventricular myocardial repolarization characterized by a prolonged QT interval on the electrocardiogram (ECG) (",
"    <a class=\"graphic graphic_waveform graphicRef77018 \" href=\"mobipreview.htm?26/24/27008\">",
"     waveform 1",
"    </a>",
"    ) that can lead to symptomatic ventricular arrhythmias with symptoms and can lead to an increased risk of sudden cardiac death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. This syndrome is associated with an increased risk of a characteristic life-threatening cardiac arrhythmia, known as torsades de pointes or \"twisting of the points\" (",
"    <a class=\"graphic graphic_waveform graphicRef73827 \" href=\"mobipreview.htm?42/7/43134\">",
"     waveform 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The primary symptoms in patients with LQTS include palpitations, syncope, seizures, and cardiac arrest.",
"   </p>",
"   <p>",
"    The long QT syndrome may be congenital or acquired [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. Mutations in at least twelve genes have been identified thus far in patients with genetic LQTS; the distinct genetic types are designated LQT 1 through 12 (",
"    <a class=\"graphic graphic_table graphicRef58937 \" href=\"mobipreview.htm?42/34/43565\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/0/28681?source=see_link\">",
"     \"Genetics of congenital and acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Two clinical phenotypes have been described in congenital LQTS that vary with the type of inheritance and the presence or absence of sensorineural hearing loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The more common autosomal dominant form, the Romano-Ward syndrome, has a purely cardiac phenotype.",
"     </li>",
"     <li>",
"      The autosomal recessive form, the Jervell and Lange-Nielsen (JLN) syndrome, is associated with LQTS and sensorineural deafness. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/9/2202?source=see_link&amp;anchor=H21#H21\">",
"       \"Clinical features of congenital long QT syndrome\", section on 'Congenital sensorineural deafness'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Romano-Ward syndrome can result from any of the mutations found thus far in congenital LQTS; in comparison, the JLN syndrome thus far has only been described in LQT1 and LQT5, both of which affect the slowly acting component of the outward-rectifying potassium current (IKs) (",
"    <a class=\"graphic graphic_table graphicRef58937 \" href=\"mobipreview.htm?42/34/43565\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/0/28681?source=see_link&amp;anchor=H2#H2\">",
"     \"Genetics of congenital and acquired long QT syndrome\", section on 'Phenotypes of congenital LQTS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acquired LQTS usually results from drug therapy or electrolyte disturbances (",
"    <a class=\"graphic graphic_table graphicRef57431 \" href=\"mobipreview.htm?2/48/2830\">",
"     table 2",
"    </a>",
"    ). In some patients with acquired LQTS, an underlying genetic predisposition has been identified. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/9/2202?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical features of congenital long QT syndrome\", section on 'Acquired LQTS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The ECG features and diagnostic approach to persons with suspected congenital LQTS will be reviewed here. The epidemiology, clinical features, and management of congenital LQTS in children and adults and the clinical features of acquired LQTS are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/9/2202?source=see_link\">",
"     \"Clinical features of congenital long QT syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/3/26682?source=see_link\">",
"     \"Prognosis and management of congenital long QT syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/55/23418?source=see_link\">",
"     \"Acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ECG FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prolongation of the QT interval is an essential component of the diagnosis of LQTS. However, the QTc varies in response to number of factors, such as autonomic state, electrolyte imbalance, drugs, and diurnal changes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Thus, the sensitivity of measuring the QTc on a single ECG is less than 100 percent.",
"   </p>",
"   <p>",
"    Other ECG features, such as T wave morphology and QT dispersion may be useful in the evaluation of the patient with suspected LQTS, but the corrected QT interval appears to be the most useful diagnostic and prognostic parameter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     QT interval",
"    </span>",
"    &nbsp;&mdash;&nbsp;The QT interval reflects the time required for both depolarization (the QRS complex) and repolarization (the T wave) of the ventricles. Repolarization is a larger component of the entire QT interval, and QT prolongation is generally considered to reflect abnormalities of repolarization.",
"   </p>",
"   <p>",
"    The QT interval varies inversely with the heart rate; therefore, the QT measurement is adjusted for the heart rate, resulting in the corrected QT interval, or QTc. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Correction for rate'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The normal value usually cited for the QTc is &le;0.44 to 0.46 sec (440 to 460 msec), with different values for men, women, and children. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Normal range'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Measurement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The QT interval is measured from the onset of the QRS complex to the point at which the T wave ends (",
"    <a class=\"graphic graphic_waveform graphicRef77018 \" href=\"mobipreview.htm?26/24/27008\">",
"     waveform 1",
"    </a>",
"    ). The QT interval should be measured for three to five consecutive beats and averaged [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Controversy exists regarding a number of features of QT measurement, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Which lead should be used &ndash; QT intervals vary significantly among leads [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/14\">",
"       14",
"      </a>",
"      ]. Most normal reference ranges are based upon measurements from lead II [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/15,16\">",
"       15,16",
"      </a>",
"      ]. However, some suggest using whichever limb lead best shows the end of the T wave [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/13\">",
"       13",
"      </a>",
"      ]; or leads V2 or V3, in which QT measurements are typically the longest [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/14,16\">",
"       14,16",
"      </a>",
"      ]; or leads V5 or V6, because of the clarity of the Q-wave onset and T-wave termination.",
"     </li>",
"     <li>",
"      The method of correction for heart rate.",
"     </li>",
"     <li>",
"      The limits of the normal range.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to these methodologic controversies, accurate measurements can be technically challenging, largely due to difficulties in determining the onset of the QRS and the termination of the T wave. A brief isoelectric period in some leads can obscure the beginning of the QRS. This can lead to underestimation of the QT interval.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Impact of U waves",
"    </span>",
"    &nbsp;&mdash;&nbsp;Identifying the termination of the T wave can be particularly difficult when a U wave is present. Cardiologists usually do not include the U wave if it is distinct from and significantly smaller than the T wave. Erroneous inclusion of the U wave in the QT interval measurement can lead to overdiagnosis of LQTS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/17\">",
"     17",
"    </a>",
"    ]. However, if the T and U waves are merged, some experts recommend inclusion of the U wave [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/13\">",
"     13",
"    </a>",
"    ], especially if it is more than 50 percent of the T wave amplitude [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Special circumstances",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the methodologic and technical challenges discussed above, QT measurement and interpretation is complicated in the following situations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atrial fibrillation &ndash; Due to changes in the RR interval, the QT interval can vary on a beat-to-beat basis during atrial fibrillation. To accommodate this variability, some clinicians recommend averaging the measurements over 10 beats. Others advise measuring the QT intervals that follow the longest and shortest RR intervals in the ECG, then dividing each by the square root of the preceding RR interval [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/13\">",
"       13",
"      </a>",
"      ]. The average of these two values is then used as the corrected QT interval.",
"     </li>",
"     <li>",
"      QRS prolongation &ndash; QT prolongation usually reflects abnormal repolarization, but when depolarization (the QRS complex) is abnormal and prolonged, the significance of mild QT prolongation is uncertain. It has been suggested that measurement of the JT interval (defined as the QT interval minus the QRS duration) may be a more appropriate way to identify abnormalities in repolarization in such patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/19\">",
"       19",
"      </a>",
"      ]. The normal JTc is less than 0.36 sec in children without LQTS and is typically greater than 0.36 sec in children with LQTS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/19\">",
"       19",
"      </a>",
"      ]. However, the validity of using the JT interval in this manner has been questioned. An alternative approach is to adjust the QT interval as a linear function to account for QRS duration and heart rate in the setting of ventricular conduction delay [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/20\">",
"       20",
"      </a>",
"      ]. Another approach is to use a threshold of 0.50 sec for a prolonged QTc in the setting of a wide QRS complex [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Correction for rate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Under normal circumstances, the duration of repolarization depends upon the heart rate. The QT interval is longer at slower rates and shorter at faster rates. For this reason, formulas have been developed to \"correct\" the QT interval for heart rate (or the duration of the RR interval), although none is ideal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/10,13,21,22\">",
"     10,13,21,22",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"calc calc_professional\" href=\"mobipreview.htm?7/48/7937?source=see_link\">",
"     calculator 1",
"    </a>",
"    ). The most commonly used rate correction formula was developed by Bazett [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/23\">",
"     23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    &nbsp;QTc = QT interval &divide; &radic;RR interval (in sec)",
"   </p>",
"   <p>",
"    Although this approach is simple, it is inaccurate at heart rate extremes and results in overcorrecting at high rates and under correcting at low ones [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another approach corrects the QT interval to the cubed root of the RR interval [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/10,24\">",
"     10,24",
"    </a>",
"    ]. Linear and logarithmic regression formulas have been used to predict the effect of heart rate on QT interval [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. However, because of substantial variability of the QT-RR relationship among individuals, no formula for heart rate correction can be accurate for everyone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Normal range",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal range for the rate-corrected QT interval is similar in males and females from birth until late adolescence (0.37 to 0.44 sec). In adults, females have slightly longer QT intervals than males. A corrected QT interval of more than 0.44 sec is considered prolonged in men; the normal range generally is extended to 0.45 to 0.46 sec in women (",
"    <a class=\"graphic graphic_table graphicRef78934 \" href=\"mobipreview.htm?8/61/9179\">",
"     table 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although these figures serve as useful guidelines, genetic studies have demonstrated that QTc measurements overlap in individuals who are carriers and noncarriers of an LQTS gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/29-31\">",
"     29-31",
"    </a>",
"    ]. In one report of 199 family members (83 of whom were carriers of LQT1), QTc intervals were 0.41 to 0.59 sec in carriers, compared to 0.38 to 0.47 in noncarriers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/29\">",
"     29",
"    </a>",
"    ]. A QTc &ge;0.47 sec in males and &ge;0.48 sec in females resulted in a false negative diagnosis in 40 percent of male carriers and 20 percent of female carriers. On the other hand, use of QTc &ge;0.45 sec resulted in a false positive rate of 11 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Automated measurements",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many ECG machines automatically measure the QT interval and calculate the QTc. However, the accuracy of these automated tools is limited. This was illustrated in a series of 218 subjects in whom simultaneous ECGs were recorded on machines from two different manufacturers; the ECGs were then analyzed with four currently used software packages from the same manufacturers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/32\">",
"     32",
"    </a>",
"    ]. Among the four software packages, the QTc varied by 26 msec (range 406 to 432 msec). The two newer software packages produced more consistent results, but both were notably longer (15 to 26 msec) than older versions that remain in use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Recommendations",
"    </span>",
"    &nbsp;&mdash;&nbsp;For increased accuracy, the QT interval should be measured manually on serial ECGs, using multiple leads, and at similar autonomic states. In addition, beat-to-beat variability and respiratory sinus arrhythmia affect formulas used to correct for heart rate. As a result, several successive beats should be measured and averaged for each ECG.",
"   </p>",
"   <p>",
"    Diagnosing LQTS in a patient with a borderline QTc (0.44 to 0.46 sec) is difficult. In this setting, further testing usually is warranted to determine whether the patient has QT prolongation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    congenital LQTS. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other ECG features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other ECG features of LQTS include abnormal T wave morphology, T wave alternans, and increased QT dispersion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     T wave morphology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The T waves of patients with congenital LQTS are frequently abnormal with a biphasic contour or a prominent notched component. In one report, notched or biphasic T waves were present in 62 percent of patients with LQTS compared to 15 percent of control subjects [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/33\">",
"     33",
"    </a>",
"    ]. A variety of other atypical T wave shapes have also been described in LQTS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Characteristic T wave shapes correlate with specific genotypes, although there is clearly some overlap [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/34-37\">",
"     34-37",
"    </a>",
"    ]. In one series of 284 carriers of LQTS genes (131 LQT1, 93 LQT2, and 60 LQT3), typical ST-T wave patterns were seen in 88 percent of LQT1 and LQT2 carriers and 65 percent of LQT3 carriers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/34\">",
"     34",
"    </a>",
"    ]. The typical patterns had the following features:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The LQT1 group had a broad and pronounced T wave or late onset of a normal appearing T wave. An infantile ST-T wave pattern was primarily seen in children below the age of two years.",
"     </li>",
"     <li>",
"      The LQT2 group had low amplitude T waves or bifid T waves that were obvious, subtle, of low amplitude, or widely split.",
"     </li>",
"     <li>",
"      The LQT3 group had the latest appearing T waves that were peaked",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bifid or were asymmetrically peaked with a steep downslope.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Abnormalities in T wave amplitude and T wave duration can help to distinguish among LQT1, LQT2, and LQT3. This was illustrated in a study of 153 patients with genetically defined LQTS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/35\">",
"     35",
"    </a>",
"    ]. The amplitude of the T wave in lead II was small in LQT2 compared to LQT3 or LQT1 (0.13 versus 0.36 or 0.37 mV), and the T wave duration was long in LQT1 compared to LQT2 or LQT3 (262 versus 191 or 187 msec).",
"   </p>",
"   <p>",
"    A rare form of congenital LQTS, LQT7 (also referred to as Andersen or Andersen-Tawil syndrome), has characteristic T-U wave morphologies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/9/2202?source=see_link&amp;anchor=H24#H24\">",
"     \"Clinical features of congenital long QT syndrome\", section on 'Andersen syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     T wave alternans",
"    </span>",
"    &nbsp;&mdash;&nbsp;T wave or repolarization alternans (TWA), is defined as the regular alternation in T wave amplitude or in polarity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/38\">",
"     38",
"    </a>",
"    ]. In early reports, TWA was detected by visual inspection (macroscopic TWA), and the standard diagnostic LQTS score includes macroscopic TWA as one component [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/39\">",
"     39",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Diagnosis'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/48/5898?source=see_link&amp;anchor=H14#H14\">",
"     \"T wave (repolarization) alternans: Clinical aspects\", section on 'Long QT syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a review of 4656 ECGs from 2442 patients in the International LQTS Registry, macroscopic TWA was identified in 30 patients (1.2 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/40\">",
"     40",
"    </a>",
"    ]. A strong association between TWA and the magnitude of QT prolongation was observed. However, after correcting for QTc, there was no significant correlation between TWA and cardiac events.",
"   </p>",
"   <p>",
"    Macroscopic TWA is much less frequent in LQTS than TWA of smaller magnitude (microvolt TWA), which occurred in 17 of 39 patients (44 percent) in one report [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/41\">",
"     41",
"    </a>",
"    ]. Microvolt TWA assessed during exercise may increase the accuracy of diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/36/9800?source=see_link&amp;anchor=H3#H3\">",
"     \"T wave (repolarization) alternans: Technical aspects\", section on 'Methods for analysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     QT dispersion",
"    </span>",
"    &nbsp;&mdash;&nbsp;QT dispersion is defined as the variability in QT duration among different ECG leads. Increased dispersion is thought to be an ECG marker of heterogeneity of repolarization. It is determined by subtracting the minimum QT interval from the maximum QT interval in any surface lead. Whether increased QT dispersion predisposes to ventricular arrhythmia is controversial. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/51/26425?source=see_link\">",
"     \"QT dispersion: Measurement and interpretation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    QT dispersion is increased in patients with LQTS. This was illustrated in a report in which 39 children with LQTS were compared to 50 age-matched controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/42\">",
"     42",
"    </a>",
"    ]. The children with LQTS had a greater mean dispersion of the QT interval (81 versus 28 msec) and of the JT interval (defined as the QT interval minus the QRS duration; 80 versus 25 msec). QT dispersion &ge;55 msec correlated with the development of critical ventricular arrhythmias (ventricular tachycardia, TdP, and cardiac arrest).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnostic approach to LQTS includes evaluation of the specific clinical setting (cardiac event, asymptomatic family member, or incidentally discovered QT prolongation) and assessment of the ECG features described above. Symptoms of torsades de pointes in patients with LQTS include palpitations, syncope, seizures, and cardiac arrest. In some cases, additional testing is necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     LQTS score",
"    </span>",
"    &nbsp;&mdash;&nbsp;A weighted scoring system for the diagnosis of congenital LQTS, also called the Schwartz score, incorporates the measured QTc interval and other clinical and historical factors; the score was developed in 1985 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/43\">",
"     43",
"    </a>",
"    ] and revised in 1993 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/39\">",
"     39",
"    </a>",
"    ], 2006 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/44\">",
"     44",
"    </a>",
"    ], and 2011 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/45\">",
"     45",
"    </a>",
"    ]. An algorithm was developed in which diagnostic criteria were assigned points as follows:",
"   </p>",
"   <p>",
"    ECG findings (in the absence of medications or disorders known to affect these features)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      QTc (=",
"      <span class=\"nowrap\">",
"       QT/&radic;RR,",
"      </span>",
"      interpret with caution with tachycardia since QTc overcorrects at fast heart rates)",
"      <br/>",
"      <br/>",
"      &ge;480 msec: 3 points",
"      <br/>",
"      460 to 470 msec: 2 points",
"      <br/>",
"      &gt;450 to 460 msec (in males): 1 point",
"     </li>",
"     <li>",
"      QTc at fourth minute of recovery from exercise stress test &ge;480 ms: 1 point [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/45\">",
"       45",
"      </a>",
"      ] (see",
"      <a class=\"local\" href=\"#H17394416\">",
"       'Exercise-recovery QTc'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Torsades de pointes* (in the absence of drugs known to prolong QT): 2 points",
"     </li>",
"     <li>",
"      T-wave alternans: 1 point",
"     </li>",
"     <li>",
"      Notched T wave in three leads: 1 point",
"     </li>",
"     <li>",
"      Resting heart rate below second percentile for age (restricted to children): 0.5 point",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Clinical findings",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Syncope* (*Points for torsade and syncope are mutually exclusive)",
"      <br/>",
"      <br/>",
"      With stress: 2 points",
"      <br/>",
"      Without stress: 1 point",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Family history (The same family member cannot be counted in both of these criteria)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Family members with LQTS: 1 point",
"     </li>",
"     <li>",
"      Unexplained sudden cardiac death in immediate family members &lt;30 years of age: 0.5 point",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The points are added to calculate the LQTS score. The 1993 version of the score rated &le;1 point as low probability, 2 to 3 points as intermediate probability and &ge;4 points as high probability (and did not include the exercise recovery criterion) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/39\">",
"     39",
"    </a>",
"    ]. The 2006 and 2011 versions rate the probability of having LQTS is rated as low, intermediate, or high for scores of &le;1, 1.5 to 3, and &ge;3.5, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. The limited sensitivity and high specificity of the 1993 version of the score is described below. The 2011 version of the score is likely more sensitive but its accuracy has not been prospectively evaluated.",
"   </p>",
"   <p>",
"    The value of using a scoring system for diagnosis, particularly for family members, has been questioned. The accuracy of the 1993 version of the LQTS score was assessed in a series of 513 relatives of 77 LQTS probands [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/46\">",
"     46",
"    </a>",
"    ]. All probands had an identified LQTS mutation; all relatives were screened, and 208 relatives were identified as mutation carriers.",
"   </p>",
"   <p>",
"    Among the 513 relatives, the following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      41 of 208 known mutation carriers (19 percent) had a LQTS score &ge;4 (ie, high probability). Only one noncarrier had a score &ge;4.",
"     </li>",
"     <li>",
"      An additional 59 carriers (29 percent) and 26 noncarriers (9 percent) had LQTS scores of 2 or 3 (ie, intermediate results).",
"     </li>",
"     <li>",
"      A QTc &ge;430 msec in lead V5 was significantly more sensitive but less specific than a LQTS score &ge;4 for detecting mutation carriers (sensitivity 72 versus 19 percent; specificity 86 versus 99 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The sensitivity of a LQTS score was much higher in probands, 57 percent of whom had scores &ge;4. Although the corrected QT interval performed better than the earlier LQTS score in this series, genetic screening may be preferred when the specific mutation in a family is known [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Genetic testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Exercise testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most children and young adults, the QT interval shortens with exercise and increased heart rate. In contrast, in individuals with LQT1 or LQT2, the QT interval may fail to shorten or may lengthen with exertion and higher heart rates and may be prolonged during the recovery phase after exercise. One limitation is that the performance of diagnostic tests as a screening tool in unselected populations is likely to be worse than in the cohorts of known genetic carriers as in the studies below.",
"   </p>",
"   <p>",
"    At least part of the variability in the response to exercise in LQTS patients results from different responses among the major types of congenital LQTS:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with LQT1 have diminished shortening of the QT interval and a reduced chronotropic response during exercise followed by exaggerated lengthening of the QT interval as the heart rate declines during early and late (eg, one and four minutes) recovery after exercise [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/48-50\">",
"       48-50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with LQT2 have marked QT interval shortening and a normal chronotropic response during exercise [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/48,51\">",
"       48,51",
"      </a>",
"      ]. There is exaggerated lengthening of the QT interval as the heart rate declines during late recovery (eg, four minutes) after exercise [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/48,50\">",
"       48,50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with LQT3 have a more marked decrease in the QT interval with exercise than either patients with LQT2 or controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These characteristics may explain the observation that most cardiac events occur during exercise in LQT1, while events are more likely to occur at rest or during sleep in LQT3 (",
"    <a class=\"graphic graphic_figure graphicRef64239 \" href=\"mobipreview.htm?9/27/9662\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/52\">",
"     52",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/9/2202?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical features of congenital long QT syndrome\", section on 'Triggers of arrhythmia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Accentuated heart rate (HR) recovery following standard exercise testing, a marker of vagal activity, appears to be a marker of increased risk of cardiac events (syncope or aborted sudden cardiac death) in patients with LQT1. Among 169 LQT1 genotype positive patients who underwent standard exercise testing and achieved similar maximal HR and workloads, those with prior cardiac events had a significantly greater HR reduction during the first minute following exercise compared with those without prior events (19 versus 13 beats per minute in a 47 patient South African cohort; 27 versus 20 beats per minute in a 122 patient Italian cohort) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/53\">",
"     53",
"    </a>",
"    ]. Greater HR reductions immediately following exercise in persons positive for the LQT1 genotype appears to risk stratify them at a higher risk of arrhythmic events.",
"   </p>",
"   <p>",
"    Alternatively, another diagnostic approach involves a \"burst\" exercise protocol as opposed to traditional exercising testing. As an example, a trial of 31 patients with genetically confirmed LQTS, 13 with a normal baseline QTc (latent LQTS), and 31 controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/54\">",
"     54",
"    </a>",
"    ]. Subjects exercised at maximal exertion for one minute against a fixed workload on a bicycle. Latent LQTS patients had a significantly greater increase in the QTc interval with exercise compared to either controls or LQTS patients with an abnormal baseline QTc. Among those with a normal baseline ECG, an increase in the QTc with exercise of &ge;85 msec was both sensitive and specific for LQTS (85 and 86 percent, respectively).",
"   </p>",
"   <p>",
"    Another value of exercise testing is that ventricular arrhythmias may be detected during the test. In the Pediatric Electrophysiology Society study, 30 percent of those undergoing exercise testing had ventricular arrhythmias, including 9 percent with nonsustained TdP, 3 percent with nonsustained monomorphic ventricular tachycardia (VT), and 1 percent with sustained monomorphic VT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17394416\">",
"    <span class=\"h3\">",
"     Exercise-recovery QTc",
"    </span>",
"    &nbsp;&mdash;&nbsp;The response of QTc during exercise recovery may be helpful in identifying LQTS in asymptomatic relatives of individuals with LQTS as well as in identifying probands. A multicenter study derived the following algorithm for identifying LQTS carriers based upon the QTc at rest and during recovery in 69 asymptomatic relatives [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/50\">",
"     50",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Supine QTc",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      If &ge;470 ms in males or &ge;480 and females, then probable LQTS",
"     </li>",
"     <li>",
"      If normal or borderline normal &ndash; check four-minute recovery QTc",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Four-minute recovery QTc",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      If &ge;445 ms, then probable LQTS",
"     </li>",
"     <li>",
"      If normal, probable non-carrier",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If probable LQTS, check one-minute recovery QTc",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      If &ge;460 ms, probable LQT1",
"     </li>",
"     <li>",
"      If &lt;460, then probable LQT2",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The sensitivity and specificity of the algorithm in the initial cohort were 94 and 90 percent. The algorithm was validated in an independent cohort (n = 152) with sensitivity and specificity of 92 and 82 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Summary of initial diagnostic strategy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Our strategy for the diagnosis of the congenital LQTS involves the following analysis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The clinical circumstance in which presyncope, syncope, or sudden death occurred is carefully examined and a careful family history is obtained.",
"     </li>",
"     <li>",
"      Secondary causes of QT prolongation and the acquired LQTS are excluded (",
"      <a class=\"graphic graphic_table graphicRef57431 \" href=\"mobipreview.htm?2/48/2830\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The ECG is examined to determine the duration of the QTc interval and the morphology of the T wave. QT dispersion is calculated, but we do",
"      <strong>",
"       NOT",
"      </strong>",
"      currently use this value as a basis for decisions. When available, ECGs are also obtained from immediate family members to determine if any first-degree relatives have QTc prolongation or other associated abnormalities.",
"     </li>",
"     <li>",
"      An exercise test is routinely performed. A prolonged QTc during the fourth minute of recovery suggests probable LQT1 or LQT2. (See",
"      <a class=\"local\" href=\"#H17394416\">",
"       'Exercise-recovery QTc'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The LQTS score is calculated. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'LQTS score'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with an LQTS score &ge;3.5 are considered to have high probability of LQTS, while an LQTS score &le;1 tends to exclude the diagnosis. In patients with an LQTS score of 1.5 to 3, close clinical follow-up for possible LQTS is indicated; additional testing may also be performed, as described below.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Additional testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;In some patients, the diagnosis of LQTS may be uncertain after application of the diagnostic criteria outlined above. Additional testing, including ambulatory monitoring, drug testing or face immersion, may helpful in such patients.",
"   </p>",
"   <p>",
"    Genetic testing will identify a specific mutation in approximately 75 to 80 percent of patients with LQTS. It may establish the diagnosis when it is uncertain, allow for efficient identification of affected family members, and have prognostic and therapeutic utility by determining which gene is involved. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Genetic testing'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/0/28681?source=see_link\">",
"     \"Genetics of congenital and acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Ambulatory ECG monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;The QT interval and other ECG features of LQTS may vary with activity and time of day. As a result, ambulatory (Holter) ECG monitoring is sometimes used to help establish the diagnosis of LQTS and to add corroborative information in borderline cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/55-58\">",
"     55-58",
"    </a>",
"    ]. Holter monitoring can detect intermittent QT prolongation, bradyarrhythmia, macrovolt T wave alternans, and T wave notching [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/56-58\">",
"     56-58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ambulatory monitoring also may detect ventricular tachyarrhythmias. In the Pediatric Electrophysiology Society study, Holter monitoring detected ventricular arrhythmias in 41 percent of patients, compared with only 16 percent on routine ECG [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the results of ambulatory monitoring should be interpreted with caution, since the standards for QTc on ambulatory monitoring are not established, and tape speed may vary on the recording devices, hampering the accuracy of measurements. As a result, discrepancies in measurements often occur when Holter recordings are compared to standard ECGs. This was illustrated by a study in which the Holter recording underestimated the QT interval in V1 and overestimated it in V5, compared to a standard ECG [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/59\">",
"     59",
"    </a>",
"    ]. Thus, some of the quantitative information obtained from ambulatory monitoring may not be reliable for LQTS diagnosis.",
"   </p>",
"   <p>",
"    Given the limitations of Holter monitoring for establishing the diagnosis of LQTS, we do not recommend making the diagnosis of LQTS based solely on the QTc measurement during ambulatory recordings. The results of such testing should be used only as ancillary information.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Electrophysiology study",
"    </span>",
"    &nbsp;&mdash;&nbsp;Programmed cardiac stimulation induces TdP in only about 10 percent of patients with congenital LQTS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/55,60\">",
"     55,60",
"    </a>",
"    ]. Furthermore, inducibility of ventricular arrhythmias has not been predictive of clinical events in congenital LQTS.",
"   </p>",
"   <p>",
"    As a result, electrophysiology testing is not a part of the routine evaluation and management of these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/60\">",
"     60",
"    </a>",
"    ]. We do not currently perform electrophysiology studies in patients with LQTS and do not recommend using this modality for establishing the diagnosis of LQTS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Drug testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of the QT interval after provocative testing with drugs may help differentiate patients with suspected LQTS from normal patients, and among those with LQTS may distinguish one genetic defect from another [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/51,61-64\">",
"     51,61-64",
"    </a>",
"    ]. The most commonly used drugs are beta-adrenergic agonists, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?22/31/23029?source=see_link\">",
"     isoproterenol",
"    </a>",
"    and epinephrine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/63-66\">",
"     63-66",
"    </a>",
"    ]. Pharmacologic provocations studies have an advantage of not causing motion artifacts on the ECG as commonly seen during exercise testing.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Epinephrine &ndash; In a report from the Mayo Clinic, 125 patients with LQTS had continuous ECG monitoring during an infusion of intravenous epinephrine at escalating doses (0.025 to 0.3",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per min), which usually shortens the QT interval in normal subjects [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/64\">",
"       64",
"      </a>",
"      ]. None of the patients was treated with beta blockers at the time of the test. All patients underwent genetic screening, and 81 had mutations in LQT1, LQT2, or LQT3. The following findings were noted:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The QTc prolonged in all LQT subgroups. The prolongation was greatest in patients with LQT1 (141 msec increase versus increases of 69 and 3 msec for LQT2 and LQT3, respectively).",
"     </li>",
"     <li>",
"      Epinephrine caused prolongation of the uncorrected QT interval in those with LQT1 (78 msec increase), but QT shortening in those with LQT2 or LQT3 (4 and 58 msec decrease respectively). Thus, use of the uncorrected QT interval was associated with less overlap than use of QTc.",
"     </li>",
"     <li>",
"      A paradoxical QT response, defined by the authors as an increase in the uncorrected QT interval by &ge;30 msec during an epinephrine infusion of &le;0.1",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per min, was observed in 37 of 40 patients (92 percent) with LQT1, 4 of 30 with LQT2 (13 percent) and none of the 11 patients with LQT3.",
"      <br/>",
"      <br/>",
"      Although the above results suggest that epinephrine infusion may be useful for identifying patients with LQT1, some limitations should be recognized:",
"     </li>",
"     <li>",
"      Among 22 patients treated with beta blockers at the time of the study, the diagnostic performance of epinephrine infusion was reduced.",
"     </li>",
"     <li>",
"      In an earlier report from the same center, 37 patients with LQTS were compared to 27 controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/63\">",
"       63",
"      </a>",
"      ]. Although only patients with LQT1 showed a paradoxical response (as defined above) with low dose epinephrine (0.05",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      per min), at higher doses, 6 of 27 controls had a paradoxical response. Further data from larger series of both LQT patients and controls are necessary to define the role of epinephrine infusion in screening for suspected LQTS.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adenosine &ndash; Because abrupt changes in heart rate may result in pronounced QT prolongation in LQTS patients, the impact of adenosine was assessed in 20 LQTS patients and 22 controls [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/67\">",
"       67",
"      </a>",
"      ]. Adenosine or the related compound adenosine triphosphate (ATP) was administered in escalating doses until heart block, sinus bradycardia, or limiting symptoms developed. Compared to controls, patients with LQTS had less QTc shortening during bradycardia and greater QTc prolongation during the reflex tachycardia that followed adenosine infusion.",
"      <br/>",
"      <br/>",
"      Further study of this effect is necessary to assess the possible utility of this test as a screening tool for patients with borderline baseline QTc values, as well as the impact of specific genotypes.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/9/10389?source=see_link\">",
"       Mexiletine",
"      </a>",
"      &ndash; In one report, mexiletine (a class Ib antiarrhythmic agent with sodium channel blocking properties) shortened the QTc interval (from 0.535 to 0.445 sec) in six patients with LQT3, which results from a sodium channel mutation, but produced only a nonsignificant shortening (from 0.530 to 0.503 sec) in seven patients with LQT2, which results from a potassium channel mutation [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/51\">",
"       51",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Facial immersion test",
"    </span>",
"    &nbsp;&mdash;&nbsp;Syncope during swimming, including immediately after diving into the water, appears to be relatively specific for LQT1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/68-70\">",
"     68-70",
"    </a>",
"    ], although swimming-related events may also occur with familial polymorphic ventricular tachycardia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/71\">",
"     71",
"    </a>",
"    ]. Some of these events could be mediated by the diving reflex (also called apneic facial immersion), a vagotonic maneuver that can reduce the heart rate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/9/2202?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical features of congenital long QT syndrome\", section on 'Triggers of arrhythmia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cold-water facial immersion has been proposed as a provocative test for LQT1 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/66,72,73\">",
"     66,72,73",
"    </a>",
"    ]. In a study of 17 children with prolonged QT intervals and 48 controls, immersion of the face in cold water prolonged the QTc interval from resting values in children with a high probability of LQTS by the LQTS score, but not in those with low and intermediate probability or controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/72\">",
"     72",
"    </a>",
"    ]. The children with definite LQTS also had notched T waves during immersion. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Other ECG features'",
"    </a>",
"    above.) Because patients who responded had been previously identified by the LQTS score, face immersion appears to add little to diagnosis. We do not perform facial immersion testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Genetic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic testing to identify specific mutations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/7,74-76\">",
"     7,74-76",
"    </a>",
"    ], is now commercially available for clinical use. As a result, genotyping is likely to become more frequently utilized as part of the evaluation of patients with LQTS. However, congenital LQTS is a complex and genetically heterogeneous condition, so a negative test does not exclude disease.",
"   </p>",
"   <p>",
"    In a consensus report of the European Working Group on Arrhythmias, clinical scenarios were identified in which genetic testing may be useful [",
"    <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a patient with the diagnosis established by clinical criteria, identification of a specific genotype may result in modifications in treatment. For patients with LQT1, strenuous exercise should be limited, while beta blockers may be beneficial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/52\">",
"       52",
"      </a>",
"      ]. In comparison, beta blockers are less likely to be effective in LQT3, while",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/9/10389?source=see_link\">",
"       mexiletine",
"      </a>",
"      may be beneficial since it shortens the QT interval [",
"      <a class=\"abstract\" href=\"mobipreview.htm?33/6/33897/abstract/51\">",
"       51",
"      </a>",
"      ]. We have not discontinued beta blockers in patients with LQT3, but have added mexiletine.",
"     </li>",
"     <li>",
"      In a patient with borderline clinical criteria for LQTS, identification of a specific mutation can confirm the diagnosis. However, the diagnosis is not excluded by failure to identify a known mutation.",
"     </li>",
"     <li>",
"      In asymptomatic family members of patients with an identified LQTS mutation, genetic testing can confirm or exclude the diagnosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Genetic testing in long QT syndrome is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/0/28681?source=see_link\">",
"     \"Genetics of congenital and acquired long QT syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41937607\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The long QT syndrome (LQTS) is a disorder of ventricular myocardial repolarization characterized by a prolonged QT interval on the electrocardiogram (ECG) (",
"      <a class=\"graphic graphic_waveform graphicRef77018 \" href=\"mobipreview.htm?26/24/27008\">",
"       waveform 1",
"      </a>",
"      ), ventricular arrhythmias, and an increased risk of sudden cardiac death caused by torsades de pointes or \"twisting of the points\" (",
"      <a class=\"graphic graphic_waveform graphicRef73827 \" href=\"mobipreview.htm?42/7/43134\">",
"       waveform 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The long QT syndrome may be congenital or acquired. Mutations in at least twelve genes have been identified thus far in patients with genetic LQTS; the distinct genetic types are designated LQT 1 through 12 (",
"      <a class=\"graphic graphic_table graphicRef58937 \" href=\"mobipreview.htm?42/34/43565\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The corrected QT interval (QTc) is the most useful diagnostic and prognostic parameter for LQTS. Since the QTc varies in response to physiologic factors and drugs, the sensitivity of a QTc from a single ECG is less than 100 percent. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'ECG features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The normal range for the rate-corrected QT interval is similar in males and females from birth until late adolescence (0.37 to 0.45 sec). In adults, females have slightly longer QT intervals than males. A corrected QT interval of more than 0.45 sec is considered prolonged in men; 0.47 sec in women (",
"      <a class=\"graphic graphic_table graphicRef78934 \" href=\"mobipreview.htm?8/61/9179\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Normal range'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For increased accuracy, the QT interval should be measured manually on serial ECGs, using multiple leads, and at similar autonomic states (ie, resting). Several successive beats should be measured and averaged for each ECG. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Recommendations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other ECG features of LQTS include abnormal T wave morphology, T wave alternans, and increased QT dispersion. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Other ECG features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnostic approach to LQTS includes evaluation of the specific clinical setting (cardiac event, asymptomatic family member, or incidentally discovered QT prolongation), assessment of the ECG features described above, and exercise testing. Symptoms of torsades de pointes in patients with LQTS include palpitations, syncope, seizures, and cardiac arrest. In some cases, additional testing is necessary. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The LQTS score may be helpful in evaluating individuals with suspected LQTS but it is probably not adequate for screening of family members of affected individuals. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'LQTS score'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial diagnostic strategy includes evaluation of the presenting event (presyncope, syncope or sudden death), obtaining a careful family history, careful evaluation of the QTc, exclusion of secondary causes of QT prolongation, calculation of the LQTS score, and exercise testing. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Summary of initial diagnostic strategy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In some patients, the diagnosis of LQTS may be uncertain after application of the diagnostic criteria outlined above. Additional testing, including ambulatory monitoring or drug testing, may helpful in such patients. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Additional testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Genetic testing will identify a specific mutation in approximately 75 to 80 percent of patients with LQTS. It may establish the diagnosis when it is uncertain, allow for efficient identification of affected family members, and have prognostic and therapeutic utility by determining which gene is involved. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Additional testing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/1\">",
"      Moss AJ. Long QT Syndrome. JAMA 2003; 289:2041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/2\">",
"      Li H, Fuentes-Garcia J, Towbin JA. Current concepts in long QT syndrome. Pediatr Cardiol 2000; 21:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/3\">",
"      Jackman WM, Friday KJ, Anderson JL, et al. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988; 31:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/4\">",
"      El-Sherif N, Turitto G. Torsade de pointes. Curr Opin Cardiol 2003; 18:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/5\">",
"      Passman R, Kadish A. Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes. Med Clin North Am 2001; 85:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/6\">",
"      Khan IA. Clinical and therapeutic aspects of congenital and acquired long QT syndrome. Am J Med 2002; 112:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/7\">",
"      Wehrens XH, Vos MA, Doevendans PA, Wellens HJ. Novel insights in the congenital long QT syndrome. Ann Intern Med 2002; 137:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/8\">",
"      Camm AJ, Janse MJ, Roden DM, et al. Congenital and acquired long QT syndrome. Eur Heart J 2000; 21:1232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/9\">",
"      Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol 2000; 36:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/10\">",
"      Funck-Brentano C, Jaillon P. Rate-corrected QT interval: techniques and limitations. Am J Cardiol 1993; 72:17B.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/11\">",
"      Malik M. Problems of heart rate correction in assessment of drug-induced QT interval prolongation. J Cardiovasc Electrophysiol 2001; 12:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/12\">",
"      M&ouml;nnig G, Eckardt L, Wedekind H, et al. Electrocardiographic risk stratification in families with congenital long QT syndrome. Eur Heart J 2006; 27:2074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/13\">",
"      Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA 2003; 289:2120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/14\">",
"      Cowan JC, Yusoff K, Moore M, et al. Importance of lead selection in QT interval measurement. Am J Cardiol 1988; 61:83.",
"     </a>",
"    </li>",
"    <li>",
"     Goldman MJ. Principles of Clinical Electrocardiography, 8th ed, Lange Medical Pub, Los Altos 1973.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/16\">",
"      LEPESCHKIN E, SURAWICZ B. The measurement of the Q-T interval of the electrocardiogram. Circulation 1952; 6:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/17\">",
"      Taggart NW, Haglund CM, Tester DJ, Ackerman MJ. Diagnostic miscues in congenital long-QT syndrome. Circulation 2007; 115:2613.",
"     </a>",
"    </li>",
"    <li>",
"     Garson A. The Electrogram in Infants and Children: A Systematic Approach, Lea &amp; Febiger, Philadelphia 1983.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/19\">",
"      Berul CI, Sweeten TL, Dubin AM, et al. Use of the rate-corrected JT interval for prediction of repolarization abnormalities in children. Am J Cardiol 1994; 74:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/20\">",
"      Rautaharju PM, Zhang ZM, Prineas R, Heiss G. Assessment of prolonged QT and JT intervals in ventricular conduction defects. Am J Cardiol 2004; 93:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/21\">",
"      Toivonen L. More light on QT interval measurement. Heart 2002; 87:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/22\">",
"      Hnatkova K, Malik M. \"Optimum\" formulae for heart rate correction of the QT interval. Pacing Clin Electrophysiol 1999; 22:1683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/23\">",
"      Bazett HC. An analysis of the time-relations of electrocardiograms. Heart 1920; 7:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/24\">",
"      Fridericia L. Die systolendauer im Elektrokardiogramm bei normalen menschen und bei herzkranken. Acta Med Scand 1920; 53:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/25\">",
"      Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993; 72:23B.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/26\">",
"      Sagie A, Larson MG, Goldberg RJ, et al. An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study). Am J Cardiol 1992; 70:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/27\">",
"      Malik M, F&auml;rbom P, Batchvarov V, et al. Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval. Heart 2002; 87:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/28\">",
"      Manion CV, Whitsett TL, Wilson MF. Applicability of correcting the QT interval for heart rate. Am Heart J 1980; 99:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/29\">",
"      Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med 1992; 327:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/30\">",
"      Kaufman ES, Priori SG, Napolitano C, et al. Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: experience in 101 related family members. J Cardiovasc Electrophysiol 2001; 12:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/31\">",
"      Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999; 99:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/32\">",
"      Kligfield P, Hancock EW, Helfenbein ED, et al. Relation of QT interval measurements to evolving automated algorithms from different manufacturers of electrocardiographs. Am J Cardiol 2006; 98:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/33\">",
"      Malfatto G, Beria G, Sala S, et al. Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome. J Am Coll Cardiol 1994; 23:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/34\">",
"      Zhang L, Timothy KW, Vincent GM, et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 2000; 102:2849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/35\">",
"      Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995; 92:2929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/36\">",
"      Moss AJ. T-wave patterns associated with the hereditary long QT syndrome. Card Electrophysiol Rev 2002; 6:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/37\">",
"      Zhang L, Benson DW, Tristani-Firouzi M, et al. Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation 2005; 111:2720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/38\">",
"      Schwartz PJ, Malliani A. Electrical alternation of the T-wave: clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome. Am Heart J 1975; 89:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/39\">",
"      Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993; 88:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/40\">",
"      Zareba W, Moss AJ, le Cessie S, Hall WJ. T wave alternans in idiopathic long QT syndrome. J Am Coll Cardiol 1994; 23:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/41\">",
"      Burattini L, Zareba W, Rashba EJ, et al. ECG features of microvolt T-wave alternans in coronary artery disease and long QT syndrome patients. J Electrocardiol 1998; 31 Suppl:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/42\">",
"      Shah MJ, Wieand TS, Rhodes LA, et al. QT and JT dispersion in children with long QT syndrome. J Cardiovasc Electrophysiol 1997; 8:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/43\">",
"      Schwartz PJ. Idiopathic long QT syndrome: progress and questions. Am Heart J 1985; 109:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/44\">",
"      Schwartz PJ. The congenital long QT syndromes from genotype to phenotype: clinical implications. J Intern Med 2006; 259:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/45\">",
"      Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation 2011; 124:2181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/46\">",
"      Hofman N, Wilde AA, K&auml;&auml;b S, et al. Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system? Eur Heart J 2007; 28:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/47\">",
"      Rossenbacker T, Priori SG. Clinical diagnosis of long QT syndrome: back to the caliper. Eur Heart J 2007; 28:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/48\">",
"      Swan H, Viitasalo M, Piippo K, et al. Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol 1999; 34:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/49\">",
"      Takenaka K, Ai T, Shimizu W, et al. Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 2003; 107:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/50\">",
"      Sy RW, van der Werf C, Chattha IS, et al. Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation 2011; 124:2187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/51\">",
"      Schwartz PJ, Priori SG, Locati EH, et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. Circulation 1995; 92:3381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/52\">",
"      Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/53\">",
"      Crotti L, Spazzolini C, Porretta AP, et al. Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. J Am Coll Cardiol 2012; 60:2515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/54\">",
"      Walker BD, Krahn AD, Klein GJ, et al. Burst bicycle exercise facilitates diagnosis of latent long QT syndrome. Am Heart J 2005; 150:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/55\">",
"      Garson A Jr, Dick M 2nd, Fournier A, et al. The long QT syndrome in children. An international study of 287 patients. Circulation 1993; 87:1866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/56\">",
"      Eggeling T, Hoeher M, Osterhues HH, et al. Significance of noninvasive diagnostic techniques in patients with long QT syndrome. Am J Cardiol 1992; 70:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/57\">",
"      Eggeling T, Osterhues HH, Hoeher M, et al. Value of Holter monitoring in patients with the long QT syndrome. Cardiology 1992; 81:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/58\">",
"      Lupoglazoff JM, Denjoy I, Berthet M, et al. Notched T waves on Holter recordings enhance detection of patients with LQt2 (HERG) mutations. Circulation 2001; 103:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/59\">",
"      Christiansen JL, Guccione P, Garson A Jr. Difference in QT interval measurement on ambulatory ECG compared with standard ECG. Pacing Clin Electrophysiol 1996; 19:1296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/60\">",
"      Bhandari AK, Shapiro WA, Morady F, et al. Electrophysiologic testing in patients with the long QT syndrome. Circulation 1985; 71:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/61\">",
"      Wang DW, Yazawa K, Makita N, et al. Pharmacological targeting of long QT mutant sodium channels. J Clin Invest 1997; 99:1714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/62\">",
"      Windle JR, Geletka RC, Moss AJ, et al. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation. Ann Noninvasive Electrocardiol 2001; 6:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/63\">",
"      Ackerman MJ, Khositseth A, Tester DJ, et al. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc 2002; 77:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/64\">",
"      Vyas H, Hejlik J, Ackerman MJ. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. Circulation 2006; 113:1385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/65\">",
"      Shimizu W, Ohe T, Kurita T, Shimomura K. Differential response of QTU interval to exercise, isoproterenol, and atrial pacing in patients with congenital long QT syndrome. Pacing Clin Electrophysiol 1991; 14:1966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/66\">",
"      Katagiri-Kawade M, Ohe T, Arakaki Y, et al. Abnormal response to exercise, face immersion, and isoproterenol in children with the long QT syndrome. Pacing Clin Electrophysiol 1995; 18:2128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/67\">",
"      Viskin S, Rosso R, Rogowski O, et al. Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome. Eur Heart J 2006; 27:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/68\">",
"      Moss AJ, Robinson JL, Gessman L, et al. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol 1999; 84:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/69\">",
"      Ackerman MJ, Tester DJ, Porter CJ. Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clin Proc 1999; 74:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/70\">",
"      Batra AS, Silka MJ. Mechanism of sudden cardiac arrest while swimming in a child with the prolonged QT syndrome. J Pediatr 2002; 141:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/71\">",
"      Choi G, Kopplin LJ, Tester DJ, et al. Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation 2004; 110:2119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/72\">",
"      Yoshinaga M, Kamimura J, Fukushige T, et al. Face immersion in cold water induces prolongation of the QT interval and T-wave changes in children with nonfamilial long QT syndrome. Am J Cardiol 1999; 83:1494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/73\">",
"      Kamimura J, Yoshinaga M, Kono Y, et al. A simple method for evaluating abnormal lengthening of the QT interval during the face immersion test. Pediatr Cardiol 2002; 23:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/74\">",
"      Priori SG, Barhanin J, Hauer RN, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management parts I and II. Circulation 1999; 99:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/75\">",
"      Priori SG, Barhanin J, Hauer RN, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management part III. Circulation 1999; 99:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?33/6/33897/abstract/76\">",
"      Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000; 102:1178.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1053 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-3453397B85-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33897=[""].join("\n");
var outline_f33_6_33897=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H41937607\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ECG FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      QT interval",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Measurement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Impact of U waves",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Special circumstances",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Correction for rate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Normal range",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Automated measurements",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Recommendations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other ECG features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - T wave morphology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - T wave alternans",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - QT dispersion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      LQTS score",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Exercise testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17394416\">",
"      - Exercise-recovery QTc",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Summary of initial diagnostic strategy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Additional testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Ambulatory ECG monitoring",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Electrophysiology study",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Drug testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Facial immersion test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Genetic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41937607\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1053\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1053|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?9/27/9662\" title=\"figure 1\">",
"      Trigger event vs LQTS genotype",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1053|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/34/43565\" title=\"table 1\">",
"      Long-QT syndrome genes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/48/2830\" title=\"table 2\">",
"      Causes of long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/61/9179\" title=\"table 3\">",
"      Ranges for corrected QT interval",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1053|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?26/24/27008\" title=\"waveform 1\">",
"      Prolonged QT interval tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?42/7/43134\" title=\"waveform 2\">",
"      ECG torsades de pointes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"mobipreview.htm?7/48/7937?source=related_link\" title=\"calculator 1\">",
"      Calculator: QT Interval Correction (EKG)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/55/23418?source=related_link\">",
"      Acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/9/2202?source=related_link\">",
"      Clinical features of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/0/28681?source=related_link\">",
"      Genetics of congenital and acquired long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/3/26682?source=related_link\">",
"      Prognosis and management of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/51/26425?source=related_link\">",
"      QT dispersion: Measurement and interpretation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/48/5898?source=related_link\">",
"      T wave (repolarization) alternans: Clinical aspects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/36/9800?source=related_link\">",
"      T wave (repolarization) alternans: Technical aspects",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f33_6_33898="WHO weight for age boys 0 to 24 months";
var content_f33_6_33898=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50006%7EPEDS%2F67950%7EPEDS%2F58632%7EPEDS%2F53474&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50006%7EPEDS%2F67950%7EPEDS%2F58632%7EPEDS%2F53474&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 593px\">",
"   <div class=\"ttl\">",
"    Weight-for-age percentiles, boys 0 to 24 months, WHO growth standards",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 573px; height: 532px; background-image: url(data:image/gif;base64,R0lGODlhPQIUAtUAAP///+Xl5QAAAPDw8GBgYDAwMKCgoODg4ICAgCAgIIiIiEBAQNDQ0MDAwLu7uxEREVVVVTMzM5mZmURERLCwsO7u7pCQkCIiIszMzBAQEFBQUHBwcN3d3aqqqnd3d9bW1mZmZo+PjyoqKsjIyHJychwcHDk5Oaurq7q6up2dnQ4ODkdHR2RkZD8/P39/f7+/v/Ly8vj4+Ovr6zQ0NK+vr9/f38/Pz5+fn9XV1ZycnOjo6OPj4+np6VxcXO/v7wAAACH5BAAAAAAALAAAAAA9AhQCAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqoAKtrq+wsbKztLW2t7i5uru8vb6/wMHCw8TFxsfIycqvicvOz9DR0tPU1dbX2NmxzQJdrVvfTgFP407d4uRP503l7Orp6E3r7vHy8PT29Uvt+Uz8++bmWQl3haAhg1kQDhSo5F/Dd/oAmrvnDyK+iv0uSsy4ESPHhxqXMETiMEnJIwqppJSyMlBLlSNhUuwocibIjyZtJol55GTP/4k6SVr0SLRmxJxDbxbdyTPKS3VN/zxlGRXK1CE+jWQtUhVrUJRftSZVSnMnlK1E0A7pKkRt27FIlyph6xaA26vy2IrUqwcvVHB669YNHJZr4bRwhR5Fwldw4p+LGR9++7iI47xa/M7lm0cz5swCAogeTbq06dOoU4sOrbq169esX8uePTo27duqbePefVo3798BfAPfLXz4bM9ME3LGg3wv4MmUcSoOaTYyZOnX5YKFbreyZe6EqVfXnn0zaOXcvC1Pbl0sUPHl53IfPP89fPfY8ZM3En4///bffYZFc/ytZweB7KEHIGL2lRUXE/35R0SEDm63oFcNkqXheBJGl/8fg/dNaGCBCh6CIGMjknihh0aFCCKE9WX4YIX/xfjhizTW6CKLLeYYIIQpiljiQUGqOKSPOMq3YncyTtehEBRuaOGOPHKIJIY3YnnlWkveVSSUX544h5hGDlicccehCdyZarrGZpupvQlnnHPiJmedpd2JZ3BfAkCmn32+8aeQ53XpXZIzKkklk1lW6aSii9JnaJPxPdqjlJWi1OefgwoaKJjPTdooo0/6aSOMol66JamqJuqqZCvWZWqkARVa0KdtdAqqraVKSiul+q0a5as6/jrqZccuOWuvtR4pEyK6AhqqsahS26qlxBa76l1ngXfqtZkGC+6PTw7KKa5srKT/gCsKCOFABC916hey1TILLLnCfmvltodqmW+sVqVqnrMVPNBKBBwIAUIr7ZZZyFMdCFABBwKAACRge6aZMWwbc9xxbh+7GTLII6OmJ57mNhWBBwCAcAEGCRK5hAIXAODBBAKaqe++2eILKb/3IortlPYmu+Sw4RLds9AOV9FSBRdIUIEADgxsIiwuEEEx1QBMYLAACAvxwizTFl0v0EYvinTSE3Z79M6wUikrXdCl7EoRC+PsgABfNwxAC7CkpwQGAnAAQcMRWIxi2Wifjam4PA/NdtsCRy455HGbPa7Pl2u7tL8xL6QEBCAQLkTECXOF7horTVB1xBgoEEEFAKwc/7rolVuO+eRc5p554z8DH/znjipN/Ny+N/0sERJAIEQEzj8gAQAR06664Easy7AQELQygfWaMv4457+Pz7TnxLM6fOfnU548+uyDrjv5uxvPe/HXO4sBvGAn7MAFfJue8gQRLXmdbE8HRFnJTLZA0yRQgQ3MUwQlOEE+8cppq1NDAQM1L2+9zzAfdJ/m5ke/+oHQWuu7H/JQuDhnTSFa6cKVAeFmv/upj4Tyix+UaHhCFpYvfb560gpH2EKdGfFq6klCxIigAIPhLHwh7J0Pa2jC9olQeD8EYr/wV8IebmmIWITiEZY4hCYK4In5uxX2LjiECRBEAgIQYBGJmEUbBv8xjFTsohV3yEMvmi+HedzjDXE4yPu17o1xvN0LM5iGDSZhb0OIgN/miEf42XGLhayiFOloyUsGDZCa5KPcAjbFNBoBks+b5ACdwkg0bPAVWRsCKv30NTSOTRu4zKUud8nLXvqSGUSYJd+8NwTAAVON0JIhT2b5gKpxQHpi5GQn9QhKP2rxk1wUZGM8WEpr6hCMf8zmro7ATGdC05QYXKML3bUO0gHgmR2IZiW96cm0lWptodzm26IoSiGSUpqEImc7LQbPVVqllWdw5BHc2IrpcYB/LJNnODNJz1BS9IoTvWNGsSnOji4LoBg93j/nuZaYMDSRD21FRNG5PJlxYYb//PwoSTc5037WVJ9q62NIvznSjeYMd8hE4ks5iE9q2tSn9vxXN2laU5ki1XEi3SK9rBZUoLpUfBisYG20uhquBoerD6xTWOE01jaV1TgpW6dLlIlVHV6UqddM6kSLqk235TSmdPWoU93qJTYuUp1HDGxT8+pRwr71qHHdnFEPu1e+YtIt4EwsVa2azmQm0a+O5ehUU2hRjUqWkB71bGbl6tbGdrZZgm3pw9iK2XpCdbSvda1iq1lXncIVtrPtaGRxq8i/pnYQClXraTXLTZDeVragZaxokQtayPb0s5SsbFVXe1nlePWsaMIuWsHq1a9y97sTTOtvCcha4S52ucMl/61bDcst2yKWt81VFt1WJN7pEkJd7BoCBy6ARolK17jvZW4d0xtbAnPWwAcWJGMJu1sBG/SgRijYwVIHgHVV7cF+gJjEAFABePUXw3/Bq3tNi+D40teu9xwxg58LX//6Fgm2AwAcuQZiPjyFZs8DAQg+zNL/DlbFQOYnTlMsYoBJtW6b4gnUpteBB0Tswj0mLyy11oqqTQBnOx7CLbfR2hIP+LyPLe5NUaxUAJPYqA32co2BdDci5A0Ae3MAxaBszDYLNQmE25oreFxSjIG3gtodTqB/M+g1XffQgE7y6HQMCyj32bILfZ0AYKYwPj/avApGL5iJu8+lBtjB08x0mP8XdWbamlpazmre85wnhDm7eK1I0J4AJpnl3r7YzOwd9V09XWpRc3rX/jwyfRVdhP1NWL80jjKsh9pWUFd00+q1Ya5HpVxdE3mUwnbRARZQX8ret7zjdfZOxX1cNYf61Icdcpl/bGRsbrYICMiAne17a+oyu8vQLnC+c1vtX5eLzHMNMrbd/ZUGJEAAC2BAt3387eqaCdFaLTRvJG6n7lK84n/e2AhWIAAVhGA1xKY3eR0ucnJ/et8JRremfa1vlJsY2F9ksWwHgIBWbGAAly45hCHdbKoIHNc/H3PQn8pv52abKBaQ9wIOoGxWYroPwTUCGWX8CkfnnN287nVorb3/JXUHvMgDb1RdZCAEChy8AA149dRnXOU1T7bh9zYCQ4cggZq9HbpfZnnLVc71cHo9fdOO9mK1LqsXcDsDBujt3IVQ97v7nOetnSXbVXl1oqd86/5et+XzrveiizmcaR58CzKAAJzbWvL5dbutAfFKV8SSnUaAI6W3/Mva2/72uM89MGLZvTPSTnvnrPMuijBLuk9aCMIPE0LNEHXijyTZAQU62KXP67+vd+hRJXiFL0C7CXhgavH0gN1Re8rnWx3VOpcKuJ0/BAhMTwIPAF/0sU79+gt9+vSPubDF//sIAOACEFABCsBq5Md+3PN+8ad60QVc69dGrjA9wCdHTedy/5yHeYK3WIHHb/12gQq2YsKWUnzjf7IzARdwfo53UhDYCuc0gQUIdz3ndPi3eRW4gXtngRr4bjOIg4F0aqGXJBAAAYRDO3sjf87xdBcDeUb4UzK4gzboeZ0GYNYnbdjHU0dXYVRDOPEER0ToeI+XfhnWgFmVcRF0cbdBhhojhg1khmfoGjAgBAAUNUIQgUIgA7ARct7GgCR3hy3GhDTohDC3hM9GgXyog+emWzJnBCPwAnmoWoyIh3EXbuYWiHyXeV9XfQAHeFOoQoc4BAdAAALwevgWYl4IdWDYiHtYiH14ean4cv+WiZE4bqEUejQnbytQA4tYb6a4bC+4c1mXgf9+eG1QeInXF4PZJx2ziHANQIjzx3C46IjZk1/GVjFc2IX2B4iS2ISqqIzl9orb2HnZKF9HEG/IiI1H0AALx2FfEzYe0Aov82qsFxXVIwEsQziU5o6sBHGAho9jaHH6uI+kEQIlIAAlcAJ7kgIm0HtdZjtACAA/aI9fODPjx2HHt4C5yI0n542sqHl4h4qrmIOfV4zVYgAHlwCJJ4giSQBMd45DsGRE4AEEuIwMOGXIBn3ep2VkE4qTyIHo5ovfeGKuKIioaHQTYXYCQJLwZQAFgJKVBxPz1jJnFEwPQGHJB1jFVjgcljhFmITa2I05WYMdOYh1I4xSSIxUaA6HZwH/T0VzBVB6LNiCROBOMtaODkmKSOA61DNpDrCCqweDvfiTGOmRPkmWJqd1h+UWDXB4bDlRMSAENJcAidmWSqhqteM8EzA7e/mQRyBr7bIwrqA4c+mWp3iNXxmUHxmaXNmVv6iRZZkEhykA8mZ6qwIANYAABWAAsKmA0RWNCKNnrUBhSzlyj3gr/ZiGw1kyariG4dVAI2ACHUcCH3AybegEPfBxraGS1GhvuyiK1biRpPmE99eXghmLSNCJraCUhNd+3kM7nKkZ1smXV4WToDmYPJmRlRiMfomaPbkU5CkA5nmRlEEz3ccyOtaMBOqe2AmfSsidormV/kmOgEklUWhR//P5oB2xn/15muXAfxXmf5xZgrw4ikd4Zwgaottpmqc5mgsalvfpoGBJDxbKdExYDiD4AP43BCDwAB+qhwbqgiOalSUqnyuKoicqpCfKoIQJWce4dJfnEA0pS3zRnjnKo0kIJMVpnFUaMscpG1kqMnDyASSgAgJgAgRZnbMRnXHINREAM7VGh25ih8wInNkZnxZ5pKUJpEImlhIapFuRpGnXKB9gA24oAHDIkAdTjwlaoFHqjK01dexEeeP0o3M6oS0KoXiKgXqaBEl6ApvImAhQAjRwi3fpfI56LlSph4snBBhgMI6KfpAKlCnqndY4pEYqqd1ZBHzKWCR2ALRpAP8f0AXmaFIGkaqz9pk+eqBqNUvPVHer2kGwqqCw6KrP+pccOauXWgRJV5R9iqsx0YlGyViLqQQGsACeuEzrkKwXMKrKV6pvCmfnsF/tcq4UaafgOa/2GZ7QWqREIJJFWZLo5lSdWJvSepIpSa6tBq/wipsIWwet1wqgiEpstz0AQHu6N7EUW7EWe7G/YIAPO6x/EziQqH6gWnxuuKy0+qp/6Kz4Gpj0mn8Noa/dakOzcpgLkK35ppaP+agGSAQHC5nFKqXjhYI6S7LVerIm2qBESphHS6fNegQGEJAvW1oCQAHiygA+xa38GmVAOwQ7C5PX6bMgeqjy2qrSWqutaK//YxuI+loCV5s+BsCfMKqYNkAAC7C2PNuziAqywamjkTq0wPidYoufuuOyBiCU4JqU8+UECECz8bqjd4uZcQq2e2u2gEuhXVepHTiFBueaCGCImEqbbHm4j2u3XauoU7oXV4qlp9sxW8qlEWcaJ8CcKuCcbeKlJSC7XSUb0dl73wNnBiOXbFqdblqReBu6ohu2LIuyRsugEWqp09eapHebhWkEulqb0DtfANo1LPMA7eIBNSqniTq6cFoEmikEDOWZxEqix1u0Sku0Jre8l1tkznuzPEgEVluBGcp9GxqE7Pq9XSth/cO7gmqov6mLSFA9AFpQi8u46luy0Tq5k1q2/ysbq2sRv9ArSOXwr3TbwEwyoxGASnvjm8WrwM+TvdvbvVxLwJlZMxAQUROwqqz6tdQquSxKtpXLt1vyq8/7RQ2gATNbg0wKhBsmsiHMv0umv0L8wt8mk63Wdi1MvoojsU2pt/eavHUauZZow+bTmgIgv/HTACbQw41yAp9aRlyjvTZjwuiLQU35Zh5slR17TO95BHm2wuTrwgaUuqqLxxmzumTaQK/bnIVmkBCAArQhJyFwkDgQqIOalwE8h3XYZaRjxM+3fGXQOpIWO9yHwOc7xGerwUnLwClLqVj8KhS8vkYgsNoKrgmAkrLivdrJeKwGPQBgxty7ycwRE+PbNf+tYL4Ju2YxHMHIa8o1LMOpWMpUfMpJ+ba7ZbOm18qQG6W66T+9K8A467VSzL9W/LczbLIQrM00qMUEUL0UMQAWsJbQC07MrGBmysmu/MyO26PTOMXCXJ/p276Wu5Mxsm3l+baeXA6NycWpLAT1a5FQ+srWvK7ga7wSfMzsS9D3XFjz8aLNpZYWUMH92g0MILcZvM0DLMLYPLzwzBR6vMcjDUFoOBwj0HsQMAJ97BojwAIiQJ1mZQJiOobB27h0mbcILc+gzNB9u9Dui88LItEtx60hsCLhKgBUC4U3ndDvCKpOzdOjPIxXTMxZYaEjUBmdOLfRuwQCC7pd19QeDdL/pRvPnRzKPx3MPR3UEB0ZEi1aDSC32Uq4tuq5pgfWfifWH/3OZX2ZDkzD9LzQ80w8bL1gNkHUhl0EMqu4dM2p5qzByqvXBk26H7vXf83NqqnQyFvYK6cliN3WQnCYGqC4nMuJBPC0GIpkId3LY1KKi1TSJp2PrQvbAZDSrbDSgiYagszSbYICEGACMu1AESfZ7Wxjrh3VZ+3TmZ3NflvPWvHZGIjKoAcAi51bkb3addsZxz3WyT3YVO3NyvvQic0EB9B7F3o/bXveOhQCUyt2k3EABV3ce9B8RDB1uezLVSzVVq2iZgvd7IOUNXcYIgkB/GzdhbHDBdAS9p162Z3A/3z9swpRPcT6y+Cd38nN2Vo9rgSQ1dbxzzi3Nszcg5NLzqtMtYfEEBLe4LZ8B/TtpNkTkSfM3ILd095tSOItWm+tEx6O1kOQzgE9Qv9a0QMsxDjG2tVM2beixPs7k1AGxRj75FAe5VLuSzn7Tm2HfB77tX3h2kKcZxNu4Zfdz2DO0Ub7yfSr4QWOLNO70f2R0VxtUecJBWq5AQU+5Azh5Spu5HHQ4rBHvpf85Uur2QvsXhgOFP5dbQPtkdUNtcqCACRp0XbeRn+e55ROB3wOtPfNsxTu3Ppd1b146B41Aqe90Z7M3gSw1OkT505gi2lMvg9ohRBb6R1N1pU92YO+3/+B7tDu9atueyWdaAIU8EkDXucwO18PWzPr+aTE7c45HXtf41D8s7sObuuCXu0yvtk3zgTgTOwm5ObJWBkhDo4h4U4DitwtWAEMZZlyqOdwsBIeAIE4WsvJ6tcBQdtzwsd0Mtt+DLskEGivW9NliBpeKgK2i0BlGkxW2aEX9ru5Ebwc8D1QowDgZzMwfuThO0Y4WndS8wDUPOuWTebKHdhqTejZXo6I+eE6seigbdqo3dhLWgQxZqM4Su0eLUn/F4ADuOIHgjVFsF/x9FA3SoBOTlRTPZbAXLSFTgTGLMyHeep5OgRunsEuT0j8AH9EeMT0zmYKITtxGAEkSGdZHsf/RJCqAkTH2Jv1rX7rR2/tU5z0AHAAGqC54lwPTc/tkqLy4tkvA0ACNyAEER9Jampp036oIGCZkryFMMQ6uCyXDOl/HbZS7I7EI4/rDd32JW+hFk0Y0r1e4er00+0dGZ0AIeADcYi/3FOoH5/GQD8EWEh1iE/JZLASAPSAICjtOg/old/dNL7WNz4AG7DPoBUCq8ztgpTexG/Bhxiuo42r8t2zxw7reunxzY7dBWLvZGX9akKGXgqmJsDb+d4aAInbaDLw/d6PI0ACJcAC3h8A67wEDB8ny572KFzr8r3pM170+XTPBqB0pA0EAOEQICAehYYC4hBAPoVO6ACxHBSh/09pdrjlDo3DBqFgQHq/si84vF4L2u4sXF633790PFe/R/bX0LgE5+oIoQ6f4r4Sz+oWBw3lICO5KBIEElIes5QQrgAajwgPCBLMwCTdRI/ClAgaEFXfKPcA/YpqcXd3b3lzf9lmAznlWLuKV4fzlivf7BIbFgQyzI6FIAcsrIiuQ48YCBZQiXQdlR83Epicid18/eDx5IPrJ81t8e3oz9Hfm7N404fMWDJ3/pgBLEXtUxSDVNaB6jZL2oJYigBqkdNAgwBy7Rjdq8fv0UB7J1uZLGmP5MSCkzJqhPkSYcKaIAstowKHgMRvMyE2lKnMwAICDPjEHPVlgIEER016u//WUuQvqiixAjt59Z2AAF/BhhU7lmxZs1+9nlW7lm1atm/hgnUbl+7ZuXQRqBBgYkTdsAI+kChB4oNfsiFKQOir9q5huCNYiCCM1nFltCrzYJ6jOWswrlU9q5RqMCTNZ6ZL/0ONEwpmKZcEFLjYj2lsCz5lMa1CAnfOm7mPUNAwrtXqgKB5fd7cmXlrzplZilZa3Djw07+t2zy4PakhaZk+0p5SRXoWKlYETicoRNtTpH+qD4Uemn5z+8K2Pneufv117qxb48+hmbCTrzs3DoCAod6WMq8KM8pDopRT+tMutdJK4SbAAsVbrr7k9LvvDuVoiU7An1TjsMEU/zuOwBb/s/ONCyoyEICAA7A7j5wIhwiHOJdYvHAQChZYgAL/ADTQQ6tCLKdJEZH7kMkT04uvQxmFTBI+K1e08AmnBFgAhWZ0pA6himYDEkkt2bNAhBtfZFNNPp7ED0Qo7SNxvtAs67OxPun6E1C4BB10rUIDOEEEAUpIobLARAiBLETLCsEECFAAlNLHIBABgcIINbQuPRWpUys8OyN1ySm5nPNAGJXEUs4KX83SxTWFOKCjDBCg1cUyN1zFKThnxSYjIo0cMM5bYU1pJFNVRbXE/Exs1ddgm+3SS2ZtxbbbWDE6YicbfZIKWFmfoMJTBq/0FiRtCiBW2SC5ZfMAdaJ1Ukpp/6nt94kO2pDgATgk2M/aebeNsV50FW44XBVd9daAGhd4L+J0SSiDXnGr+PTECDO8rV13HW63qQLgQFkXgIcQmOBS9+X3WZTkmaAPDwpW4AGDIb724Wwv/vnbkbfsGWHfGkA5gSPBJeK8EEgjYkJURlv2OGSZblrohaGAAQkKCIAjgQ1wrPnmnHf+A1pTZXbWXyQcgKSDtNWmMmqutTYTaJ+L3vvoAHVlSMsyqwRHnI+q3jjdKuQtue9ijzgAAUxszPpUuOWmW19W2642OjjgcIGIuI/g4IIOhngB9NVZb93112GPXfbZaa/d9ttxz1333Xnv3fffgQ8edtHlaEH3I/9IJ8J01IUwfvWYO++FbTsxJwKDBwrm2W8UcXU86MchL3z7YwyAo+Kbzv072KJg8Z5vvb8u8shrvMHCnwtAnwAABwa+AIPmqbEBi9UNCskTwvWyR8A7RW9mT3CZALLngAjwgx4GVID/6GQ3q7lPfVvDG9HgF74vfEcAlrtQ+t5XDgAMC0cf1Fat2hSvFnIPcvY7yAUSCIAHKAAAHoiAEBBgQpgVsA0X/J/2hFABmwkgAhUQAgjgwEMFMnCBSMAZAHQGAA4IAATTQsISIQgA/IEuh9Qb2gsZlrfvhdCFa1ThwWjotLDxyjXsmZwF2sie2LDjjG5MhdTIIDI/xhGGwBn/YwQ4gAEBONGAXYECGAs2xpe5TXkTqEAFLsBDEGAQiVSMBz7m1kP9eZFz47sbBwlJMlSKr4/XQkCN4FTHyQnFexARALtAOEgbYo2D9YvKESoQAQgkL24cWAn0hhABBVRAAA7IoCdBtDriDWF5AJjAwJhoTACoznWeM+UG1ZjCPxotlR5cJRIagAmLjNMNIdCQljIEIQ2+oz2Ny2UHzdkhBUxAkYzETL7YADokKOCHccOmFAHgPIFCU3pZQKAQICDFCHSxk7iAg6j8simMjkWjG/2LR8UyAhMIQAWS+ihbEDOZyoygUyYNQEdBOgIBSAZUILULXLzmAEsGk4c77OEP/wEgg7awTR4gaCIAFCkEgGlzcwz9JBSMOASCOjECHlhVFb+puHDik43nBOc9BzQuWrITCkm7UeLEUKQ02TCrWeDINATkSzcMIAQ30OIEBWDJ/fXviFGyKCQ4MFEiYA8AAHMiJZ06j1pIMowKyuthh4jMrZYTfHnk6hvJyUoRTixMM+yqEBiwAA20EK1Eal9lvZquYSGFRzXExxhCRzOiQkICq7vA/vBH2Ckmdh/Tw8b0uILWhE1Ws5al7GfBCoATTCMBa+1qKdYpzgGxMI3JJcUG3tla47JVahagHAE2IdsGYpW3x/QmeUX4VTSiUrvGbS8SBjDHXm3rQcn9wDb4WP/d9RpoDBpD7n4BDD7hiE1k3oiBX59ayvIiuKHjbetwrXtK4ko4l68UAARwiVkhpHOs4qRCCTqsygknIV7ONdbB5JqryVHjKLqcymwlu+CKNphPNm2LjW+MY8YM6gQlmOkJQvWVE1xqMX6BTKRqeqiYCoYERZ6UjndsKTggGcoA/W2MZbxbBdP4wYVMbfdGrNV2Ba4alzXWAYo0wKZNzcwnNhoDIEAhMIPVGwygRgA9G+BBWvlyf82yeR2MXuMW98sQ1rN0uYuTcW1AIlMRh4mv9NY0EVqNRdHACSh86OMC4GTmC0+Y9yRoxf6ZwX4OdHrFrOlNkxXVc9YWbBaQZ1b/7ESI3JKGBpxL6ZGdh2yrdrPfGhGOGq3jlwfjs5X5zMBkX/nUg860i5+NaF2vKLSZqHUjdFTHJDwlz4hub8gaHe02E6I9cNAA04pttGOvjdSOfJuoQW1oaKt33qmeyAA2AIcQd9ApDanjK7qty9byUtXvFY8BOpIJC3g23X5bN5bb3ect/xXKN614WWAK0oyHQC8rcPJbUjCYmsI0MCIXVca/8gHEKMZPNk0BBPSiAggAmaMX5yiMJx7xpjY7wZkVt6+BbvDkmqQBI20ud6RhT5N4lzdwFM293jlZoRMBBfgSwLm9HGF353xEvu3csiVuap/TW9o/F27WhxBfks73/yBoPh9qieCJAZxdv2KAgH9b+eszHmAbns6w3p29dXj3VufPPC+X8x70ebq63q62ACxHIAnoQjrRcdcQ3UU8hFdg2ukxQbjY8sv4Nvv64VwvPNiTHdyPLV7eZQdn0mITC298oL5evkTjMJ9PXuMo93DvkLBZjJQUdzl+pR+8zlEP3KkLnPVoV3Vx1Z4BPLYZASWYvpeS3u3eszGe4e48TfhOOQ0gbh9wTEQ9D2B8xBd+5xAvic2fDH+xoHyjjSGBXiCQZJTS9C1zGbLHbe4uhswEHKXK6CIEVmDKPsUy6M8wUKBTFvClcO74Ii75Di/w7M31MnD0xCedYo9ozIr3Zv9CV6Kr0LqjKdzDBOsOtCCgRjJAgLar4b7Aa9LOu07LjMRu/diP2S6w54gv857P7FYPAMjs09TH7WZoKibvBxVBciKi1Qwt/Myt1lSt8iZrCMAmAQQJsXRw1HZQy+CNZYhAma4KCp2v8VqPAznBwhitXpbQjwbA2sxPDuxMzhKP0gZM4SKPnKwwuQDAnVqsDIdADJMJobjQB7+QB3luiYYgbgTAEA8RA0VPDcmOEt9BndSMNlCIq85D2yAGWZbP25CAATbABQORfsoPHZQIDo4KihbqBQSPCBhRCBwREnEwHxIxEgHggRLIdEZpxvZnESbAFm9RBYEQDc9QA7mgCP3/wbuuj2i8q1c8EVZOJpaazzc6LUzCAxXFTQo4YKcyCQBAgKK6LgsayZqIUeJWkYkgSwGaKbJyMex6CG2SaIJ+sVSkaXSE0RC5SXj88R8BMiAFciAJsiAN8iBBZ5qEgAxd8QKcKaGORx+PYBiJQKF84RsvKRx3EQ4eUhfZjyRCCQAmCgTuEQxpcR8F0RjzSes2EOgawQMrRiWWy56UJAQ17MH669NCsc3S77soz9eGT0gI6ghAQHNICXlQEh6RgAznBmA6sv0SkR+qaQL0hyQNr3pkMR3lMd6S0RIn0SWnYFdQYSBKwQR+Uk1urdumMTWIBNeOURmhoChSxgD+DihT/3E7jAqyTpLwiGgi05EehjJuHGCLnrIYP5J1FPKhtmh1RqkfWeeRyCgY4eC2lNIMV9Ar0xAsv6ZG2hDwOGZpquYNfc+6qjHgWE0SDccF8y2u7vILUgAWA4scRfJ/rBLQZDEyHVEAKDMlFmoI8lIcWechLdLr2kYeooooS9IjvXDsWnL7bhIKB6Ajju45icAZORDfpvMtpesAMmbf/gsZ4cXcxpI1M40UE4AFamAjQee2HCsC+ioWc1AIYhMJCLMyv1AeGCuBahMYl5MJRxMZL1MzhYACOLM3auESaOkaBiBjjPA73SgcEgBqKlFAAQC2MiH0djIopYZx5gcr1E8Iav9rPanpHU3yMMXrWeRv/lL0pEDqAxKwBGiu5sQCBYjML0KA/5RsUFLABEwgRvvPpkZAMOBg5uJvRV8qpBBABFYgBJKMBt1AqA5lArvQRN9tSlnyK53zNM+JQAWgM38mvkpwjdKJ0aYCGuKS20QRjlIg4coAlzI0FZtCAwpgCxHtwOATEfH0Pr0u9XZS8eZwQmcvbLJzQzbRZ0JrtNpsLYMCN6bNje7FFDPxP6XLl7Iw9ILwTnHR9JBvT5XvGrWTQjPzGhrAx3riGeSONUST9Mw0V0yBLqUuJppiGsJEQpvzYMCmSyP1Uo8yPvN0By2Q57gyQLPUM90HAUiKCv/AKOr/Eg02sUwl4a2Q1U/R5/MyodcadVK/gBTjhQJksFg+tFeptAczlTmxdAhV5ABQZgE+AEHCJldpwymecc/sABDPUloPIk7hIAMIwHKuddygwAn3VUuv9Cqt1DajklOjw0gpQ2Eb8DD0AgHeggQihf56jAX0L6PYgvZEgOUwCuVOAOZICgIK0DEaNi5GIEmXVP9K1k+klFf5ZWCyZ2AoCn9kkz/HVVMB9FOHtQ9NJmwK4D0agQK44elEyzSlCx8kBz3M9Qu4U/yitV/tktOUoE21c1i/9WafwBGNyRELZjHLCA9sposc8ba8dlcp0GBRsytBVW0JgQFQplSPsGgFVlzu/65eVfVfWxUunS9W53JZhdANPgDh5tRoiXVgU7I/XfYIYBaL4KCLQpSp/MAdb8sd4YADtNZsC5YvyTVUlzZLJqbMXAUi1mogqoBWHe4JoFVXwQz4XnAPyWn5hAPECJc6J8tJ/7XvWhZchyBsrWkyGXc3ccGgehdm3TE57TNz0VYlJRUz2VaOYiMT0UBo47VwB1Rpje0I2MfEdjYblGAKmVdYswBsCkCANHS7brcABvdqEfcJileHHmBgvvERg2Fg+GeHuMhmtBIqz7bUDBd8v88f3JZchgLNNIBddCG0iMVqNQ9NlVdvgG8dPGt7mwFCAxHoeFaXJGQbNGDhDLMccf/WoOKGKiGIfoPBZuxxiy6AhDE3cfNBYY+UYesiBVSgpNZCYn1URsXiAyCgR3EMMJjsYg1Q5RZFAFZgZHWsAVEgMkSWAXFqENuAf3TziITqZJWUSW8OWDWXCwZmghSgtibIKHGBcsNojMDYZteXhftXZzs3EvItAdw1FNyW7WSl9nI2cmLDVf2zFQhg2Cy1jpcXjrErYFHpgtdjFnWIh3yIxMbPTXMXayGzchczr+ohN43JFY33eNHYgze3ef93DT5gGgr4CzLmjdlJaPdt+yZkLWele68uWr/3LflOBBY58Qh5XpKnn4JRCF6gLtVXk7mAcilzjPL3DvoHRKOIfx3/OZP92EFfeSWJgAF8TI6fwG1JoBgI2GhzT9JqWW+lphQzQQBml5szj+8KYPzWlQ8bjpjCoJiS94zdGSm56Ik4Epp+1f2a+Y8leA0mRgVcuQoYQCDwTTbuEHVFazZUmWuIxNO2eW3RBV6oNmor0QtueZFyuZ19WZnbrZ5xVpydeZlplwiMtQDGJAviePQUbnOp66PjzZZecIb6VHzidHA1rXytw4B8KpEtOosxmtQ0GkRceGU15SxcdC+AGCyqL1PigkYBw8ZulGNVFMcecMqsmEVX1CtUbgU85eN6GC52QAggaa+iWAiglDEa+Z1PD2GxWHU5t5MjB2U24G8GYAG8//S4wNTOqOQ8vHOhwZKVb5CZGTpdrk4LZ5cb6Y0US8CuqlR3c7oC0dqe/7qjORq1GKBGyEEQLkGIGsG7xvNgFvQJ1dbXuJOPCfel1yALBYCUsVXCzNOcPbSsL/pgoYAXkQqvatYjCTGwJqlE0xiy75mNPneA0GADFoBBDsFtvXT5nmZCN81Cf2StCyQcxpe1yHNZtHWWgc5Ov4BbV6YNcDuMtGwdj8oDJvM9O3hToeCKskgCrEqRyFt/e7cNIAACCouidVutOfl1kcACnndF0FWaQ1e41Uzo2MxZrYSvR7pWVyNpBZl6Z/outXXBEc12xcUAyCDfasGQ43u+9VIR5f8THHkIAv4nw+ubsb8gJJNIANrbMG2aeUhUOe3bf/GbCHy2N15jUA/ODlV6vdgsUVc1cizsCaE2cWJ1HAx0ut/hwZG1fiREcGFwK1ccGwpzK0XSED1AvkccVVxRfksiH5XndGTRqnR5dhTSgEjUux0TIdE8zdV8zdm8zd2cdxTyC4azdpASDB7Su+fcF4ayER+AqYazDuJXN7/2F/BXjLQcU5FKtwAgmGrbI5+8CKJcyl9cjb9vANw6C0ZgCZThPH6SR1L1aHucr6H3b9eAO0usXFUEybvVN58HAGxAHay7RB+9xYvxN0GUk6580fHHARQJxU/CEZ0Iii75eI9zrwb/3dHhW74NC5N3G59XjwEwoUEBgAJKwG5DIWn829mJ8NEsyzUkh4/ZJciZQgkWIATqksEHqbgDOWtW/YlqNgRc2cmTXcO1bD5396jMWAjcEajwZ5jvAGBYB6gwNT+zPJ5n7Ku7+9hVj60tszUmG3SfoArOeQ0GYAVirTk/HaxUogEcq7nZKyaykIPFvSaQfHkToSEjPSURHq8G3RdCdDIjuXJzXbxZB8wnWebNOpkV26PndtIVIQMyIFejkwBWzSnCawMTRKBPV59ltYIhR7ugzulH3h2yEMKZmRWKUqd3OtR+WTebY4KsXAEaPd+1fuvzeZPjkhpyNbSohmmVtVHj/ytCBcQcWBoBXHd7IuRkxu9VDyYFTMHqeZsVzpHrt55gs6ACBkaKQMDf8YDmBUDRV3jn3w+GVzQE4KCoU0AEkHotkvSGc6wsIMWlOrYsWEovIsXGUO7lQEyrMVZHISAxjHjH3gIHoMA9xXGUxtouXLvsoYADHIuJUrw4G3ujezvHPVq/UQYKqqBcoMC4vU+r7iiyn5OE3FL6jR+0WCAFE++9xDdgadppEK4EaAAK2jP4yT7yFzujh39/H1vbVWTGs4EAiB6NqmCtiutUrf/XwERftQ8IAMIhsRgoIomCJHFgKWhSzORxWlxaidUhhVDYMLTZK/PwLFgO2zFbKMC2rf/vuBxOv+Pz8/x0z7/aZa0JxgVaDR5aEQgQDAAEHhQYUBUxFCBQtgU2LBAcICFOhSYtHSBkCCRYOGayjZJOUWigOb6CFsZVdX2F3eISNWwkaBiwAtjy+f25Geo1L0P/KUc/PjvnYmtmu04tEgzZMSQ0MK0hFPT6ssExLCyQt44hgy8KLEwmts2DIzEIg4nR94tNCi8ARdFZMmAXAQrxssSwcsAAgQTTpFlLmJHaHQxvMNy5CE1kso0BuWkTqBKJNyVDDCxI5+vAgg3G1I0pReBdPpRWKCx4QwAeoZU5h5iB4hBn0XVjdrGQibDNAQGzDpbbNmShsDcZNJDEE1YjHY//AkByLGIWbSGTId1qEhBgLt26du/izat3rty9fv/ahSAAgt2+JER8+ItAxAnAjgeXaOx4ct4PIUoIUCFgBOXOjwOEWCEiRGLPpun2xZsCgggWKE7rRcFCxIrNjmXAyK17N28dc1GQMPFGgAkSrwOMJRstudqPaTkyf5s2upB91QfK0yqkJRkC37J80KDhZtYxAxAIwJfdKNJTqYrBvc5+CgMBXz41Xe+0yC6sx+Zz4QUBxTwC4BQ0EIBKKhtQQB51OcVXx3PRVOCcctNFmMWD1v2Xkk/6bccIKZeM0UAJS4HIhAGXxMfhIAzUswCKEbqYhRkJLKJdT0cBMIABGiTg/98Q1g0yEZAbEOWGgUy08FUafWQIJTUPAlDhWRMOYSVbcU1IpYYt6thHmOWF+F0RVak3xTkjjClEA184AuZKQAklFY1j+jgLgXJ+qOGPQUplhEoMnLPAk7D0SYQHb1yAlg3rRMmEl5JGqCWWQlh6IXSRUtomU3J4KmiZSYiz0QA1dZioEAdosAB+BS4Jio8WZYDAqy6FetIQDRh0K58pJpGnAEKSacUABRUwIHlIwPUKBCBBAIGmy0xKSqUWYplpW11yam2uQ2KXX1HcFdFAAvVZYe5SNRZx3jhkxNoECagkQKCkdLALgCnJJslPvLq2+yMvv/ZjwQIFRBXuVFZ4IP/ttlN2q8S1V16qLZfPVUspbBvXlRrHeAlG2F0hIIacXotx9jHJJODl8ccjCEZcCH+5/HFdlplgAml61WwzXpaJhkDKJsMGtAgQhDD0ZD3fhQICOVjhwAMcCCEDYBkzGzE4E2/5nMWQcovht/Ltp2o55BKxIivPeHdTvu00cm+snAh1godmI9EABJfcKjfe6uSJRt+w+mTGwYeCqzARFHQlgAtTSNCodBBTHsfXaV3+Zdibjp0qj38XIZiZRGwwnr9NoPEpQgNsUEC/8JptAK0bfGLdnRK1ToDdd4t7SOCIM5tLUhoAD7CGSJgB1huGojDFBBFUIJbWW1feRuaXPiz/Nuf/Jl42sEygPYR3sAvRTprdyyO7BZ+n6G4qCBhjO75M+AgFgRwSTL8BKwjOPn0biIAYyxKVh4JRAK80hBWj4MBw3kC1iy1netXAHgU7hTEJMqNz+PuWBQaThPGRTxyBIpuNTBA3//XkABtAhSRUh6j5dEEVt9pgrH7HJt5VQhjE+AD3wEERBV0iUBzK3kgkiLUKSm9z1ftesY73LwPYZxADIAAmgle+cy3MCghIwO68RwheLe91JATVNlSYrBHSUFVG6p/nnJjDZKGISGxggMG8QozBoW97EVwiEitIEgk84A0SEMIE3gACCW3KZ7BhmmlCIICS3Ww0eenLCUpw/5zTVJJllGHkXVIgnMEobZGdsQxtZmYzTu5lBIsRgdBESZfVHC0FirRLCliAGQFgRpaAqUAMeunLXwKTB1fD4EUqUEgBQA8AUhOA5LLWx2eSxAODVMADAKCAC1SAAw/ogJT0yMSHkPFvFLBPLbbSwns9AY/G28oGXDXGcFpBdgKolTrX+cKn8K944BSTQJLCRhfCIoYNyeKOVvWj4RjqE80a2xElhgQOTKACFbiAAgDwgIp6IALeeiYSk9OBakLAA4SsqAX5WNCT8hNvDMhAAhQohAGcU1JtYyIFVGHPeyLhPPQKwQD3iVNS/aN5PSScjc7xzybGwj7EAigBCXXAef8qC1ffZKpDTUqECCjAI9FzQDMaylEINfBxRODABbg5AZJO4JAAeEEDG9gGB1xAAA8Y5EZBd1Mrmm2lGUjHEWB6vnYJYH2JGoB4yJPGMyXIHpPIlxtz+gQNrKtzG0nKAmwVr/7kjwkfiOEbeOG33hG0m2OAq1zpCojhIEEBGuWqELj6wBa09at+tAYG5iqEkI5UtFm4qDIFED1nDvWwoB1ABvaqBb9awRIEkx2K7ko+N9VDA0RhLDy5MItVODe7pzvTY+8XpjwBSknxSt5wiFdP8U6VgJpjA2+5+tuqIgEEydRqb+sqWyZ0IALMjKtIIViEa7Llmtncpm6nUCGSEhj/uHbNY3VPClMBNBcAH4hpEmqKrpXQxHQ+vSedGNE36qYUADAKL1W1i95VdddtWgGvkDIr4ta9IQEQaBAOkRraklrhwEJIMHyHwIEIqHXHGNWogsdATWS+gZuYC+Qg9dtfsCUhrsMZ5DGDbK2wTkEBbwikktna1i+DOcxiHjOZy2zmM6M5zWpeM5vb7OY3wznOcp4zneNsBS3LVQBKhq1biyCBBl5AmYFsJiDa0AG5csBKSuaIlqsJACcT0apW8EjXMhhcxTVxEVU0ZwisULq15YKwGr6xpOSpip62EaWk0BOqGUxqUqRY1TkNwXXPS1RCGK68BphhQi4N5ThQusgY/2mDYCZQpSQ/Z1FEhrR/Jc2EHxvbvqC18Wfzg57R9UgSrwDhibOQggREmNp5i/FfS+xqIsDogLY2caqR94T0tPrcWxGYZb04hQawwCKpGOiGfypuc08wDtCWdknaAGlFP0fLgX60AJ4MISVm4c+DeW+hfW3vhUFxAe1qYShgKtjtToGwK4i3vHcVFAHAb8HvRDGOHHI7labYxf58knADllj7IGCE7L71qwFOHYlDgOLU2yMbBHNIhKfFLA6YaMMjTXRnA7zd1c5HfQpwE+SmGutSvTcaQEyEAyyiVi4Gp8DsxXNZf8ofwzA7wWbO6xrn+g3EuGF6n9tz9SLy6dSCi//CK8BVPU8IkAKYQFxJ+mtvFlGDmKaEXm+l9Re9C69MaF3t8LQBoShU8av6x+Berh+1C1DyRaGsPqV+z2DoO0hxHOrZ+433Ag9b71lY1GDe4ADs1ZZih4f6W2ZpGlTa5QMiUMEl57ICU+IFBZacZGxEoEmbkUAzJhga8GETAhMcn2e+r4tsSnD80rRsMqosJfg5JgDLQEAzj0RA8bffMfc/hphGjJLCsaTfN0Rg0buX/d41f/FyBMX5UBEBvYnOtd6KyAR11ZR99MvYnQkL8E1j1d2LiUBUSWASJMUKmB3aIUUH2dEGvt6/id7dmZhXWVrisYGVvMEEPNB9wR4K8h7/u9XcFAjGpm0HtnWI2jSYqBnWNtBNvfibCAIATERBjfWcP8DRDKKY/QyA1+1K4wxLuLleyY2gEFLh0PHfNbgglphgj8HgBK7c1KmIiJAODv6HDlaXJZRbjUzRPKVcEG6YKQRJ5f2fjSEhv5neCCJh6IUhOPnIzaHBhancEC1UD3WhCXZhNJiF/jndFzoiB7KbW9SHCNzEj5QDGsLTE+ici7iHJzTYjTWAnpTg/AzBHYZbGoEeCOYhAcWdVbDd2BCixa1XFiYRG+CZ0CUdstWi9sTgFfpitwVLcdHdEFodE4TAApAcrBDWCU2hEFAAZvDEBWbRrBCAEBlhVpgiCYJD/yqimosgYYzh4dZNW9S1XtTZjvz1ojW9AS5yxCJqIS9GEPwtzV+IgABIxm9A0l1EyzyigCRxzAgIhwogn19Un12MwGyQQPn9nvjNBgTo0sfIxmDszMd8wGqon/O1X2HI42ds5F4c4vy1wS3iniHFVUQ1Yv8hHiT+YjmGyPpUgTiok3fgDwJO1Xm8AQLw0DWCQijewzjanbtBAU/FiimOHXm9gQauG0uGYDOCnDb2YcXR4uQY2RvgmZVRg1lUVFxZZd6lZOyp3CqKYxFA0Xf0FTqAzzdYxwBYRTK+wgK6kxIigQFUoBj5XMiVXTkBSDYCY2h94745BFwCXCx+5Tl25f8uZgGeYYBZmNZVIlshOcz+PaJXgiFYNmUpklN1wJQUAgAI7UMkZBZNpMLq6WSPPMEGDKNPhiUA8EoEruQa6GVqlsdCAGLORSIs9tpgNptk6maWraNFCYDhMSbghcxJ7mZxWuFT/mSPJEAGvEoAEMNZXqG5NED+uIdN1GYZnEPKOaHk7ctQMOV/vGYVMsEIHJTc7dp3OuDOFaLKfWQ6imQgAaciIttw5mZkFpwsSiMABEVzsYAZbuboIEM6KaWuvIk9WCPcVUSabCcZ+Ig7qOIvUgAEhqMYVsI5IBCNOeWA/qJgTiZhpuMsHmZvwudzuCN9QiZKQkxH0gxekIAAPB//aKxAXuzjZERLaRTkzbBAZiDAx7jMCayACdzjRg6G84WSaaxGCTjkPObFkb5Ba2Qkj6ooQUbpJKFjVP6XiP4mic6nB9UnilrpUqLnuGncrhRAThbBBuDgKHgcbFICBaDCqEUdHHBCNJpjFjiBRdClTwlUZPGOsMgdzUmWbS4emPpcldpnamFpfG4hFhbmO3ZouBBXBhjDASSAGsSlGYaCOERYfIRHKuQpcroEJ3hihr4Cr5ya570YHBEqvNDRU2VAAsngoK7qSmooZYLqCR7qtCyqlWKVEPzYCrIjrubqrK5kIAQFUcBUGAwCTCAVBZhlciKBBWiGdaKmEuDIuoGY/xOcUWVORXhGYuMECV0uKLQG5m0+6okaJhEc2hDgmW0J267a59+RVEYBgDYtJlR+aazeDXrY4HN6Dibi3RMMkEmApgh8qnbJU1LaquesJghGyAhYwDBoJhX+oYIkVLUWq6COZmt2aboS0h5UCDd5wMLhK7zm6lkJQeRIQAU8QKUx6rDqa9nUx5gKAQKYyRYArHrNFBwKgQWgwo6Giux4QnqKwZ16J8/OWwGYwIO6UNx9hQAk48ICJrEubK2O68saJ2sJwQUEnQI8pheaLEZgGRGgbL0C2QM8ppd9GYZMqfYFwAeUgAoMTQqIQPLl4158wAqwgEfqBUA+0pOexmVAQP/K3ChloAAElABO8u1ehAYrFSllnIAtvUEJsIAuFa77Xe72Za4ifSRqEYHWWlMEEN7tCQGfeW7YCoGWEZmuki1J4RYATIDDlayXYuytihdYoAilqhhMEoLWUagB/CzH5k2y+Mq3rMgKHOxeqqZB8BU2VGxnWYCd+B8KOSWH1q6ttmcSaC19ude7WoFgyG7CIZPHtu5taVQFRED4Yq1xfucGjdMGmFO/BIAIyYP5oBBh2UcCaoeodp6nqFAC2Ir8fN05TKitHgCtfaA6EW3G9pD1qqTtZi8SbC/g/RkuUgn4Ys+hDcfXPpz2Dkeg/ergBWvAjZaUqS8Jn+s6HABLGQP/AXzcEHxATLABCmCR/7jpsPTgSnCCBijwmPCkeghw/dxDTyFDUoDjxHJr+8qqiTkwqXZsEZBW03nvMQnANG3ZvQorwzSQolKD6pIv7U5B+gLAobUg2DqxJgRFOlhiu4hAufVDCRgg7LCOpyoxq9Ap0gIMNUqF7cRQ6dmTES+IUNVhnW7shprr9XroGIgxGXvvFzMBBmOPF0tloxaBfGEAXLHjhkgWypViMRaBBnTaGMDEaZJRqcApu43ATiQvn5jRG86qCjFCHOfxuy1IL0xtzFLvcTbxcWIvXFgyJjfyJI8BJF+KJLPu3o2t9gJZlgqB2tbZM0NzNEvzNFNzNVvz/zVjM51FzTIbnukiYoQQM5YYM3He5xgQGMsyYhaf8Rio2xBswAsLAUWsog7iT1C4EyRGrAXc8hCEAL98j6keCo3IAgJt4hIL7yBT7S4rMboWwTnz2Po6chKEc+DJ1QjjWDo+gEjVVjqjMCKzAXrAAVAggbPipYp4snWMEydPVU1p5xK7Cwko7Bp0p/SyAa9oxqsi8cIusO3Wqq0qNCF3sDlr9EOrc0TH1/hS0DFxMIim4zJJcTADNX3YAxbobiW0VB9i4j5cngAkbxjCTXMOKtjVSxNmA0wMMdKq3VG6cZxOb34y5U9TbS+/VSA9tRkbdRGEMBfvaiIWtaN6dBYUAP9zYsEdZ1vzJgHAFvEBgYWOTBFhKyFPiuYM98on6gstSwJZD9VO67TGIvRBMzX7HjPqhnY556tnJ0EHrc8SWAD8FgGFhULO2sINp7Z2nMMaKsyKVOOsausK5HS3+akMmTZlL3RnG7JBS+0TjzY5izZD+/XetS1djIAK1C1y9KNCQsCL5gXJKKRftOjyEU1nZNJ2e0ZqfMBisMDj+sWRKi5HBsAJpF9mQADgau5zhx99a6R984WhgvFyJ/ddKzcuI0Eau8GzvoQGMEXOrtyp2IMxgAmr8PADF8h5XEI3YiABG3ZO/K/cTezVJnFUu3W5GjeHdzRo/zd/v+B+k/ZfV5j/Sj+CDYqYJ+sKgr9Tqbh4i5xD8uJPgqbIXeo2FHUW0wZ3iKl4Lr/1IUN4IsMsc5v4iZN4fwd5j7DwqkAt6qDRS8D4gc9TuMFFA7AS94BRb8vH/9LOv3XBcIw5bhYyT++z7cI1gDO5MKf4kiO3f8/5k18eUQRFEfRkJrRDq63BIhQAHhFsq5Dy3c3pdOaCWa/1ymU4I4wTKX6lZq+5Txv5On92nDe3nAc1JcO5pVumgTvjYg8BArA241VqUSg4M5IrADzBX7YJbuOHJBIAKyXlGtTPj4NaWwu3h+96Qlc6LyM5ine6pnPlh0JI2wpHygjfCKTGCUy3XsCtfNuF8rno/+LaLQuIdyMhqdJwEimtwENC7ntTbihtru+VO+fi9/ulewQLO7ETXJLXuZqPNIsjACZgAUyd14R1dQC4aQbkdDNIuP4ahba6MremW71xiCrpWwErL7Ab93GnOaWHOEPpd5O7O0RbfLxDPBEkwFXrSwLcLjwjgQa2AXrUcIO9iYtDvLsUvDjWD2QRa3nSQq/H9aSLeE/L0cQbYsVj+sW/e7sP+3D3bHoMQTQugSxkAQGwQBsAejLaAevcc81LeMvDTrqVni3ACCpkQMIQudB/eM0/fM6nuYize8ZfPF+PuNkzFnGBvJuA+iMMgMeriAbMA/5CQNTKaeoc5wCQAIX1Qf/9HK2N3borYi+kT6akhz3rrScYln3P+/zswruSezZ6EMWpuwHMcx1mh9wBbcAGNfZ5zQPYFUAoj0HVYZe4gNH7gDVxPzket754FrnOsyfPZ/rjQ/4Q9Gpr3V+xO/dGfoAKmABdkMCLEsdeKB96cx9mDOTVOPuObgzMlMDyVwbJ1IZnjAAJ3BIEBGlnnDu6pztffD/4rzvtj7EdgABV/rztQ7S8+qoAbCVUBz1QU/5Lyb1a1lOy9qFe8al52AMQHABDYpEYMBIPhIThmFQSCgihAHoNUDQCQcEywF6TVnESWS6e0UPyGqBew9HtuPttZ9vl5f2Vi5+jI5r4GwK5wBD/KwRkbHQEWISaUBjymHCLfCTK5MM7G8hYINpwIkIQNFoovYOiyMhgeFpjKEAV21tqMuprWFigKLJNOthQEcggiO3EBOwLsxOGcpbGizbTA7RO84TWrhZ2IKsQcCjj1ERPh+RidzGaHJp44IrgGHphz/f+5sYGOG0w5ECBIrSibdiwLYkBAQmUDZlmqgCDfRCL5FqlkIiBAsnGoDGwgIuJjMvWVLToj5nKOtD6tXTpJuKuburY5DMSbki4eQIoDWmhz+ZQdOcG/YTwMwIIRShPopy5DZSoIQsCErEqLCRNIwwLgNEIZWBCSP0w3hoywEKBDUKgCGNAIMOxtlFlnWz2/xIvSzR28/BFWw1w4KdDjeoEgIFMBwH2jBglGtmcNXgAFESoACCCh6ZEIV/DZkEAMAC9ihggUDYJLbB3h3ht7doIhQRXVcs8y2cAgimxPxYZwJGLBtKsZMYc/Gzl8eRv9Zpc3vd5Z5uH2zyQAIBx5sdOJUe2zuXCEAhcJnB/631yAPbt3b+HH/99iRLtTYxo/6HEhwAC4H8QAQX52itPBP4GfO8DCFY4kD3/EMyPBBFCgDCAESCYsML+2kMBAmNKIAE/DUeU70ESTyTRRBRXHFBFFl90z0UYWfwsG1sI4SI7By4QALv0vgOyMPDUo445mRgqBbUiNrDgryJUoWYIAv8EWMA32QCgpcnH1titgBDWyOVLaNRKYLjiuDJyjrya+y1N6ZCD6U04oZMzEMOIHAPPIDWpsZE++WFzlwQSIKIAtwAYaBMjEHpmytQIe20i58TYTZeIlvjFODQaYCeBL+gE1Y813TRnOkjVDPTKUkk9tch0/hRyT1mD0dOPinhkJ7s8Tb0iBAGSROBJ2+jYKgxH6yRAAyudNKJSBMByBlPbZiKTCwJsC1U5VFNVVVRuU4quzmy9jVNcV8vANcdd1YF1VnZr/REQxRzrjlcoTMgAjAESaK0BDYIhgrVbjn1zIC3JLcKCBJ4NSyACrEIziQambEg0e0Hb61tNty133Db/O9Y2Y3NbtZWRedd9FV53axqSkQmYipdVKDgN9p+aqzpUtQEkFYMFAR6VroHaOAaAgt4wRvRhbK+s9ueroLoY4KgbXlXmKMP1mOqqRw753DVejrkolVeO9c583CmjgwfoxUcft9+GO26556a7brvvxjtvvffmu2+//wY8cMEHB3wNtekNCqd3yZ61XZbtuOCnsLk24gABIBgCgYwWyLksC4CGgiERloUCAmWZGWCDApbepcuSrmn62kmtRnprkLtWZOpuZ7+9dqJJxn1yNCIveXHG93QcE5QUeAA9lHsvYsoRANi5iInHEPgKrz5wY4AFWKiGtoPFIMFTN06g2FPS/2+DPmLbKfc9d439Yh9+reVv//7n0WDeeVqrG9vxiueZilTgAZITHvCAkwENIEFzT+ocJHgGBYp8JSq0MIBfLHe6MnCEBOtLi8KsxbqP2U9/W9IduERmwt2VMGstdGHwrmYnNxgQgfUyngC/k7yypWxqAAnAAQhFhOuN4XUBe4UQZsIAh2zsCiLc1AIIMICIaIELCwOh1GjnPvxt8YQo9CIMtZg/Fa5QgfFLoCN4mEYd+rBld5paAggSAAJs7iFEsNgVQAGLMnbFUH1s1gKUFY0DaIBzgKwWMmJBP6h9yyn0Y2QKndhFFk6Skmfk4gDduMk2ElAya7TVjN7jKwqNoP8+7TmBCeCDAhHIiD0AEsAJNIQAA40oBSVIgYPi8wESlECWA7rQh0LQoBO5UpTFPOYxjZnMES2TmRVy5jNLFEBQ4rCTnnwjAKNWgCFCICOyA85EhLGFjDiDAKCz5ACS1RpUcGR84PLXcFgXyfnNqZKW5N096RlGfOYTk1/cBDXHVs1rsvERBLUm9GiGqBJchCrRa5ItNiAAsqjqnPHLEhixJMVlIaEX1oogIBGmT3u+UIyKqmdJZZjJS66Upfvj00ADWNB1fHKm7YrIFsCwATFJ6UwAMMC/6gdUAQi1Yd57Zx/Xcse/pG51YjiBSDLAsH+ilJ/9HCMZRerPqm41hi7/PalVSao8OOaQppzUZlmtZrnU7EwNQqwcv5iFpQx8BWk7O6KmBqCBKTpHfGL46FSziNWsmtSrhTUsYcU6Vqx1lX5DBWtYERrQtJ4VrWa9rAInKgTNqaGOqRgWcBLAR4zhlTAMgJIfBEm6A0j1gxprJD8fKcnYahWykVXsYrua28nepLKWjalNCXjMD6hAlQByjynfQwIWxMg9JhBALhEEIApVKAQBGhAJYimfC3GBBcSUZjSlGR/xjpe85kVRedHbHvWit7c1xSxw/TRT36r1dgwBxgPP8NmA2dWqE70Z7AqQ1ydsoEpXoMUpoLCbuRDALZAUTErNmNh92rbClXxs/0UgTNbfBle+HsZmh7M1KOrJFQnVK8IE/0IBKulmwGv4wAIqmgTexAIVtKEStjbcWNzydlS2re09g7zb26JxhpOxL4g/PF/hJjlUnGqSAWrmwIwgIMB5OEAG5CqGD7wYDQwQQV4TLFbUNuSnuUXzkLs6W9hK8sKGzbCEaRhfNdL3mp+JAAI5cIFLeE3JI9NAvgDg3wCgeAi0eMvOBMDUZoV5DbRBwRVqLLXUcYGqLzXyV49sWDZfVc09/nSmNY1pUlNWxENgjBEUQA6DLhnJUAiHT4hQgQgIoM+azGzX2ArUigbggYViNCSmRGDqeWkNHKHiaqbwERwfssdv3q1fOv8NZDdHmJ9xvqq0BSqJSEiAC+WAqas5fIXKaAYEILh1q200I5/hRwQiCgBy20MCEkwTAhCCQHURBAEIgJc9EhIQfASwAgHgcr0Qaq97D56ihWso4QpveIu2Des2qI0x4E6ouB8niZ9M4BLofvWpuxaK0oCOBKtAtFi6AEICJGQae+21EmS8LNFQdLA7nvCzVarznYsaoLp1bDbkHPJcIyYcDuAAq8Ot8cmc7R2USHo++tw2t4W4XEgCwAIeMoAStAZiUKhFsIlw0XR6OSW0IWFruSB2n4e1yG0/LNCjbW0L0x3DQs/2xsXGjpyQAQT6AHfi+M50QJH7hiD380GDzE3/RD30HyTA44yX9BklAZIWPy20gWk+FwUP/X1z5zHPQw/3NKcQ23Ufd9EFkXSM/4/weidCrAUwHiIgHtdi08tCCVCcfXGvxMti8RbEwBGqMZHRKPCCWEQiqVCTvvmlnitjc77p3T7f7W//edzrS2ccCUBXAGC9ul+/fSf/GTpTGsC+imDl/R4RFPyCi3/LaDRGG0AEwbYA5+VOfVBXe/SkhzbRmz64Oz3pIzrco7PxWzrziykW+YDLCQAS0LcAqKUASCX5gC5ZciUUKAF4i4/r8jcWMAF/+wDowi72ijiES8EWWUEEeTjzesHxikFmeq/eei+aukHyy7WrAYhBaw0p/7sDrYMC0agZVNgZRlMDZGuWZZMDVxCAK8O+7Cs9zxspA/w8AfydoLM70OshBmQyBZyz8lO8l5AjXksxMAiAyqucutIts1MIC+CggEkA0lADdWoIErI+t8tD7YtCKQxA/gPEUYM+NOtDNNM2MWSEHLwzO2sX5rG12wsMFnMCZwOqKZO/J1m0xSKApLIIsjuNCToDg+grrsLCKwzEQZw2IfO//8u+AqQw2BMDR0w3U9tBMNTBBEwCb/s+8UuJBcgXBjAqHxwCEoBCACDCMUIAdEoDTxy7OLwD0cgAYtvDKcw7VvTDLeTCARxEV8zGAxQDXUy8RLSzTlJEWMmzMJQOy/9JiN3biJrhOivJMoLQIqMpAwhAJ++RPAD4gC34I1MEQGwsxSp8xZ4bRGrUKm4MSF48x3C0EVv0xpRxOj/oiVujOsKxyIvEyIzUyI3kyI70yI8cHHOYSCIQPBscxzYqx4p4gHLgAB9ZQDOYCmM8mMrrvYV4wo84QjE4JzhgItZhCBU4M4FMSFI8xexLxcSaxj8kQLxDvS68gpUEP5d0vVq0xZS0AwhgipbsAF58A/wCgC37Srdgv2bRMudILSi4KDUQGqaywwKYHoK8Rrh0O2n7MVWkQqEsSj6MvqHMODHAyqjcyr6sM4dkyMF0Aw6oNQHgDK4MAMYrIqACGgtKBQH/wEMEyMexe5QzUMKLqIUpUsqC/My41EbQBMi81Ms9REjT5K2KQEwuWEzB/ELCfEnDFDkoQIGbBKescwsghINjfAvHMwJPRILNJAInLIXQnMvS/EdrTE651Evk5MPUXE6npE0ElE3Y9MLqRIPyOABDe8wEUCIlYEOVIx1mTMNL/IeGeAjoNETlJE3mfE73FM3RDCvpfE/qjE3rvE5aRMT5GpHiWoEI1Lf7YI8TuLf3ILhfSpBWkg9+G6V+cw8FEYARfJEZfCYLTSYMpcEWLBEOPS8PZa+Jo0owtMr+TBjKFMbSeChnOwMWu0wA2ERbYEagwhzO/BnnW0X6jE/4bE/n/+xR+PQL+5zPh9TOMdzPqTTRhnSDBGgoCgAaDbgK1HqCfQHL0/gXVJhR1ODJuTgi9sS5LORLxOpGf7xPHc0tIW1O/BTH2nTIEmVTIrpJDVCG1hq7aQGAiQpKgRGELBWFJDwGsfNS2spRMi1TMFXNQL2qQvzSwiw8/TxSN8XF6BGAD0gUKbmKSoUIigBOYGOWz/EjNMycLgip0xxUQk1TQz1U+TxVVN1GprRCSCzSWJVNSB3RAfgZXysFTCWFNBCJkNqAm2mDYukvaIFRKgEhRPW0UsXLVPXRRW0p3ELTHVVTJR1RBaRVsamQU5ClUwqAfHslEXiPFBCAeoOPFFAlFP8MABB0Dw6EN1g60A0FUeeKV12aV3StVw1VpnsVUUfdTzz7CQxITJiBVVktAhILAbJQv8wZH66r0rSoUiswmtjISYFoJU7E0bskyulk1UI1VWk10yB11YGc1kYtglSrBPFIhNkkUXDggp+QAM5QjJTlymnlFCcwAbFchUs8hSPKlGDInrQwOwbg0jbDWEEc0mcNUzFlViDVGEVNoRq8kUWAgETgt5llus8otyEYB5lVWZJNgkAbgAMwAaBtxwUa2ySwgHxUz4LoWbrKgBMQ1KLVqFfNWI3d2FXt2DMN2TEd2DWluCTwgBrFzjaljBuagNe0WiIViBvlKYUlAvCUVLj/NYKfTYtMlMOHMIBXYABnXVaORVq7/VzQDd2jHd363NukvUUjTQLEiL21SVxxcxu0OYpZW4oiqEjFYdNTYAC3+r0hcNKCuNUkULFiowPj24i15dy6Jd3OXV6jbV7n9di7jc7TXVp0jKnBiz06kABEKIKSPEkdwtqfcACpZNRvQJASANcQIFf1tQ8PhC4P/DdydY8V8JX8KIGAS1cBqMD1wldR6l8Y+d8ZCeAKrVd6jVeovQLWnQDMKN/xC4/ZA4C/YweB7VpY9N1fGbQDQAL/8hfruUmelMfoSQgy8B7MXTm8Ld3ozdvknVu6VV4UZl7TVdUftV7VLYLuk4CoYwd6/+HPR2XEm4oGsAXGrryZ3Bw0QYOD4Q2qPDCt1zhhGH5hFU5hGs5bKl7huL026hXd1+Xiwa3KH7a6i7hRdgwAyG2807hJ47CyyT2wsjA72PDcGJZiObZiOq5jOmbhFtZC58zjHs5Oaj1S+Apjfg3V3ZXHEAAa/hoCEkuJlCOCiRW2mXzi59Vj1N1LSz7K6lNWPG5aDXvaff3jL24ykStDC9CSmyXb412FMxheDciIG3Vi9JzjKL5jWu7jS7bkQqxl6NXbGb5lQa7WkbVWML6T+BBXCtkPC3xXCcwPFeDWeZNf9kCAd83f9vCV/U3BAaaRAtbmbebmAt6QeUXgSBXlbP+iM7AtogWItEVujZ1NA0c+NPkziCHgFFmGYl7+ZV3+5UzuP7lV2qX05U9O0tTz4VGOr12TnV7QzJuJSV7FFkg+QisQWkHjW04m2mo0012u5OqV3l7mY4F+UwsmzGu9Am9jh9bzY91N2Gs5A7DswfWTPCZ5EmBYNM11YXzG4qbsaI3+5zi25U7259SFApP+tgqu4Vkl5jXYXustwwei0+EEmoZ+5K6zHsdjFAkiLZH92Jy+6Z72aZy+6IPU4q9G0jJY6gY+6pFOajQg6hvqYUkURtlBAkp86bFLAdE6FAp4KC4gtnve6C3+aUeqS6Tc5MC2Lad1pIpo6y4u63794Yj/NGsBSNnbBcnKtuzLxuzM1uzN5ux98LaU9d6QHmaDhgaUJj9bTQ05hdHjhFJTQNEU0+DiDMavY4iknGGe3j/A/mvd3m1K9moZ/ujE9hPTNslA9uNghoDskIDmCRvRaIBEMbQReCjLAU4DcDmHbWeyqCDbblau1uoqzmfuZtpE9WThdoPkBoDl9h9gDuWVJe1Y5ALyRVISe6BfAwAIKI4pWRq72q+DSbk9spzCButkDWpdxm1c5u3fnt6ANu81WLUe2cXjzs+CNudNgrKvLLapVoIWO40pU9FH5hmRCAjx3uqw7urcTnAU920VB27m3GdQtmEKH2QQQz/rrkRT6Cn9/zYCQtuZQ5Hp9CxCAe9tv1bwA+dn1STxjgZZBpctGCdYwn3vBow3CCTQZI43bh2BCV2uaKY3VDrXE9ByAxZncO5mZCLzM/9mcXbyCXfsKDdS56bTx5SyM6jr3h0C5ANxIdgXitZn765ow9aqI79YjC7xwy7vJh9oYXbgtXYjxtvV3JRMqc6cADMB2/jxLTiTJL9iE//uKT7wPuf0PXZxkCZnkYbyCsc9imgSgsBUJXGg18bujRBc0yAqydP0KQ5vIWdxIt/1T0fNsV5x9m5vgm5zMVhIAMARCjbqwpiSAwBC+/6jQiO59TuYmiw2IYhH37h1iyZwQgdvP8/lX2fyQP9fc5MFgPGdPa6VcLVO4JYdAgW4gArQSrR+ClD4lz8aopKDiDo3tDu1ADqvmbAbcGorcFCXrcHW5IIX9+BG9FPDESI4IADwgAhgbPkKX/JYzKz1YhvxlRRAgQANgeZiDxP4peI613nTtxEAV/ZgpX8b1w+9VzQfc5mf+ZhXczFEDMXIDNZt7OuM3aeLh46DGcq+QS5gPHZ0NjodRljPcKwIiLmOBU3ldoL39k0/eF3v9Vz/lmg1coHC3p0gA6NrDKAQCuMW9htGiox363WfL5sjiCG21LRQAeDcVd8VqgBI22LLgFHddkC3y6q3Y60H/KlPLMRu+ATMeQHYeVtQRHL/LNx3j/d571txFABnbxJwgqtQPZPMH4J+/AC5migC6/uB/3ud/vZQD3fTA3ZeP3tZZd2In/iKB64Hpr1kV9z5ahJ+Sdh/WAUmDc5VWGPycAJOCUbSJ2yFx3oDF3zTt/p7MnxyLz8cPvd54N5lv1pGx73rMeVUJqqeQpR83xmwaICx3XMQGv0hn2XjXzOE7+fB93siO3ToF21Ffz2SVrxulaUKRAD5pQ8gCAiFkNCQZRSKUAGWIDWMRgXSqvWKzQqp2q43y/2KxeGxuVs+q6vptTvQfpsFAoD9js/r8/S9/w/QBzhIWGhIKHiIWKcISDeQAEBBcFcwYGcgYBBwd7DQ/1lwZ7ER0CCggXjIabhayFjYShg7+Cqralhry3qYCzjry3sLq9jr9/t3vJfYqLfMfOf8LD3tF00dWCxNZ2EAsHCAuXGXENlK0HC3gA4AOfCRkXFJKzyMS6/rej+Y3KzIr/ePjz5g9nbVK4gvoaNszKw1ZHgtYiOH0yg+tOSpEjgAphAAWJXRToNPdjZ0WyFg3TyDB1OxVOhoIDKELfcFe2mTZk6YMWsSXCQRm0SLQYsuNCo0KB1KJkVSsrMg3kc759JtZBCKggBx+XD+dOlzps6vO1d6Fds1rLGbagESO7vWFURic3HVRYrXDtGHRekwGBAKKgORAjxOHXnHwFNvDf8GZCghDyzPuGkn7wmI564dzHc4B/Ins1roy2wt5/GsFy5puUo103Kdty9s1q0DhCAhBIWJISZUfIhi4sQQESOEpIAQAKXwL3HkzHEupzl0L9KnU7e+pjp2LNq3S9lrd+js2BHB05UNIIG8qgAOCFhciiQAA4YBFDiglVTpsvx7tnU7FlqmZQaaav0YeNp+ZAko2YIM/mEeUOWNRx41EYZ3iAMCKFBNSk8dEBgABAiw0Ufq2NGOHQgg4Jh6qLmG2oujAVhZfw+KNmOCAVI2IIEIdvbWfzpKaIiGHDZDIZIVLplZkhC6hsEDG3bIXlPtvYfHCaioaFg7GqQ01Y6rCen/I5lAikljj6nliIeMP55Zo4NjxsmjjcpAKeWRfDjZJJN+XkgbIRw8IMEFeu4ZGGB3bCDAYHeYsBFg8phkCldumrmZgjfW6Z+amdK56ZxmeRomqKKGqsybnxI5yKCFHgoNn7H6ySSgrP7BgaEA6HpnNwAgYAGKGcjHEQR3IOAriJBIVWqDcp4KIZtwOovqkKOSeim2mnLKbbSYNnuUoLryuqd4tC5p62t00OGCHxKsS8eRL8BLb7323otvvvruy2+//v4LcMACD0xwwQYfjHDCChP8x7vwHtkCveaeS1664R5Cbrnz1ZdAiJIQsAoBvo5kyparUtsttDh+m62dKh+o/yq4nbqc5rXPWotyzTf3qUjGs05IccWyKtkzrD8nsFEmvtqBNCcgWhVVZDJ7y/K2L+tMtbamXo3zzDu3aTXWXAtUdaCG+KzX0EkFjZfFT6LXwGLk4KHYVOwplkl9J9tcLdhodt03NNLunbXWWwOeMsyeovZZ2bdWpLbbbF/cGnrf2KFVsOOAEwAD8t03N+Kpxtzy19PynbjoZJMetuqul7l4kIa/VjnQkyMl+Z2yIQYVs/M9FcCJv64oAAVij+54zscvv/rsXptOeOHQT71y7K2fDn3uP1+j/e0ao9caBMuhIABuw/0WwAm7BfBBCSiosL4b3Xn3Hf1jzG8/HPmTsf//df1rgT/6dW9tFlKb97bXqgjQYQIVeFtr5DOiEtHnUY4yyYgc9TrBse5vfvsWjAYHmxhdD3uBWxOmGKcZEZqtgIVQAB0IpbsD1o4QHogAAFzlQPEkC0uVkEcDjNWeBJhiMRk0ofOel7oOKq+I1FPcEaVXwiY6EXoo3ODjtFGXCgigAwDwwAViKEPbEaJQEqjAAzCQQzEyCoMTZNoI7KCBkfiOiR+MWR09ODgpwu6J1aMZHQdXxeRRjoWEuAAEKqAAIH4vjAWEV7v8wIEIgOABipyXvcDnGPmk6HecGEneonhHUoXSj3ucnmdCmMdRTk+VSSxlK6MHRu7BCxAKiMD/BC7ggDtEbJaMlKUhIOABO0wgmB0CnwXAxKUeckIdoXtl4wSJxLGRsI+m5KASSalBaELxlYHkI9HE+AcMCKCBGmrgInv5DPNAwIYViAAxYylLIZSgBENoH/oQYL4QQIAET5hOAO33TwH+DwwDBWBBuXPQKwQUOwPcizi5+C5z8gydWDREJBco0W8CTWnH6pJ6APCBAjBgWNg0Ykn16Epnli6KpywQHq24xGtG8ZknPaUBweNCAcBQoxSdiAER6Muo3EFSyQQACRBwwZOy0plLlaZJq3k4Jq5UpSOEJfOaB9UrpjNyPz3gAIFaQAYU5li+UhQ7RKAVIjI1j1N1Kkqz/+lNrNa0qm+16hRL2M25rhByE+spX4zy1aWQCEUhEhlVQhA1UbKVriqM6jSdiko7LtaadpVpNKWKIXDy1a9/BZ94ePirZEUCAJ4LwVgVC1PUubWtV32sXLMaU9f+UVV5he0gN+tLzvoUdz9dFxPYJ4IhiE8IJkjBPL2z0O0kl6EJZUNzrbBc60TXn88dQkO5qtvdAra3AoBgskgyCQQUT7KpvSxmKVvXukb2pdqkJl5lp1etdpaQ2c3sDMV4gNEyxg4FaEAGTJDKyTq2spZ1L1UHTGDZpnS1jI0ZTW2bRvpKuL60265nDcsRkqxoRCgIcHm3yWD0Nla1IUbwiElcxP/astS+E64ohfea24nlNx2DAUxaT2zeAru1qa196ooRnF7WntfEDk4hCG+K3RfL18UTY0/cqGKAqOEYxD1OL49n2967/pjI5D0hfCFczL62WMk81WwBAzCC+BEnfSYwrfkEWl3rxlnOc54udeesPzzb+Q3XFTOZ4Wlmvt7tKerIwGinbOASxzbBjH4wmJGXZS0rGsU6ZqKjD7zk8wT6z2CN8YRCkh5wKEa8xgtyg7sc19dimtKVxnKqF9xjFa/6tkweM6fTxltD5HRKdxKeAcQBGLHKB9GQju+iTS1iELoUtZFWtVNlPekI/2HXRiMgbm99zk3/oQPj7HUPf2WBL2H/kNiSrrKQW41uuBo7x+lu9JXbfWlufnnLFT4EtzOKa21z+qv5PoQCvngnR00wv0OE97kVjHAfz5rdjW6pgI9NbmfHet4LD7O/AZ7trWIb0LJ0JCA4QIdc2sGSCyu5yU+O8pSrfOUsb7nLF9aqkOtSYvr+M7+tTQhxciCGK+KIBj5p8FOz99XqfnS5zS10ZluPshHvNCB0XmaNbzzjttbDBHLJbTQqKUUJGKl+E27lh7O64Ukv6XqVvm6G1xXaSIfxHq4OgKxHfb5Tx7mnabmuagul5ysiddu5PPS0U3nIYyd7slFdUrYTntZ7oDbH6T71CDlAgRAJrAAUFezuRnvw/0E/fOCNLvG/Q9zDXq5q0/t99z+AIF6Pv7V5QA6CTNMFWSIygLg3n2jRF/70Csf90Revdt7H+9kU9z3VIb8HEFxA663ft2Y8MAG3bzW46juBAFiQ0D1HB895jrP2t69n7n9fDX0ehBZFbvG6Y8PjfpiAlAQQgZ0DgOQ016F9sDLHzgMe7aAPvf4Lj2z7p1SAVHy6J21YtC5/oCHvpye7lIDqh3qAAAFHIkkHWFGjkAmaY3z+B3YHZ3gCmD3LNoAflnspVoDAl35VdwfiZAfcJn8TpX7mUUsN5E4WuFWQcACG1n+whoIl+H+7p2xiF3ykt3QDxnvlNwgwdG9z53quAf8BGGWDD2ES4qUSG8iDPziEiLeDvWeFRUdvQPgtw9eDTKhdg+AAF6BTEtB8NtdVdodF36B5W8iFY/h7HVh2ISiEnGeHnndSYoiFKXhtgRh5bWh5I4ASxfFc45cd4hd+jNiIdVZnSOZng5hrrVEpRDeHf+iDewiCJXR2I9hsV5hwiqeJZKhpqbdxN2d5BZB/XZiJnDh6WviFegiLYPh572V6R3ZfgpiKhMhdAqCBcuiHpViHHxiLmPKJq5SHm8hopFiLUXiKKsiGlSgeXyeM7wZ22Ohuy1iMxmiL/IeLTKeLkyh1EKiK3MWN3Sh82hh2JNiNAXiM4ChvuagqSCiNZHb/jrLhiJD4iNWliIvYj/4YibtYa3WXjwQ5i7QIj98IipiYjKCUjhzYjCdIjDB4j9LnfNRYcxUpit6YhbdYccUmeMy4kB/Zh0ZWj5K4kUp2kOQYkiKZkCS5jhHphTEJky+pjkXmjsdXhhf5Yi25kh6pkDO5kxJZkiR5lDJJhIlHkc8IiAUJlb2okaiIk0ZJlKFYk674kGtVlB25dk0plGvIC0lmjr6ojwGZiPsokGq5lvzojypJlU04lT6ZlDfpisPolEpZjyKojF2ZlRNHj8gIl3RZX0AZlwY4lEt5jTT5inlpl4ipl6SCl3XJk9HIi9hmmA3zfmoolo6Zk7JYlV55/4R8CZF+2ZhfGZieYh4SsJmdKXssaZaF4AFqqAAP8JSh+Zd0aJWKaZNGSZm7CZrEl5pm93y0aZumyGKUaGGK0AHHiZyeCZwgeZfs6HCmOZm/KZo6iZVuuG3OaZFRiZm+yH64cgFcNHIvh57pqZ7ryZ7t6Z7vWS/iYp4A4IDdc3O3k5nhtFOuiZ25yZH+CZ3ZuZeMeZpXWYSLdoR4wpnP+Zo/GZuE8G/Mx58GOpKPqZsCioykyZXbeZ2e4YxhyaARCo3JKZXLWUjwsqDf2ZvRKY/TSaBbuWME2qHa6ZCagYbrkqIRCJ5NOJ6GQH+85JIuap3UeYeeqKExOqQEOJzZg/9kD6gI9dmG+PmgQdmfBcqbuGmlA5qkW1p64piSCIl84TmXAKBAEioXbJmWaJl93Nd93oemB2UNZWqZO5qRgPAAtukBvEZrcjqnK4qhLQqZFvqf11mlMxqcgOmlgrkHfEqidnCnXaSn/FmYc/Goeap3KsqojSqkHEqkfGh2R1plndqJbjWZCbqoAmCm9aYHlRqpDEphRMGql9ppZZqnxpJTUvJOKoqlhiqdgfqZGSqjohqP01Oq45gHtCoAtvpCApCrOnoHscp4cmmneCoA7icAsfeUClSrACBOX+RCzeqsuyqsDNmX2wmjoRqsSpqoqlkM2pqs3CoA3sqsTMiq1or/rZWJj5RKrRyiQOiXcZQnALT5rt86oVe6qZjIq6oJqq5Wob96kqYZpzgKAC6krOBKEdDar646qUm4rwDwhPP5r1t0pxygITZEsEjypmuqpnDKpv94Bi77HN7XriL7ACQLfxM7r8cHrR+rsdkFq/taAWiYqs46A6j6LjMAqQJQtODKnb7Kog3ZsE+Lh1yKsNr4oVVqDUWLAUebtEtLr0ArtD2rWz+btHSQo7r6BxMQsAV7qBcKoCDqsJ+arlTLlEvqibOhtmd7sdQqsWLLWfl5qnTAtE3rtlnaq4WbsHJLt4tJW2CJtZoBsExrn1E6OYBbjlU7t5z6ogsLb+NqksSK/5KKGqR9KqYmSqUUyriaC7Gcm42Ze6BjZ6qjO5YQmDbwabu3i7u5q7u7y7u9a3K0u36+K7zDS7zFa7zHi7z8ArzLy7zN67zPC73n0gBVGL3Va73Xi73Zq73by73d673fC77hK77jS77la77ni77pq77ry77t677vC7/xK7/zS7/1a7/363r+ir/7y7/9C71qSwfxFwj6KwAiV8B+AsAPoL/nsnqtSis5FQFDSx6DInKsabbnQsF24DAyxyQZDABnKLh+kqfxynwRIKtBMcLLdwdG4r9+NQGxZ0Z6d8ADTDE1NDnKJ8FMIk5oVEvnklMiN5sT650V8sMajHF+UsRkGv9MLsgkEIBGEGAsGuLAeOHEHgtEUTLFLXxAL3xDZzTAGiLF6wJylHe2eQEB93ou5+c9cidO+IYu+tucFDPDG3zCgCVyIBDBZ+jG5OEBijQBdVwUfdzFr6LFFAXA8KeGBczCNBwIHPJvS/IuF/CC57KArMc2T6hT3XYuM2wHuQKytaK/75LDuCNyk7d6gBwUDlCzd/DHtKLKHJArHII2hew9XIyz56ch0GDAuVQoSHzEtMKCcScAkxw0tRk0nBwlZVwhnKzLtDLDD8BFZvTJsVEoEtrKTFLNALDBlkzLMmTLtYnLr7BFesHLv2wUkbRzHjDEtKKEmsw2qozKfSFyInr/zCIHAWrImnucF88cTFEyzXgxARGAb9dcIQHtxrPczWxzyBeQyA6Qy3bQwCBXzuRRAZiMS5MDwvtJMQ0czxKxa7F3oxfMJB+Ns2mIxOsSe6ocwksCcvBis3RgzudMLy+I0Alt0zeN0zmt0zvN0z3t0z8N1EEt1ENN1EVt1EeN1Emt1EvN1E3t1E8N1VEt1VNN1VVt1VeN1Vmt1VvN1V3t1V8N1ls9KOO8JE9oQzR0s2Gt1kaNyR39Bwrk1ocgJeZp1oagtoO71nmd02YUwBGhITEdFHNtB3VdCOL0APqs14ndze/yfi/YwJTXQBwAwAytB6d8B084AU8IzbWZsxWd/3eDDX+YrIYAi6pmLdpG/NnCtLaKzdo3rbbKx2t5akPcNk5BW8DihKrHysl1nVMYgNu5BNcAcNceG68lvXOCTdzyOszcdth64EJo3NrR7b8t7QAuBHB5Iszj5EJnjYawIiUv+ITGQtsVoEVbJMU7x9jEbUNSjEbIXdfs7UIPEMR48C6KJN33vb/WfUMhV95cNN4jDC/N+t2X/a7j3d/jnd2ebUO43d5kXdcM3k7wMp/1jd8Vjr+kHcJSoobjrd9vvdsFTgfkTQcdcN7arFPqDa+57d43y+AtWEPVegfPbeEzPr+/bQf6jdklTd7YDQAgACuWDdriHeL9TaZTorYc8pTgdIBGaEhMSZ7brJyzwr3aNE7l7ZunGIfbHVABAKzZnYzJ8Gemf03gQl7bIw4Anq1TR+LkaNScSr7mAB7lho3YVU7n8BvehxDcPTXcdc7n8UvbdADdrYLcvSTbfW7oh47oia7oi87oje7ojw7pkS7pk07plW7pl47pma7pm87pne7pnw7qoS7qo07qpW7qp47qTB0EADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     WHO: World Health Organization.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention based on data from the WHO Child Growth Standards.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 587px\">",
"   <div class=\"ttl\">",
"    Length-for-age percentiles, boys birth to 24 months, WHO growth standards",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 567px; height: 459px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     WHO: World Health Organization.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention based on data from the WHO Child Growth Standards.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 582px\">",
"   <div class=\"ttl\">",
"    Head circumference-for-age percentiles, boys 0 to 24 months, WHO growth standards",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 562px; height: 423px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     WHO: World Health Organization.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention based on data from the WHO Child Growth Standards.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 583px\">",
"   <div class=\"ttl\">",
"    Weight-for-length percentiles, boys 0 to 24 months, WHO growth standards",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 563px; height: 508px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     WHO: World Health Organization.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention based on data from the WHO Child Growth Standards.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33898=[""].join("\n");
var outline_f33_6_33898=null;
var title_f33_6_33899="DRESS lab tests and imaging";
var content_f33_6_33899=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86762&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommended laboratory and imaging investigations in patients with suspected drug reaction with eosinophilia and systemic symptoms (DRESS)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Confirmation of diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Exclusion of alternative diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Assessment of organ involvement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        <p>",
"         CBC with differential including research of atypical lymphocytes",
"        </p>",
"        <p>",
"         Inflammation markers",
"        </p>",
"        Viral infection (PCR for HHV-6, HHV-7, CMV, EBV)",
"       </td>",
"       <td rowspan=\"2\">",
"        <p>",
"         Blood cultures",
"        </p>",
"        <p>",
"         Antinuclear antibodies",
"        </p>",
"        <p>",
"         <em>",
"          Serology for viral hepatitis",
"         </em>",
"        </p>",
"        <em>",
"         Lymph node biopsy",
"        </em>",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Minimal screening",
"         </strong>",
"        </p>",
"        Liver function test, creatinine, urinary protein and cells, pulse oximetry, creatine kinase, troponin, ECG",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          Additional investigations",
"         </strong>",
"        </p>",
"        <p>",
"         Prothrombin time/INR",
"        </p>",
"        <p>",
"         <em>",
"          CT scan",
"         </em>",
"        </p>",
"        <p>",
"         <em>",
"          Sonography",
"         </em>",
"        </p>",
"        <p>",
"         <em>",
"          Endoscopy",
"         </em>",
"        </p>",
"        <em>",
"         Biopsy",
"        </em>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    In italics: secondary investigations based upon suspected organ involvement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33899=[""].join("\n");
var outline_f33_6_33899=null;
var title_f33_6_33900="Characteristics of pancreatic neuroendocrine tumors";
var content_f33_6_33900=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F69622&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F69622&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Characteristics of pancreatic neuroendocrine tumors",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Tumor",
"        <br/>",
"        (secreted product)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical presentation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Pancreatic localization",
"        <br/>",
"        (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Malignancy",
"        <br/>",
"        (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        MEN-1-associated",
"        <br/>",
"        (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Incidence in MEN-1",
"        <br/>",
"        (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Insulinoma (insulin)",
"       </td>",
"       <td>",
"        Whipple's triad*",
"       </td>",
"       <td>",
"        &gt;97",
"       </td>",
"       <td>",
"        &lt;10",
"       </td>",
"       <td>",
"        5-10",
"       </td>",
"       <td>",
"        21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gastrinoma (gastrin)",
"       </td>",
"       <td>",
"        Zollinger-Ellison syndrome",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        25-60",
"       </td>",
"       <td>",
"        60-90",
"       </td>",
"       <td>",
"        20-30",
"       </td>",
"       <td>",
"        54",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VIPoma (vasoactive intestinal polypeptide)",
"       </td>",
"       <td>",
"        Verner-Morrison syndrome",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        &gt;90",
"       </td>",
"       <td>",
"        40-70",
"       </td>",
"       <td>",
"        6",
"       </td>",
"       <td>",
"        17",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Glucagonoma (glucagon)",
"       </td>",
"       <td>",
"        Glucagonoma syndrome",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        &gt;95",
"       </td>",
"       <td>",
"        50-80",
"       </td>",
"       <td>",
"        1-20",
"       </td>",
"       <td>",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Somatostatinoma (somatostatin)",
"       </td>",
"       <td>",
"        Somatostatinoma syndrome",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        55",
"       </td>",
"       <td>",
"        &gt;70",
"       </td>",
"       <td>",
"        45-50",
"       </td>",
"       <td>",
"        &lt;5",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Hypoglycemic symptoms, low blood glucose levels, reversible upon glucose intake.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Diarrhea, hypergastrinemia, gastric acid hypersecretion, peptic ulcer diathesis.",
"      <br>",
"       &Delta; WDHA syndrome: watery diarrhea, hypokalemia, achlorhydria.",
"       <br>",
"        <span class=\"lozenge\">",
"         &loz;",
"        </span>",
"        4D syndrome: necrolytic migrating erythematous dermatitis, diabetes, deep vein thrombosis, depression.",
"        <br>",
"         &sect; (Questionable) elevated somatostatin serum levels, diabetes, hypochlorhydria, cholelithiasis, dia-/steatorrhea, anemia, weight loss.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from:",
"     <br>",
"      <ol>",
"       <li>",
"        Jensen RT. Pancreatic endocrine tumors: Recent advances. Ann Oncol 1999; 10:170.",
"       </li>",
"       <li>",
"        Ehehalt F, Saeger HD, Schmidt CM, Gr&uuml;tzmann R. Neuroendocrine tumors of the pancreas. Oncologist 2009; 14:456.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33900=[""].join("\n");
var outline_f33_6_33900=null;
var title_f33_6_33901="Contents: ID calculators";
var content_f33_6_33901=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?15/21/15710\">",
"       Infectious Diseases",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       ID calculators",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			ID calculators",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Clinical Criteria",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/62/41952\">",
"           Calculator: CURB-65 pneumonia severity score",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/42/44705\">",
"           Calculator: Community-acquired pneumonia severity index (PSI) for adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/35/4656\">",
"           Calculator: Diagnosis of endocarditis - Duke criteria for definite endocarditis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/34/14881\">",
"           Calculator: Multinational Association for Supportive Care in Cancer (MASCC) risk index for patients with neutropenic fever",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Medical Equations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/41/2706\">",
"           Calculator: Ideal body weight (method of Devine) and dosing weight for adults",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-645B121A2C-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f33_6_33901=[""].join("\n");
var outline_f33_6_33901=null;
var title_f33_6_33902="Staging cervical cancer";
var content_f33_6_33902=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F79282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F79282&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Staging cervical cancer (TNM and International Federation of Gynecology and Obstetrics [FIGO])",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Primary tumor (T)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        TNM categories",
"       </td>",
"       <td class=\"subtitle2\">",
"        FIGO stages",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"2\">",
"        Definition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        TX",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td colspan=\"2\">",
"        Primary tumor cannot be assessed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T0",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td colspan=\"2\">",
"        No evidence of primary tumor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tis*",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td colspan=\"2\">",
"        Carcinoma in situ (preinvasive carcinoma)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        T1",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        I",
"       </td>",
"       <td class=\"sublist_other_start\" colspan=\"2\">",
"        Cervical carcinoma confined to uterus (extension to corpus should be disregarded)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        T1a",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"sublist_other\">",
"        IA",
"       </td>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        Invasive carcinoma diagnosed only by microscopy. Stromal invasion with a maximum depth of 5.0 mm measured from the base of the epithelium and a horizontal spread of 7.0 mm or less. Vascular space involvement, venous or lymphatic, does not affect classification.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T1a1",
"       </td>",
"       <td class=\"sublist_other\">",
"        IA1",
"       </td>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T1a2",
"       </td>",
"       <td class=\"sublist_other\">",
"        IA2",
"       </td>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        Measured stromal invasion more than 3.0 mm and not more than 5.0 mm in depth with a horizontal spread 7.0 mm or less",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        T1b",
"       </td>",
"       <td class=\"sublist_other\">",
"        IB",
"       </td>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T1b1",
"       </td>",
"       <td class=\"sublist_other\">",
"        IB1",
"       </td>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        Clinically visible lesion 4.0 cm or less in greatest dimension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T1b2",
"       </td>",
"       <td class=\"sublist_other\">",
"        IB2",
"       </td>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        Clinically visible lesion more than 4.0 cm in greatest dimension",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        T2",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        II",
"       </td>",
"       <td class=\"sublist_other_start\" colspan=\"2\">",
"        Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        T2a",
"       </td>",
"       <td class=\"sublist_other\">",
"        IIA",
"       </td>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        Tumor without parametrial invasion or involvement of the lower one-third of the vagina",
"        <sup>",
"         [1,2]",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T2a1",
"       </td>",
"       <td class=\"sublist_other\">",
"        IIA1",
"       </td>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        Clinically visible lesion 4.0 cm or less in greatest dimension with involvement of less than the upper two-thirds of the vagina",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        T2a2",
"       </td>",
"       <td class=\"sublist_other\">",
"        IIA2",
"       </td>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        Clinically visible lesion more than 4.0 cm in greatest dimension with involvement of less than the upper two-thirds of the vagina",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        T2b",
"       </td>",
"       <td class=\"sublist_other\">",
"        IIB",
"       </td>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        Tumor with parametrial invasion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        T3",
"       </td>",
"       <td class=\"sublist_other_start\">",
"        III",
"       </td>",
"       <td class=\"sublist_other_start\" colspan=\"2\">",
"        Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or nonfunctioning kidney",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        T3a",
"       </td>",
"       <td class=\"sublist_other\">",
"        IIIA",
"       </td>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        Tumor involves lower third of vagina, no extension to pelvic wall",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        T3b",
"       </td>",
"       <td class=\"sublist_other\">",
"        IIIB",
"       </td>",
"       <td class=\"sublist_other\" colspan=\"2\">",
"        Tumor extends to pelvic wall and/or causes hydronephrosis or nonfunctioning kidney",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T4",
"       </td>",
"       <td>",
"        IVA",
"       </td>",
"       <td colspan=\"2\">",
"        Tumor invades mucosa of bladder or rectum, and/or extends beyond true pelvis (bullous edema is not sufficient to classify a tumor as T4)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Regional lymph nodes (N)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        TNM categories",
"       </td>",
"       <td class=\"subtitle2\">",
"        FIGO stages",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"2\">",
"        Definition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        NX",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td colspan=\"2\">",
"        Regional lymph nodes cannot be assessed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td colspan=\"2\">",
"        No regional lymph node metastasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        N1",
"       </td>",
"       <td>",
"       </td>",
"       <td colspan=\"2\">",
"        Regional lymph node metastasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Distant metastasis (M)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        TNM categories",
"       </td>",
"       <td class=\"subtitle2\">",
"        FIGO stages",
"       </td>",
"       <td class=\"subtitle2\" colspan=\"2\">",
"        Definition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        M0",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td colspan=\"2\">",
"        No distant metastasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        M1",
"       </td>",
"       <td>",
"        IVB",
"       </td>",
"       <td colspan=\"2\">",
"        Distant metastasis (including peritoneal spread, involvement of supraclavicular, mediastinal, or paraaortic lymph nodes, lung, liver, or bone)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Anatomic stage/prognostic groups",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage 0*",
"       </td>",
"       <td>",
"        Tis",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage I",
"       </td>",
"       <td>",
"        T1",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage IA",
"       </td>",
"       <td>",
"        T1a",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage IA1",
"       </td>",
"       <td>",
"        T1a1",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage IA2",
"       </td>",
"       <td>",
"        T1a2",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage IB",
"       </td>",
"       <td>",
"        T1b",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage IB1",
"       </td>",
"       <td>",
"        T1b1",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage IB2",
"       </td>",
"       <td>",
"        T1b2",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage II",
"       </td>",
"       <td>",
"        T2",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage IIA",
"       </td>",
"       <td>",
"        T2a",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage IIA1",
"       </td>",
"       <td>",
"        T2a1",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage IIA2",
"       </td>",
"       <td>",
"        T2a2",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage IIB",
"       </td>",
"       <td>",
"        T2b",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage III",
"       </td>",
"       <td>",
"        T3",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage IIIA",
"       </td>",
"       <td>",
"        T3a",
"       </td>",
"       <td>",
"        N0",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Stage IIIB",
"       </td>",
"       <td>",
"        T3b",
"       </td>",
"       <td>",
"        Any N",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        T1-3",
"       </td>",
"       <td>",
"        N1",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage IVA",
"       </td>",
"       <td>",
"        T4",
"       </td>",
"       <td>",
"        Any N",
"       </td>",
"       <td>",
"        M0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stage IVB",
"       </td>",
"       <td>",
"        Any T",
"       </td>",
"       <td>",
"        Any N",
"       </td>",
"       <td>",
"        M1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note: cTNM is the clinical classification, pTNM is the pathologic classification.",
"    <div class=\"footnotes\">",
"     * FIGO no longer includes Stage 0 (Tis).",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      All macroscopically visible lesions-even with superficial invasion-are T1b/IB.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Pecorelli S. Revised FIGO staging for carcinoma of the cervix. Int J Gynecol Obstet 2009; 105:107.",
"       </li>",
"       <li>",
"        Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet 2009; 105:103.",
"       </li>",
"      </ol>",
"      Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33902=[""].join("\n");
var outline_f33_6_33902=null;
var title_f33_6_33903="Osteoid osteoma CT";
var content_f33_6_33903=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58624&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Osteoid osteoma computed tomography",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 304px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computed tomography demonstrates the lucent nidus characteristic of osteoid osteoma with surrounding cortical thickening and periosteal reaction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of the Department of Diagnostic Imaging, Texas Children's Hospital.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f33_6_33903=[""].join("\n");
var outline_f33_6_33903=null;
